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In   vertebrates,   there   is   a   large   family   of   Eph   receptor   tyrosine   kinases   and   their  
ephrin  ligands,  which  have  complex  and  varied  roles  during  development  and  in  adult  
homeostasis.  The  most  researched  role  of  Eph  receptors  and  ephrins  is  in  control  of  
cell  migration   through   the   regulation   of   the   actin   cytoskeleton   and   cell   adhesion.  
More  recently,  it  has  been  found  that  in  some  tissues  Eph-­ephrin  signalling  also  leads  
to   changes   in  gene   transcription,   for  example   to   control   cell   differentiation.   In   the  
zebrafish  hindbrain,  Eph   receptors  and  ephrins  are  expressed  segmentally   in   the  
rhombomeres   in   a   complementary   pattern   with   respect   to   their   binding   partner.  
Signalling  via  this  pathway  induces  a  unique  cell  population  to  arise  at  rhombomere  
borders,  known  as  the  boundary  cells.    
  
In  order  to  understand  more  about  Eph  receptor  and  ephrin  function  in  the  hindbrain,  
RNA-­sequencing   was   carried   out   on   dissected   hindbrains   of   zebrafish   with  
endogenous   Eph-­ephrin   signalling   and   fish   that   lack   Eph-­ephrin   signalling.   The  
transcriptional  profiles  were  then  compared  to  identify  potential  downstream  targets,  
which  were   verified   using  RT-­qPCR   and   in   situ   hybridisation.   This   identified   four  
genes  regulated  downstream  of  Eph-­ephrin  signalling  that  are  markers  of  progenitor  
cells   and   neural   differentiation.   When   Eph-­ephrin   signalling   is   disrupted   the  
expression  of   these  genes  alters,  and   the  expression  pattern  of  one  gene,  mdka,  
was  consistent  with  loss  of  hindbrain  boundary  cells.  
  
To  investigate  this  observation  further,  the  expression  of  progenitor  and  neurogenic  
markers  was  determined  when  Eph-­ephrin  signalling  was  disrupted.  This  supported  
previous  studies  which  found  that  Eph-­ephrin  signalling  is  required  for  formation  of  
boundary   cells   and   that   boundary   cell   loss   results   in   ectopic   neurogenesis.   In  
addition,  it  was  found  that  ectopic  neurogenesis  was  accompanied  by  the  depletion  
of  nestin-­expressing  neural  progenitor  cells  at  later  stages  of  development.  Together  
these   findings   support   previous   work   showing   that   hindbrain   boundary   cells   are  





Eph-­ephrin   signalling   is   important   for   normal   development   as   it   is   active   in  many  
tissues  and  regulates  a  variety  of  cellular  processes.  It  has  been  well  characterised  
that  signalling  results  in  regulation  of  the  actin  cytoskeleton  and  cell  adhesion  leading  
to   cell   responses   such   as   cell   migration.   This   ensures   that   cell   populations   are  
organised  at  the  correct  location  as  well  as  forming  boundaries  between  different  cell  
populations.   In   addition,   Eph-­ephrin   signalling   has   also   been   shown   to   regulate  
transcription   in   many   tissues.   In   the   hindbrain   Eph-­ephrin   signalling   prevents  
intermingling  between  segments  as  well  as  being  responsible  for  the  induction  of  a  
distinct  cell  population  that  arise  at  the  borders  of  segments.  As  little  is  known  about  
the  genes  that  are  regulated  by  Eph-­ephrin  signalling,  identifying  these  will  help  to  
contribute   to   understanding   hindbrain   development.   Understanding   Eph-­ephrin  
signalling   is   also   important   as   when   signalling   is   mis-­regulated   this   can   have  
detrimental  consequences.  During  early  development,  this  can  result  in  the  incorrect  
formation  of  head  structures  as  signalling  is  responsible  for  guiding  the  neural  crest  
cells  to  the  correct  location.  Regulation  of  Eph-­ephrin  signalling  is  also  important  later  
in   life  and  a  mouse  model   for  Alzheimer’s  disease  shows   that  Eph   receptors  are  
expressed  at   the   incorrect   levels.  Finally,  Eph-­ephrin  signalling   is  mis-­regulated   in  
many  types  of  cancers,  and  leads  to  changes  in  cell  migration.  
  
In  this  project,   the  role  of  Eph-­ephrin  signalling  in  regulating  gene  expression  was  
investigated  in  the  context  of  hindbrain  development.  This  has  unveiled  novel  genes  
that  are  regulated  downstream  of  Eph-­ephrin  signalling,  and  based  on  their  function  
imply   that   signalling   is   regulating   the   progression   of   neurogenesis.   Further  
investigation   has   shown   that   Eph-­ephrin   signalling   is   important   for   patterning   of  
neurogenesis  via   the   induction  of  boundary  cells.  These   findings  will  contribute   to  
understanding  hindbrain  development  and  the  role  that  Eph-­ephrin  signalling  plays  
in  regulating  hindbrain  neurogenesis.  
  
During   this   PhD,   I   have   generated   gene   expression   data   by   RNA-­sequencing   to  
identify  transcriptional  targets  of  Eph-­ephrin  signalling.  Whilst  I  was  able  to  validate  
several  of   these   target  genes,   this   list  still  holds  many  possibilities   for  avenues  of  
further   research.  One  approach  could  be   to   investigate   the  significance  of  altered  
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expression  of  other  genes  found  by  RNA-­sequencing  analysis.  In  addition,  the  quality  
control  method  designed  for  selecting  hindbrains  with  low  contamination  from  tissues  
surrounding  the  hindbrain  continues  to  be  used  in  the  lab  for  future  RNA-­sequencing  
experiments.   Finally,   during   this   PhD   I   have   communicated   my   research   by  
presenting  posters  at  several  meetings,  including  the  18th  International  Congress  of  
Developmental  Biology,  the  Young  Embryologist  Meeting  and  student  symposia  at  
the  Francis  Crick  Institute.  
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Chapter  1.   Introduction  
The   aim   of   this   PhD   project   has   been   to   identify   and   investigate   the   role   of  
transcriptional   targets   of   Eph   receptor   and   ephrin   signalling   during   zebrafish  
hindbrain   development.   In   this   chapter,   the   background   of   the   project   will   be  
discussed,   including  an  overview  of  Eph-­ephrin  signalling  and  zebrafish  hindbrain  
development,   as   well   as   the   studies   that   demonstrate   the   role   of   Eph-­ephrin  
signalling  in  regulating  transcription.  
  
1.1   Eph  receptor  and  ephrin  signalling  
Since  the  first  Eph  receptor  was  cloned  from  human  carcinomas  (Hirai  et  al.,  1987),  
there   has   been   an   increasing   understanding   of   the   roles   in   which   Eph-­ephrin  
signalling   plays,   as   well   as   the   downstream   pathways   that   are   activated.   Eph  
receptors  are  a  type  of  receptor  tyrosine  kinase  and  comprise  the  largest  subfamily  
of   this  group.  Receptor   tyrosine  kinases  are   typically   receptors   for  growth   factors,  
cytokines   or   hormones   and   have   many   roles   during   development   and   adult  
homeostasis   (Robinson   et   al.,   2000).  Eph   receptors   are   activated   by   their   ephrin  
ligands  and  through  downstream  signalling  pathways  lead  to  cellular  responses,  for  
example   through  regulation  of   the  actin  cytoskeleton  and  cell  adhesion  (Meima  et  
al.,  1997;;  Xu  and  Henkemeyer,  2009;;  Park  and  Lee,  2015).  This  drives  changes  in  
cell  behaviour  such  as  cell  migration,  axon  path  finding,  and  angiogenesis  (Pandey  
et  al.,  1995;;  Wang  and  Anderson,  1997;;  Smith  et  al.,  1997).    
  
1.1.1   Classes  and  domain  structure  of  Eph  receptors  and  ephrins  
Eph  receptor  and  ephrin  proteins  are  comprised  of  several  domains  (Figure  1),  and  
are   classified   into   A   and   B   subclasses   (Gale   et   al.,   1996).   Both   ephrinAs   and  
ephrinBs  are  comprised  of  an  extracellular   receptor  binding  domain,  but  ephrinAs  
are   membrane   bound   via   a   glycosylphosphatidylinositol   (GPI)   anchor   whereas  
ephrinBs   have   a   transmembrane   domain   (TM)   and   cytoplasmic   domain.   The  
cytoplasmic   domain   of   ephrinBs   includes   conserved   tyrosine   residues   and   a   c-­
terminal  motif  that  can  be  bound  by  PDZ  domain  proteins.  Eph  receptors  all  contain  




a  ligand  binding  domain,  a  Sushi  and  EGF  domain  which  together  make  the  cysteine-­
rich  domain,  two  fibronectin  domains  (FN),  a  TM,  a  tyrosine  kinase  domain,  a  sterile  
alpha  motif  (SAM)  and  a  PDZ  protein  binding  motif.  Eph  receptors  are  categorised  
into  A  and  B  subclasses  based  on  which  subclass  of  ephrins  they  preferentially  bind  
and  on  their  sequence  similarity.  Eph  receptors  and  ephrins  bind  multiple  partners  
within   the  same  subclass,  but  at  different  affinities  (Noberini  et  al.,  2012).  Binding  
also  occurs  between  specific  protein  in  different  subclasses,  for  example  EphB2  and  
ephrinA5,  and  EphA4  and  ephrinB  ligands  (Gale  et  al.,  1996;;  Himanen  et  al.,  2004;;  
Noberini  et  al.,  2012).  
  





Figure  1  Eph  receptor  and  ephrin  protein  domains  
Schematic  of  ephrinA  and  ephrinB  interacting  with  an  Eph  receptor.  Extracellular  receptor  binding  
domain  (RBD),  glycosylphosphatidylinositol   (GPI)  anchor,   ligand  binding  domain  (LBD),  sterile  
alpha  motif  (SAM).  Figure  based  on  Egea  and  Klein  (2007).  
  
Eph   receptors   and   ephrins   are   conserved   across   vertebrates   and   invertebrates.  
There  are  13  members  of  the  human  Eph  receptor  tyrosine  kinase  family,  nine  EphA  
receptors  (EphA1-­8  and  10)  and  five  EphB  receptors  (EphB1-­4  and  6),  and  there  are  




five  ephrinA   ligands   (ephrinA1-­5)  and   three  ephrinBs   (ephrinB1-­3)   (Kullander  and  
Klein,  2002;;  Zerbino  et  al.,  2018).  Rodents  have  nine  EphA  receptors  (A1-­8  and  10)  
and  five  EphB  receptors  (EphB1-­4  and  6),  and  five  ephrinAs  (ephrinA1-­5)  and  three  
ephrinBs   (ephrinB1-­3)   (Zerbino   et   al.,   2018).   In   zebrafish,   there   are   six   EphA  
receptors  (EphA3-­8)  and  five  EphB  receptors  (EphB1-­4  and  6),  and  four  ephrinAs  
(ephrinA1-­3,  5)  and  three  ephrinBs  (ephrinB1-­3)  (Zerbino  et  al.,  2018).  In  C.  elegans,  
there  is  one  Eph  receptor  and  four  ephrin  ligands  (George  et  al.,  1998;;  Wang  et  al.,  
1999;;  Chin-­Sang  et  al.,  1999),  and  in  Drosophila  there  is  only  one  Eph  receptor  and  
one  ephrin  (Scully  et  al.,  1999;;  Bossing  and  Brand,  2002).  
  
1.1.2   Eph-­ephrin  signalling  activation  
Due   to   the   membrane   bound   nature   of   Eph   receptors   and   ephrins,   signalling   is  
limited  to  cells  that  are  in  contact  with  one  another.  Eph-­ephrin  binding  can  occur  in  
cis  and  trans  (Dudanova  and  Klein,  2011).  When  an  Eph  receptor  and  ephrin  bind  
from  the  same  cell  signalling   is   inhibited,  which   is   termed  cis   inhibition  (Yin  et  al.,  
2004;;  Falivelli  et  al.,  2013)  (Figure  2).  When  signalling  occurs  between  neighbouring  
cells  where  one  cell  expresses  an  Eph  receptor  and  the  adjacent  cell  expresses  an  
ephrin  ligand  of  a  binding  pair,  this  results  in  trans  activation  (Marquardt  et  al.,  2005)  
(Figure   2).   Upon   binding,   both   Eph   and   ephrins   become   clustered   leading   to  
activation   (Lisabeth  et   al.,   2013),   unlike  other   receptor   tyrosine   kinases   that   form  
dimers,  Eph  receptors  and  ephrins  form  of  higher  order  clusters,  and  the  amount  of  
clustering  may  influence  the  cell  response  (Schaupp  et  al.,  2014).  





Figure  2  Cis  and  trans  interaction  of  Eph  receptors  and  ephrins  
(A)  Trans  interaction  of  Eph  receptor  (blue)  and  ephrin  (orange)  from  adjacent  cells  resulting  in  
the  activation  of  Eph-­ephrin  signalling.  (B)  Cis  interaction  of  Eph  receptor  and  ephrin  within  the  
same  cell  resulting  in  the  inhibition  of  Eph-­ephrin  signalling.  Figure  based  on  Arvanitis  and  Davy  
(2008).  
  
The   first   crystal   structure   of   Eph-­ephrin   binding   showed   that   Eph   receptors   and  
ephrins  bind  in  a  2:2  stoichiometry.  Upon  binding  of  an  ephrin  to  an  Eph  receptor,  
dimerization   occurs   at   the   plasma   membrane,   which   then   forms   a   tetramer  
comprised  of  two  Eph  receptors  and  two  ephrins  (Himanen  et  al.,  2001).  The  way  in  
which  this  structure  forms  is  important  for  higher  order  clustering,  which  is  essential  
for  signalling  to  occur  (Davis  et  al.,  1994).    
  




1.1.3   Downstream  signalling  from  Eph  receptors  and  ephrins  
Eph-­ephrin   signalling   is   bidirectional,   allowing   messages   to   be   relayed   into   the  
ephrin-­expressing  cell  as  well  as   the  Eph-­expressing  cell.  Reverse  signalling  was  
first  discovered  when   five  conserved   tyrosine  residues  situated   in   the  cytoplasmic  
domain  of  ephrinBs  were  identified  and  further   investigation  revealed  that  three  of  
these   can   be   phosphorylated   and   transmit   downstream   signalling   (Holland   et   al.,  
1996;;   Bruckner   et   al.,   1997;;   Kalo   and   Pasquale,   1999).   A   study   identifying  
phosphorylated  proteins  downstream  of  EphB2  and  ephirnB1  signalling  showed  that  
over  300  proteins  had  altered  phosphorylation  upon  activation  and  that  just  under  a  
third  of  these  were  shared  between  forward  and  reverse  signalling  (Jorgensen  et  al.,  
2009).  The  most  understood  pathways  downstream  of  Eph-­ephrin  signalling  regulate  
the  actin  cytoskeleton  and  adhesion,  which  are  summarised  in  Figure  3  for  EphB-­
ephrinB  signalling  and  are  discussed  in  more  detail  below.    
  
Forward   signalling   through   the  Eph   receptor   is   in   part   dependent   on   the   tyrosine  
kinase  domain,  which   leads   to  autophosphorylation  of   the  activated  Eph   receptor  
(Egea  and  Klein,  2007).  The  phosphorylated  tyrosine  residues  are  then  able  to  recruit  
adaptor  proteins  to  the  receptor  which  then  become  phosphorylated  and  are  able  to  
transmit   signals.   This   includes   SH2   domain   proteins   which   lead   to   activation   of  
phosphorylation  cascades,  for  example  via  Nck  which  then  results  in  c-­Jun  kinase  
activation  (Stein  et  al.,  1998)  (Figure  3).  Other  adaptor  proteins  include  Intersectin,  
which  forms  a  complex  with  EphB2  and  Neural  Wiskott-­Aldrich  syndrome  (N-­WASP),  
and   regulates   the   actin   cytoskeleton   for   dendritic   spine   formation   (Irie   and  
Yamaguchi,   2002;;  Mohamed   et   al.,   2012)   (Figure   3).   In   addition,   focal   adhesion  
kinase  (FAK)   is  kinase-­dependent  and  binds   to   the  SH2  domain  of  Eph  receptors  
and  also   leads  to  changes  in  the  actin  cytoskeleton  to  regulate  the  morphology  of  
dendritic  spines  (Moeller  et  al.,  2006;;  Shi  et  al.,  2009).  
  
Ephexin   is   another   protein   that   interacts   with   Eph   receptors   and   is   a   guanine  
exchange   factor   (GEF)   (Shamah   et   al.,   2001),   which   then   activates   Rho   family  
GTPases,  including  Rho,  Rac  and  cdc42.  These  are  active  when  bound  to  GTP  and  
inactive  when  bound  to  GDP  (Figure  3).  This  family  of  GTPases  then  regulate  the  
actin  cytoskeleton  and  are  important  for  processes  such  a  filopodia  and  lamelipodia  




extension   and   retraction,   as   well   as   growth   cone   collapse   (Kozma   et   al.,   1997;;  
Moeller  et  al.,  2006;;  Tolias  et  al.,  2007).  In  addition,  another  GEF,  TIAM1,  is  activated  
by   binding   to   Eph   receptors,   which   results   in   increased   Rac1   activity   as   well   as  
facilitating  Eph  receptor  and  ephrin  endocytosis  and  neurite  outgrowth  (Tanaka  et  
al.,  2004;;  Boissier  et  al.,  2013)  (Figure  3).  
  
Eph  downstream  signalling  can  also  regulate  the  mitogen  activated  protein  kinase  
(MAPK)   pathway   by   either   activating   or   inhibiting   this   pathway.   The   GTPase-­
activating   protein   (GAP)   RasGAP   activates   Ras,   which   then   activates   MAPK  
signalling.   Active   Eph   receptors   have   been   shown   to   block   MAPK   signalling   by  
binding   to  RasGAP,   resulting   in  cell  differentiation  (Haupaix  et  al.,  2013).  Another  
study  has  reported  an  inhibition  of  MAPK  signalling  resulting  in  growth  cone  collapse  
(Elowe   et   al.,   2001).   As   well   as   repressing   MAPK   signalling,   there   are   some  
experiments   showing   that  MAPK   signalling   can   be   activated   downstream   of   Eph  
receptors,   which   induces   cellular   processes   such   as   cell   proliferation,   cell  
differentiation  and  cell  survival  (Zisch  et  al.,  2000;;  Poliakov  et  al.,  2008;;  Bush  and  
Soriano,  2010).    
  
Signalling   via  Eph   receptors   can   also   occur   independently   of   the   kinase   domain.  
Kinase  dependent  and  kinase  independent  signalling  can  induce  different  responses  
(Kullander  et  al.,  2001),  or  contribute  to  the  same  response,  resulting  in  blocking  of  
kinase  dependent   and   independent   signalling   having  a  more  dramatic   phenotype  
(Grossman   et   al.,   2013).  One   pathway   that   is   kinase   independent   and   is   shared  
between  Eph  receptor  and  ephrin  signalling  is  via  Dishevelled  (Dvl),  which  interacts  
with  the  PDZ  domain  binding  motif  of  Eph  receptors  or  ephrins.  This  then  activates  
RhoA  and  causes  cell  responses  such  as  cell  segregation  and  cell  migration  (Tanaka  
et  al.,  2003;;  Lee  et  al.,  2006)  (Figure  3).    
  
Reverse  signalling   through   the   two  ephrin   subclasses  differs  because  of  how   the  
ephrins  are  bound  to  the  membrane:  via  a  GPI  anchor  or  transmembrane  spanning  
domain,   for   ephrinAs   and   ephrinBs,   respectively.   EphrinBs   do   not   have   a   kinase  
domain   and   are   phosphorylated   by   Src   family   kinases   that   recruit   SH2   domain  
proteins  (Palmer  et  al.,  2002;;  Daar,  2012)  (Figure  3).  One  adaptor  protein  that  binds  
phosphorylated   ephrinBs   is   Grb4,   which   binds   to   ephrinB1   when   activated   upon  




binding  the  EphB2  receptor.  Downstream  signalling  regulates  spine  morphogenesis,  
synapse  formation  and  focal  adhesion  disassembly  altering  cell  shape  (Cowan  and  
Henkemeyer,  2001;;  Segura  et  al.,  2007;;  Xu  and  Henkemeyer,  2009).    
  
Signalling  via  ephrinBs  can  also  be  mediated  via  the  PDZ  domain  binding  motif  which  
can   interact   with   PDZ   containing   proteins.   It   has   been   suggested   that   it   is  
constitutively   activated   and   some   of   the   proteins   involved   have   been   identified,  
however,  this  has  not  been  resolved.  One  mediator  is  Rgs3  which  binds  to  the  PDZ  
domain  binding  motif  of  ephrinB1  causing   inhibition  of  G-­protein  coupled   receptor  
signalling.  This  is  important  for  the  cell  response  to  neuronal  guidance  cues  such  as  
SDF-­1   (Lu   et   al.,   2001;;   Bush   and   Soriano,   2009;;   Yu   et   al.,   2016).   An   additional  
signalling   pathway   downstream   of   ephrinBs   is   the   Par   polarity   complex,   which  
regulates   cell-­cell   junctions   and   is   important   for   cell   adhesion   and   migration  
(McCaffrey  and  Macara,   2012).  Studies  have   revealed   that  ephrinB1  can   interact  
with  Par6  which  prevents  cdc42-­Par6  binding  and  results  in  aPKC  inhibition  of  tight  
junctions  (Yamanaka  et  al.,  2001).  When  ephrinB1  is  phosphorylated  and  becomes  
activated,  it  is  no  longer  able  to  bind  Par6  enabling  the  cdc42-­Par6  complex  to  form  
and  activate  aPKC  (Lee  et  al.,  2008).  
  
For  ephrinAs,  reverse  signalling  is  yet  to  be  deciphered,  but  it  has  been  suggested  
that  signalling  occurs  through  transmembrane  proteins  that  associate  with  ephrinAs  
(Pasquale,  2008).  Reverse  signalling  by  ephrinAs  has  also  been  shown  to  activate  
Src  family  kinases,  as  discussed  for  ephrinBs  (Holen  et  al  2008).  In  addition,  some  
of   the  proteins   that   interact  with  ephrinAs  have  been   identified.  This   includes  p75  
neurotrophin  receptor  (p75NTR),  TrkB  and  Ret  to  mediate  signalling  that  is  involved  in  
cell  responses  such  as  axon  guidance  (Lim  et  al.  2008;;  Marler  et  al.  2008;;  Bonanomi  
et  al.  2012).  When  EphAs  are  activated  by  their  ephrinA  ligands,  this  causes  ephrinA  
and   p75NTR   to   colocalise,   which   results   in   the   phosphorylation   of   the   Src   family  
kinase,  Fyn,  which  causes  cell   repulsion  (Lim  et  al.,  2008).   In  retinal  ganglion  cell  
neurons,  Trk  has  been  shown  to  interact  with  ephrinA5,  which  increases  the  activity  
of  Akt  and  results   in   increased  axonal  branching  (Marler  et  al.,  2008).  Finally,  Ret  
and  ephrin-­As  have  been  shown  to  colocalise  leading  to  increased  phosphorylation  
of  Ret  and  the  cell  to  respond  to  chemoattractive  cues  (Bonanomi  et  al.,  2012).  





Figure  3  Downstream  pathways  of  EphB-­ephrinB  signalling  
Pathways  that  are  regulated  downstream  of  EphB  and  ephrinB  signal  activation,  with  the  focus  
on  pathways  that  regulate  the  actin  cytoskeleton  and  cell  adhesion.  Forward  signalling  is  relayed  
into  the  EphB-­expressing  cell  (pathways  shown  in  blue)  and  reverse  signalling  is  relayed  into  the  
ephrinB  expressing  cell  (pathways  shown  in  orange).  




1.1.4   Eph-­ephrin  internalisation  and  cleavage  
It   was   shown   that   ephrinA2   is   cleaved   by   the   metalloprotease   ADAM10,   which  
terminates  EphA  signalling  (Hattori  et  al.,  2000)  (Figure  3).  Later  studies  showed  that  
after   Eph   receptor   and   ephrinB   binding   and   signal   activation,   the   receptor-­ligand  
complex  can  be  internalised  into  either  the  Eph-­expressing  or  ephrin-­expressing  cell  
(Marston   et   al.,   2003;;   Zimmer   et   al.,   2003).   Endocytosis   of   the   EphB2-­ephrinB1  
signalling  complex  is  needed  to  overcome  the  strong  binding  of  cells  as  a  result  of  
Eph-­ephrin  interaction,  to  enable  cells  to  move  apart  (Zimmer  et  al.,  2003).  A  similar  
mechanism  was  also  shown  in  venous  endothelial  cells  with  EphB4  and  ephrinB2,  in  
which   Rac   is   needed   to   mediate   actin   polymerization   for   endocytosis   to   occur  
(Marston  et  al.,  2003).  Upon  internalisation,  Eph  receptors  are  either  recycled  back  
to  the  plasma  membrane  to  receive  further  signals  or  are  inactivated  by  degradation  
in  lysosomes  (Boissier  et  al.,  2013).  One  mechanism  of  Eph  receptor  degradation  is  
by  ubiquitination,  mediated  by  the  ubiquitin  ligase  Cbl  (Walker-­Daniels  et  al.,  2002;;  
Fasen  et  al.,  2008).  
  
1.1.5   Roles  of  Eph-­ephrin  signalling  
There  are  an  increasing  number  of  examples  of  how  Eph-­ephrin  signalling  is  able  to  
induce  a   range  of   responses.  To  demonstrate   the  diversity  of   responses  and   that  
signalling  operates  in  a  variety  of  cell  types,  some  examples  are  discussed  below.    
  
A  major   role  of  Eph-­ephrin  signalling   is   to  mediate  cell  segregation   to   form  sharp  
borders.  This  is  important  during  development  to  ensure  that  cells  are  organised  into  
tissues   or  within   tissues   (Fagotto   et   al.,   2014).   There   are  many   examples   of   cell  
segregation,  including:  separation  of  the  ectoderm  and  mesoderm,  their  roles  in  the  
notochord-­presomitic   boundary,   the   formation   of   somites,   hindbrain   segmentation  
and  cell  segregation  in  the  eye  field  (Fagotto  et  al.,  2014).  The  segmentation  of  the  
hindbrain  neural  epithelium  into  rhombomeres  will  be  discussed  in  detail  in  Chapter  
1.2.4.  Another  example  of  cell  segregation  is  in  neural  crest  cells,  which  migrate  to  
form  many  tissues  in  the  embryo,  including  the  bones  and  cartilage  in  the  head.  One  
mechanism  involved  in  the  segregation  of  this  cell  population  is  driven  by  Eph-­ephrin  
signalling.  In  Xenopus,  EphA4  and  EphB1  are  expressed  in  a  complementary  pattern  




to   their   ligand  ephrinB2   in  branchial  neural   crest  and  are   required   for   the  cells   to  
migrate  in  to  the  correct  locations  (Smith  et  al.,  1997).    
  
During  neural  circuit  formation,  Eph-­ephrin  signalling  contributes  to  guiding  axons  to  
the   correct   locations   (Cramer   and   Miko,   2016).   This   was   discovered   in   early  
experiments   investigating   topographic  maps,   in  which   it  was   identified   that   axons  
were  directed  to   the  correct  region  of   the  brain  by  a  gradient  of  Eph  receptor  and  
ephrin   expression   (Cheng   et   al.,   1995;;   Feldheim   et   al.,   2000).   There   are   many  
examples  where  Eph-­ephrin  signalling  mediates  axon  guidance  via   repulsion.  For  
example,  studies  have  shown  that   in   the   limb  mesenchyme,  Eph-­ephrin  signalling  
acts  to  guide  motor  neurons  to  their  target  muscles,  with  EphA4  being  expressed  in  
motor  neurons  and  ephrins  in  the  mesenchyme  (Kao  et  al.,  2012).    
  
Vasculogenesis   is   the   process   by  which   the   vasculature   network   is   laid   down  by  
differentiation  of  angioblasts  into  endothelial  cells  and  angiogenesis  is  the  process  
by  which  new  blood  vessels  branch   from   the  already  present  vasculature   (Patan,  
2004).  During  these  processes  EphB4  is  expressed  in  venous  endothelial  cells,  while  
ephrinB2  is  expressed  in  the  arterial  endothelial  cells  (Wang  et  al.,  1998),  and  when  
the  two  cell  types  come  into  contact  with  one  another,  Eph-­ephrin  signalling  results  
in  repulsion  which  sculpts  the  capillary  network  (Oike  et  al.,  2002).  Mutants  of  both  
EphB4   and   ephrinB2   gave   the   same   developmental   defects   in   cardiovascular  
development  with  veins  and  arteries  not  forming  the  correct  morphology  (Gerety  et  
al.,  1999).  
  
In  the  intestine,  the  stem  cells  in  the  crypts  proliferate  and  undergo  differentiation  as  
they  move  up  through  the  villus,  before  being  shed  into  the  lumen  (Yen  and  Wright,  
2006).  Eph-­ephrin  signalling  regulates  cell  segregation  between  the  stem  cells  and  
differentiating   cells   which   express   Eph   receptors   and   ephrins,   respectively   in   a  
graded  complementary  pattern  along  the  crypt-­villus  axis  (Batlle  et  al.,  2002).  This  is  
important   to   ensure   that   progenitor   cells   are   maintained   in   the   crypts   and  
differentiating   cells   migrate   towards   the   villus.   Experiments   blocking   Eph-­ephrin  
signalling  causes  cells  to  be  mispositioned  along  the  crypt-­villus  axis  (Holmberg  et  
al.,   2006;;   Jurek  et   al.,   2016).   In  addition,  Eph-­ehprin   signalling   contributes   to   the  
control  of  cell  proliferation  in  parallel  to  Wnt  signalling.    





There   are   some   examples   showing   Eph-­ephrin   signalling   can   regulate   apoptosis  
(Magal  et  al.,  1996;;  Park,  2013).  For  example,  a  decrease  in  apoptosis  is  observed  
when  EphA7,  a  receptor  for  ephrinA5,  is  knocked  out,  which  results  in  an  increase  in  
neural  progenitor  cells  and  a  larger  cortex  in  mice  (Depaepe  et  al.,  2005).  A  similar  
effect  is  found  in  the  mouse  diencephalon  and  mesencephalon.  When  ephrinA5   is  
mutated,   there   is   a  decrease   in   apoptosis   of  EphA7-­expressing   cells,   causing  an  
increase  in  cells  at  the  dorsal  midline  (Park  et  al.,  2013).  In  contrast,  another  study  
showed   increased   apoptosis   when   EphA7   was   knocked   down   in   human   lung  
carcinoma  cells  (Li  et  al.,  2016).  Together  these  studies  demonstrate  that  Eph-­ephrin  
signalling  is  important  for  regulating  size  via  apoptosis  and  ensuring  that  the  correct  
number  of  cells  are  maintained.    
  
In  addition  to  the  roles  described  above  in  morphogenesis,  there  has  been  increasing  
evidence  that  Eph-­ephrin  signalling  can  control  cell  differentiation  in  some  tissues.  
As  the  main  focus  of  this  project  is  to  identify  novel  Eph-­ephrin  transcriptional  targets  
in  the  hindbrain,  a  more  comprehensive  review  of  the  known  effects  of  Eph-­ephrin  
signalling  on  differentiation  will  be  covered  in  Chapter  1.3.  
  
1.2   Hindbrain  development  
1.2.1   Hindbrain  specification  and  segmentation  
The  hindbrain   is  segmented  which  underlies  neuronal  patterning  and  neural  crest  
specification.  The  hindbrain  is  specified  in  the  neural  plate  as  a  result  of  anterior  and  
posterior  signals  that  give  cells  positional  information  and  induce  specific  identities  
along   the   anterior-­posterior   (A-­P)   axis   (Kiecker   and   Lumsden,   2012).   The   neural  
plate   initially  has  an  anterior   identity  and  the  combined  input  of  retinoic  acid  (RA),  
Wnt   and   fibroblast   growth   factor   (FGF)   signalling   results   in   the   specification   of  
posterior  regions  (Kudoh  et  al.,  2002).  The  result  is  the  specification  of  the  forebrain,  
midbrain,   hindbrain   and   spinal   cord.   FGF   signalling   in   the   hindbrain   induces   the  
expression  of  RA  degrading  enzymes,  one  of  which  is  Cyp26a  (White  et  al.,  2007).  
This  results  in  gradients  of  FGF,  and  RA,  from  posterior  to  anterior  (     




Figure  4).    
  
The  neural  epithelium  is  segmented  into  seven  regions,  called  rhombomeres  (r1-­r7),  
each  with  a  distinct  identity  and  different  pattern  of  gene  expression  (Lumsden  and  
Krumlauf,   1996).   This   segmentation   process   is   regulated   by   the   integration   of  
different   signalling  mechanisms   leading   to   specific   patterns   of   transcription   factor  
expression  which  give  unique   identity   to   the  different   rhombomeres   (White  et   al.,  
2007;;  Hernandez  et  al.,  2007;;  Walshe  et  al.,  2002).  One  key  transcription  factor  is  
Krox20,   which   is   expressed   in   rhombomeres   3   (r3)   and   5   (r5)   (Wilkinson   et   al.,  
1989a),   and   its   discrete   expression   pattern   is   visible   before   the   morphological  
segments  have  formed  (Irving  et  al.,  1996).  Krox20  regulates  the  expression  of  many  
genes  including  EphA4,  which  is  expressed  in  r3  and  r5  (Theil  et  al.,  1998).  EphA4  
then   plays   a   key   role   in   border   sharpening   along   with   other   Eph   receptors   and  
ephrins.  Krox20  also  regulates  Hoxa2  and  Hoxb2  expression  in  r3  and  r5  by  binding  
upstream  enhancers  of  these  genes  (Maconochie  et  al.,  1996;;  Nonchev  et  al.,  1996).  
  
There  are  other  transcription  factors  involved  in  specifying  segment  identity,  which  
act   as   part   of   the   gene   network   and   are   important   for   the   development   and  
segmentation   of   the   rhombomeres   (Tumpel   et   al.,   2009;;   Krumlauf,   2016).   This  
includes  variant  hepatocyte  nuclear  factor  1  (vHnf1),  which  is  important  for  specifying  
the  posterior  regions  of  the  hindbrain  and  in  combination  with  RA  and  FGF  signalling  
induces  MafB  expression  (Hernandez  et  al.,  2004).  MafB   is  required   for  hindbrain  
segmentation  and  acts  to  specify  r5  and  r6  by  acting  in  combination  with  vHnf1  to  
give  posterior  hindbrain  identity  and  repress  r4  neuronal  fates  (Moens  et  al.,  1996;;  
Hernandez  et  al.,  2004).    
  
The  hox   genes  are  also  part   of   the  gene  network  and   specify  A-­P   identity   in   the  
hindbrain   (Tumpel   et   al.,   2009;;   Krumlauf,   2016).   The   hox   genes   are   a   set   of  
transcription   factors   that   are   conserved  across   vertebrates   and   invertebrates   and  
their   overlapping   expression   patterns   result   in   specific   identities   for   the   different  
segments   (Wilkinson   et   al.,   1989b;;   Hunt   et   al.,   1991;;   Tumpel   et   al.,   2009).   The  
expression  of  hox  genes   is   regulated  by  various   factors   including   the  gradients  of  
FGF  and  RA  as  well  as  other  transcription  factors  in  the  hindbrain.  hox  genes  can  
also  repress  the  expression  of  other  transcription  factors,  such  as  the  repression  of  




krox20  by  Hoxb1a  and  Hoxa1  (Helmbacher  et  al.,  1998).  Mutational  analysis  of  the  
hox  genes  has  shown  that  they  are  required  for  hindbrain  segmentation  (Waskiewicz  
et  al.,  2002),  as  well  as  A-­P  identity  (Bell  et  al.,  1999).  
     





     




Figure  4  Hindbrain  patterning  and  morphology  
(A)  Three-­dimensional  schematic  of  a  cross-­section  of  the  hindbrain  at  20  ss  showing  the  anterior-­
posterior,  dorsal-­ventral  and  apical-­basal  axes.  (B)  Schematic  showing  FGF  and  RA  gradients  as  
hindbrain  identity  is  specified.  Aldh1a2  is  expressed  in  the  somatic  mesoderm  and  produces  RA,  
which  then  diffuses  across  the  neurectoderm.  Cyp26a1  is  expressed  in  the  anterior  and  degrades  
RA,  resulting  in  a  RA  gradient  across  the  hindbrain  and  gives  different  identities  to  rhombomeres.  
FGF  also  interacts  with  Cyp26a1  and  Aldh1a2.  The  regulation  of  the  RA  gradient  is  robust  and  
elongates  with  the  anterior-­posterior  axis  as  the  embryo  develops.  (C)  Schematic  of  neural  tube  
formation  in  zebrafish  from  neural  plate  (tailbud  stage),  neural  keel  (5  ss),  neural  rod  (15ss)  to  
neural  tube  formation  (20ss).  Illustrations  are  cross-­sections  with  the  dorsal-­ventral  axis  labelled.  
(D)  Schematic  of  hindbrain  showing  the  regions  of  Hox  factor  expression  that  are  responsible  for  
segmentation  of  the  hindbrain.  Illustration  is  from  a  dorsal  view  and  the  anterior-­posterior  gradient  
is   labelled,   rhombomeres   are   labelled   r1-­r7   and   otic   vesicle   (ov).   (E,F)   Schematics   of   a  
rhombomere   and   surrounding   boundary   cells   to   show   the   role   of   hindbrain   boundaries   in  
patterning   neurogenesis   from   lateral   (E)   and   ventral   (F)   views.   The   boundary   cells   position  
FGF20a-­expressing  neurons  to  the  centre  of  segments  in  the  mantle  zone.  Signalling  via  FGF20a  
then  inhibits  neurogenesis  in  the  overlying  neural  epithelium,  known  as  the  non-­neurogenic  zone,  
and  restricts  neurogenesis  to  the  adjacent  region,  known  as  the  neurogenic  zone.  Figure  based  
on  Clarke  (2009),White  et  al.  (2007),  Moens  and  Prince  (2002)  and  Terriente  et  al.  (2012).  
  
1.2.2   Hindbrain  boundary  cells  
Hindbrain  boundary  cells  arise  at  the  border  of  rhombomeres  and  are  a  distinct  cell  
population  from  the  other  cells  of  the  hindbrain  segments.  The  boundary  region  is  
comprised  of  a  two-­cell   layer  that  spans  the  dorsal-­ventral  axis.  In  chick  embryos,  
there  is  a  larger  extracellular  space  between  the  boundary  cells  and  the  arrangement  
of  these  cells  is  different  from  those  that  comprise  the  rhombomeres  (Lumsden  and  
Keynes,  1989;;  Heyman  et  al.,  1993).  Experiments  in  chick  found  that  the  S-­phase  
nuclei   of   boundary   cells   are   situated   closer   to   the   basal   surface,   whereas   in   the  
rhombomeres   they  are  at   the  pial   surface.   In  addition,   the  boundary  cells  have  a  
lower  rate  of  cell  division  (Guthrie  and  Lumsden,  1991).  At  the  hindbrain  boundaries,  
the  neural  epithelium  is  constricted  and  experiments  in  zebrafish  show  that  increased  
myosin  phosphatase  results  in  altered  cell  morphology  in  the  hindbrain  as  a  result  of  
increased  cortical   tension.  This  suggests  that  during  normal  development,   tension  
and  cell  shape  are  different  at  the  boundaries  (Gutzman  and  Sive,  2010).  
  
During  hindbrain  development,   the  boundary  cells  arise   in  a  non-­sequential  order  
with  respect  to  the  A-­P  axis,  but  following  a  specific  and  reproducible  pattern  (Fraser  
et   al.,   1990).   The   boundaries   either   side   of   r4   are   specified   first,   with   the   r3/r4  
boundary   initially,   followed  by   the   r4/r5   boundary.  The   remaining   four   boundaries  
arise   in  the  following  order:  r1/r2,  r2/r3,  r6/r7  and  r5/r6  (Moens  and  Prince,  2002).  




Cell   transplantation   experiments   have   shown   that   juxtaposed   odd   and   even  
segments  induce  boundary  formation  (Guthrie  and  Lumsden,  1991).    
  
Currently,  the  genetic  markers  that  have  been  identified  for  hindbrain  boundary  cells  
are  expressed  in  all  six  boundaries,  suggesting  that  all  boundaries  are  the  same  cell  
type.   Such  markers   include  wnt1   and  wnt8b   at   early   stages,   from   14   hours   post  
fertilisation  (hpf)  (Riley  et  al.,  2004;;  Amoyel  et  al.,  2005),  and  radical   fringe  (rfng),  
which   is   expressed   in   the   boundaries   from   16   hpf   (Cheng   et   al.,   2004).   pax6   is  
expressed  at  higher  levels  in  the  boundaries  than  the  rest  of  the  rhombomeres  (Xu  
et  al.,  1995).    
  
Rfng  is  expressed  by  the  boundary  cells,  and  promotes  Notch  activation,  which  in  
turn   prevents   neurogenesis,   enabling   the   boundary   cells   to   be   maintained   since  
differentiation  is  inhibited  (Cheng  et  al.,  2004;;  Qiu  et  al.,  2004;;  Qiu  et  al.,  2009).  The  
boundary  cells  act  as  signalling  centres  in  the  hindbrain  (Walshe  et  al.,  2002;;  Riley  
et   al.,   2004),   and   regulate  neuronal   patterning  by  positioning  FGF20a-­expressing  
neurons  in  segment  centres.  These  neurons  then  provide  a  concentrated  source  of  
FGF20  signalling  (Gonzalez-­Quevedo  et  al.,  2010;;  Terriente  et  al.,  2012),  which  acts  
to   locally   inhibit   neurogenesis   and   restrict   it   to   regions   flanking   the   boundaries  
(Figure  4).  Consequently,  the  neurogenic  zones  are  adjacent  to  the  boundary  cells  
and  neurogenesis  is  excluded  from  the  centre  of  rhombomeres  (Gonzalez-­Quevedo  
et  al.,  2010)  (Figure  4).  Previous  studies  where  boundary  cell  formation  is  prevented  
have   shown   that   neurons   are   no   longer   organised   in   the   correct   way   and   that  
neuronal   subtypes   which   should   be   separated   are   adjacent   in   the   hindbrain  
(Terriente  et  al.,  2012).    
  
1.2.3   Eph  receptors  and  ephrins  during  zebrafish  hindbrain  development  
Signalling  by  Eph  receptors  and  ephrins  is  important  during  hindbrain  development.  
Two  separate   roles  have  been   identified   in  hindbrain  segmentation   in  which  Eph-­
ephrin  signalling  is  responsible  for  border  sharpening  and  for  boundary  cell  formation  
(Xu   et   al.,   1995;;   Heyman   et   al.,   1995;;   Irving   et   al.,   1996).   To   investigate   border  
sharpening,   EphA4   signalling   was   blocked   by   a   dominant   negative   form   of   the  




receptor,  which  showed  that  the  borders  of  r3  and  r5,  where  EphA4  is  expressed,  no  
longer  sharpen  (Xu  et  al.,  1995).  When  antisense  morpholino  oligonucleotides  (MOs)  
against  EphA4  were  injected  into  embryos,  the  expression  of  krox20  was  found  to  
be  fuzzy  at  the  borders  of  r3  and  r5  (Cooke  et  al.,  2005).  Another  study  showed  that  
mosaic  ectopic  expression  of  EphA4  or  ephrinB2  was  able  to  drive  cell  sorting  within  
hindbrain  segments  (Xu  et  al.,  1999).  
  
The  role  of  Eph-­ephrin  signalling  in  regulating  hindbrain  boundary  cell  formation  was  
identified  in  similar  experiments  to  those  described  for  border  sharpening.  Injection  
of  dominant  negative  EphA4  to  block  Eph-­ephrin  signalling  found  that  the  formation  
of   certain   boundaries   was   disrupted   (Xu   et   al.,   1995).   In   addition,   boundary   cell  
markers,  such  as  rfng  and  sema3Gb,  are  no  longer  expressed  after  knockdown  of  
EphA4,   ephrinB3   or   ephrinB2   (Cooke   et   al.,   2005;;   Terriente   et   al.,   2012).   The  
boundaries  that  are  disrupted  are  specific   to   the   location  of  signalling  by  the  Eph-­
ephrin   binding  pair   that   has   been  blocked.  For   example,   experiments   using  MOs  
against  EphA4  or  ephrinB3   found  that  the  hindbrain  boundaries  at  r2/r3,  r3/r4  and  
r5/r6  are  lost  (Cooke  et  al.,  2005;;  Terriente  et  al.,  2012).  When  ephrinB2  is  knocked  
down,  there  is  only  a  slight  disruption  to  the  hindbrain  boundaries.  However,  when  
ephrinB2   function   is   blocked   in   combination   with   EphA4   there   was   a   greater  
disruption  to  boundaries  and  increased  loss  of  the  boundary  cell  marker,  sema3Gb,  
than  when  targeting  EphA4  alone  (Cooke  et  al.,  2005).  Henceforth,  the  point  at  which  
rhombomeres  are  in  contact  with  one  another  will  be  referred  to  as  the  border  and  
the  cell  population  that  arises  at  the  border  will  be  referred  to  as  the  boundary.  
  
Although  Eph   receptors  and  ephrins  can  bind  multiple  partners,   they  have  higher  
affinity  for  specific  ephrins  or  Eph  receptors,  respectively.  In  the  hindbrain,  there  are  
three  Eph-­ephrin  binding  pairs,  based  on  affinity  and  their  expression  in  segmented  
and   complementary   patterns   (Figure   5).   For   example,   ephrinB3b   is   expressed   in  
rhombomeres   2   (r2),   4   (r4)   and   6   (r6),   whilst   EphA4a   is   expressed   in   a  
complementary   pattern   in   the   adjacent   rhombomeres,   r3   and   r5.   As   signalling   is  
contact   dependent,   Eph-­ephrin   signalling   is   strongly   activated   at   the   border   of  
rhombomeres  in  which  the  binding  partners  are  expressed  (Figure  5:  yellow).  There  
is   also   likely   to   be   weaker   activation   within   the   segments   due   to   overlapping  
expression   with   binding   partners   that   can   be   bound   at   a   lower   affinity.   Whilst  




EphA4a-­ephrinB3b   and  EphB4a-­ephrinB2a   binding   pairs   have   been   shown   to   be  
involved   in   border   sharpening   and   boundary   cell   formation,   the   role   of  
EphB3a-­ephrinB1a  has  not  been  determined  (Figure  5).  
  
  
Figure  5  Eph  receptor  and  ephrin  expression  in  the  zebrafish  hindbrain  
The  three  Eph-­ephrin  binding  pairs  expressed   in   the  zebrafish  hindbrain  are   labelled  vertically  
and  the  seven  rhombomeres  are  represented  in  vertical  columns  (r1-­r7).    The  expression  of  Eph  
receptors  and  ephrins  is  shown  in  green  and  red,  respectively.  Locations  where  strong  signalling  
occurs  are  shown  in  yellow.  This  is  only  where  an  Eph  receptor  and  ephrin  of  a  binding  pair  are  
expressed   in   adjacent   rhombomeres,   due   to   the   contact   dependent   nature   of   signalling.  
Expression   patterns   based   on   Xu   and   Wilkinson   (2013),   and   Jordi   Cayuso,   Wilkinson   Lab  
(unpublished).  
  
1.3   Transcriptional   regulation   by   Eph   receptor   and   ephrin  
signalling  
In   addition   to   the   well   described   roles   of   Eph-­ephrin   signalling   that   have   been  
previously  discussed  (Chapter  1.1.5),  there  is  increasing  evidence  that  Eph-­ephrin  
signalling  is  also  able  to  regulate  gene  expression,  although  this  is  less  understood.  
This  section  will  focus  on  experiments  that  have  found  Eph-­ephrin  signalling  to  have  
roles  in  transcriptional  regulation  and  will  include  both  in  vitro  and  in  vivo  studies  as  
well  as  in  a  variety  of  tissues  and  organisms.  This  will  focus  initially  on  examples  of  
Eph-­ephrin  signalling  acting  via  another  receptor  or  pathway,  which  regulates  gene  
expression,   and   then   examples   where   Eph-­ephrin   signalling   directly   controls   cell  
differentiation.    





1.3.1   Direct  versus  indirect  transcriptional  regulation  
Before  discussing  examples  of   transcriptional   regulation  by  Eph-­ephrin   signalling,  
one  aspect  to  address  is  whether  the  effect  on  gene  expression  is  direct  or  indirect  
(Wilkinson,  2014).  When  Eph-­ephrin  signalling  is  disrupted  there  can  be  change  in  
the  position  of  a  cell,   for  example,   from  cell  migration,   resulting   in  altered  cell-­cell  
contacts.  This  would  mean  that  any  alteration  in  gene  expression  could  be  indirect  
as  the  cell   is  now  in  a  new  location  and  receiving  different  signals.  An  example  of  
this  is  in  the  intestine  where  double  EphB2  and  EphB3  mutants  have  mis-­positioned  
cells,  which   results   in  cell  proliferation  and  differentiation   (Genander  et  al.,  2009).  
The   alternative   situation   would   be   changes   to   gene   expression   that   are   a   direct  
consequence  of  Eph-­ephrin  signalling.  This  would  include  examples  where  cells  do  
not  change  their   location  and  are  receiving  the  same  external  stimuli  but  still  alter  
their   expression.   In   the   hindbrain,   a   direct   consequence   of   losing   Eph-­ephrin  
signalling  is  the  absence  of  boundary  cell  marker  expression  (Xu  et  al.,  1995;;  Cooke  
et  al.,  2005;;  Terriente  et  al.,  2012).  
  
1.3.2   Transcriptional  regulation  via  other  signalling  pathways  
One  mechanism  whereby  Eph  receptors  and  ephrins  can  regulate  gene  expression  
is  by  activating  other  receptors  that  have  known  roles  in  regulating  gene  expression.  
It   has   been   shown   that   Eph-­ephrin   signalling   can   result   in   phosphorylation   and  
subsequent  activation  of  the  NMDA  receptor.  This  receptor  regulates  calcium  influx  
in  neurons,  which  results  in  the  activation  of  signalling  pathways  that  cause  changes  
to   gene   expression   (Ghosh   and   Greenbery,   1995).   EphB2   is   clustered   with   the  
NMDA  receptor  at  excitatory  synapses  and  upon  ephrinB  binding  and  activation  of  
EphB2  there  is  an  interaction  between  EphB2  and  the  NMDA  receptor  (Dalva  et  al.,  
2000).  This  interaction  results  in  phosphorylation  of  the  NMDA  receptor  at  the  NR2B  
subunit,  leading  to  calcium  influx  which  induces  the  expression  of  genes  involved  in  
synaptic  remodelling  (Takasu  et  al.,  2002).  
  




1.3.3   Activation  of  transcription  factors  by  Eph  receptors  and  ephrins  
Some  of   the  previously   identified  phosphorylation   targets  of  Eph-­ephrin  signalling  
have  an  established  role  in  regulating  transcription.  One  example  is  EphA4  which  is  
upstream   of   the   Janus   kinase-­signal   transducer   and   activator   of   transcription  
(Jak-­Stat)   pathway   in   muscle   cells.   The   Jak-­Stat   signalling   pathway   relays   the  
extracellular   signal   to   the   nucleus   via   the   activation   of   Jak,   which   in   turn  
phosphorylates  and  activates  the  Stat  transcription  factors  (Aaronson  and  Horvath,  
2002).  In  the  neuromuscular  junction,  EphA4  activation  by  ephrinB1  causes  EphA4  
to  associate  with  Jak2,  leading  to  its  phosphorylation  and  subsequent  activation.  This  
results  in  the  phosphorylation  of  Stat1  and  Stat3,  which  leads  to  the  up-­regulation  of  
acetylcholinesterase  (Lai  et  al.,  2004).  
  
1.3.4   Cell  fate  specification  in  Ciona  
There   are   several   examples   that   demonstrate   how   Eph-­ephrin   signalling   can  
regulate   cell   fate   decisions   during   cell   lineage   specification   in   Ciona.   FGF   is   a  
diffusible   ligand   that   causes   the   widespread   activation   of  MAPK   signalling   which  
induces   specific   cell   fates   during  Ciona   development.   This   is   inhibited   locally   by  
Eph-­ephrin  signalling,  which  blocks  MAPK  activation  and  results   in  a  mesodermal  
fate.  On  the  other  hand,  if  there  is  an  absence  of  Eph-­ephrin  signalling  then  MAPK  
signalling  can  persist  and  the  cell  will  be  driven  down  an  endodermal  fate  (Shi  and  
Levine,   2008).   Other   cell   fate   decisions   driven   by   Eph-­ephrin   signalling   in  Ciona  
include   neural   and   notochord   (Picco   et   al.,   2007),   and   motor   ganglion   neuronal  
subtypes  (Stolfi  et  al.,  2011).    
  
1.3.5   Survival,  proliferation  and  differentiation  of  neural  progenitors  
A   number   of   studies   suggest   that   signalling   by   Eph   receptors   and   ephrins   is  
important   in  some  contexts   for  maintaining   the  balance  of  neural  progenitors  and  
differentiating  neurons  during  neurogenesis.  This  balance  is  maintained  by  ensuring  
that   neural   progenitor   proliferation   and   cell   differentiation   are   tightly   regulated.   A  
study  of  the  EphA7  mutant,  a  receptor  for  ephrinA5,  showed  a  phenotype  of  a  larger  
forebrain  which  was  found  to  be  due  to  a  reduction  in  apoptosis  of  neural  progenitors  




(Depaepe  et   al.,   2005).  The  number  of   progenitor   cells   can  also  be   regulated  by  
inhibiting   or   increasing   cell   proliferation.   A   study   investigating   the   role   of  
EphB1-­ephrinB3   signalling   in   the   hippocampus   shows   that   activation   maintains  
neural   progenitors   and   in   EphB1   mutant   mice   there   is   a   depletion   of   this   cell  
population  (Chumley  et  al.,  2007).  In  contrast,  neural  progenitor  cell  proliferation  is  
inhibited   by   ephrinB3-­EphB3   signalling   in   the   subventricular   zone.   EphB3   is  
expressed  by   the  neural   stem  cell   precursors  and  ephrinB3   in   the  adjacent   cells.  
When  EphB3   is   knocked   out   in   mice   there   is   an   increase   in   proliferation   of   the  
progenitor  cells  (del  Valle  et  al.,  2011).  These  examples  demonstrate  that  Eph-­ephrin  
signalling  can  have  opposing  effects  on  neural  progenitor  cell  proliferation.  
  
Neuronal  differentiation  is  also  regulated  by  Eph-­ephrin  signalling,  both  downstream  
of  forward  and  reverse  signalling.  When  EphA  receptors  are  activated  by  ephrinA1,  
this   promotes   the   differentiation   of   neural   progenitors   to   neurons.   In   cell   culture,  
experiments  where  neurospheres  were  treated  with  ephrinA2  found  that  there  was  
an  increase  in  markers  for  neural  differentiation,  and  the  reverse  was  observed  when  
treated  with  a  dominant  negative   form  of   the   ligand.  This  mechanism  acts  via   the  
MAPK  pathway  which  is  induced  by  EphA  activating  Rap1,  a  small  G  protein  (Aoki  
et   al.,   2004).   Similarly,   in   stem   cell   niches   of   the   adult   hippocampus,  Eph-­ephrin  
signalling  promotes  differentiation.  When  EphB2,  expressed  by  neural  stem  cells,  is  
activated   by   ephrinB2,   proneural   transcription   factors   are   up-­regulated   to   drive  
neuronal  differentiation  (Ashton  et  al.,  2012).  In  the  cerebral  cortex,  ephrinB1  reverse  
signalling  is  responsible  for  maintaining  neural  progenitors,  and  blocking  signalling  
with  a  dominant  negative  form  of  ephrinB1  induces  differentiation  to  cortical  neurons  
(Qiu  et  al.,  2008).    
  
1.3.6   Keratinocyte  development  
Cell  differentiation  in  the  skin  is  regulated  by  Eph-­ephrin  signalling  via  desmoglein1  
up-­regulation   to   inhibit   MAPK   signalling,   leading   to   keratinocyte   differentiation  
(Getsios  et  al.,  2004;;  Lin  et  al.,  2010).  Desmoglein1  is  a  desmosomal  cadherin  that  
binds  to  other  desmogleins  or  desmocollins   in  epithelial  cells  membranes,   to   form  
desmosomes,  enabling  epithelial   cells   to  anchor   together   (Nekrasova  and  Green,  




2013).  Eph-­ephrin  signalling  induces  the  differentiation  of  keratinocytes  as  well  as  a  
decrease   in   proliferation,   as   they  move   outwards   to   the   superficial   layers   where  
proliferation   is   not   required   (Genander   et   al.,   2010).   The  Eph-­ephrin   binding   pair  
responsible  for  this  behaviour  is  ephrinA1  which  activates  EphA2.  EphA2  activation  
leads  to  the  up-­regulation  of  desmoglein1  expression,  which  supports  keratinocyte  
differentiation  (Lin  et  al.,  2010).    
  
1.3.7   Bone  remodelling  
Bone  remodelling  is  the  process  by  which  bone  matrix  is  resorbed  by  osteoclasts,  
and  replaced  with  new  bone  by  osteoblasts.  The  transition  of  bone  removal  to  bone  
production   is  mediated   by   differentiation   of   osteoclasts   to   osteoblasts   (Sims   and  
Martin,  2014).  During  the  later  stages  of  bone  development  EphB-­ephrinB  signalling  
plays  the  predominant  role  through  both  forward  and  reverse  signalling.  Osteoclasts  
are  ephrinB2-­expressing  and  osteoblasts  are  EphB4-­expressing.  EphB4  activation  
in  osteoblasts  by  ephrinB2  promotes  cells  to  differentiate  to  osteoblasts,  maintaining  
this  fate.  Reverse  signalling  through  ephrinB2  in  osteoclasts  inhibits  differentiation  to  
osteoblast  (Zhao  et  al.,  2006).  Signalling  by  EphA-­ephrinAs  has  also  been  implicated  
in  this  process  in  bone  remodelling;;  EphA2  activation  by  ephrinA2  leads  to  osteoclast  
differentiation  (Irie  et  al.,  2009).  In  combination,  forward  and  reverse  signalling  help  
to  maintain  the  necessary  balance  for  bone  homeostasis.  
  
1.4   Aims  
This  study  has  focused  on  identifying  transcriptional  targets  of  Eph-­ephrin  signalling  
in   the   hindbrain.   Previous   studies   have   identified   that   Eph-­ephrin   signalling   can  
induce  changes  in  gene  expression  in  a  variety  of  cell  types  leading  to  changes  in  
cell  fate,  cell  proliferation  and  synaptic  remodelling.  During  hindbrain  development,  
there  is  evidence  that  Eph-­ephrin  signalling  is  essential  to  induce  a  cell  population,  
called   the   boundary   cells,   which   express   specific   markers.   When   Eph-­ephrin  
signalling  is  blocked,  expression  of  these  genes  is  no  longer  induced.  
  




In   order   to   further   understand   the   role   of   Eph-­ephrin   signalling   in   hindbrain  
development,   this   project   has   set   out   to   identify   the   transcriptional   targets   of   this  
signalling.  The  first  aim  of  this  project  was  to  explore  different  techniques  to  find  the  
best  method  to  disrupt  Eph-­ephrin  function  in  the  hindbrain  as  measured  by  loss  of  
boundary  cells.  Once   this  was   in  place   the  method  was   then  used   to   identify   the  
target   genes   of   Eph-­ephrin   signalling.   Finally,   the   target   genes   that   had   been  
identified  were  investigated  to  further  understand  the  role  of  Eph-­ephrin  signalling  in  
the  hindbrain.




Chapter  2.   Materials  and  Methods  
2.1   Solutions  and  Reagents  
2.1.1   General  Solutions  
Agarose  gel  
Agarose  gels  were  made  with  1%  agarose  in  1X  Tris-­acetate  (TAE)  run  at  120  V  and  
120  mA  unless  otherwise  stated.  
  
Phosphate  Buffered  Saline  with  Tween-­20  (PBST)  
PBST  was  made  to  1  µl/ml  of  Tween-­20  (Sigma  Aldrich,  UK)  in  1  x  PBS.  
  
Danieau’s  solution  
1X  Danieau’s  solution   is  comprised  of  58 mM  NaCl,  0.7  mM  KCl,  0.4 mM  MgSO4,  
0.6 mM  Ca(NO3)2  5  mM  HEPES  in  1  x  PBS  and  pH  adjusted  to  7.6.  
  
E3  media  
1X  E3  media  is  comprised  of  5  mM  NaCl,  0.17  mM  KCl,  0.33  mM  CaCl,  0.33  mM  
MgSO4  in  dH2O  and  pH  adjusted  to  7.4.  
  
L  Broth  (LB)  
10  g  Tryptone,  10  g  NaCl  and  5  g  yeast  extract  was  dissolved  in  a  final  volume  of  1L  
ddH2O  and  sterilized  by  autoclave  at  20  PSI  for  15  minutes.  
  
2.1.2   Fish  Husbandry  
Zebrafish  embryos  were  obtained  by  natural   spawning  as  described   (Westerfield,  
2000)  and  maintained  between  23  °C  and  28.5  °C.  Embryos  were  staged  by  hours  
post   fertilisation   (hpf)  or   the  number  of  somites,  somite  stage   (ss)   (Kimmel  et  al.,  
1995).    
  




2.1.3   Zebrafish  strains  




HSP70  Gal4  (HS-­Gal4)  (Scheer  and  Campos-­Ortega,  1999)  
UAS-­ephrinB1-­DN1-­ACC   (UAS-­soluble   ephinB1)   (Jordi   Cayuso,   Francis   Crick  
Institute)  
Mutants:  
tp53  mutant  (Berghmans  et  al  2005)  
EphA4  crispr1  mutant  (mut_EphA4a_e3)  EphA4afci503  (Jordi  Cayuso,  Francis  Crick  
Institute)  
EphB4ahu3378  (Sanger  Institute)  
ephrinB2ahu3393  (Sanger  Institute)  
EphrinB3b   TALEN   mutant   (mut_efnB3b_e1(2bpdel))   EphrinB3bfci502   (Megan  
Addison,  Francis  Crick  Institute)  
  
2.1.4   Genotyping  
Fin-­clipping  protocol  
Adult  zebrafish  were  treated  with  0.02%  3-­aminobenzoic  acid  ethyl  ester  (MS-­222)  
before  clipping  the  end  of  the  caudal  fin  with  surgical  scissors.  DNA  was  lysed  in  50  
µl  of  0.02%  proteinase  K  (Thermo  Fisher,  UK)  and  incubated  at  65  °C  for  16  hours.  
  
PCR  and  restriction  digest  
The  primers  used  for  genotyping  are  shown  in  Table  1  Primers  used  for  genotyping.  
Unless   otherwise   stated,   reagents   used   for   PCR   and   restriction   digestion   were  
purchased  from  New  England  Biolabs,  UK.  
     




Gene   Forward  primer  5'-­3'   Reverse  primer  5'-­3'  
tp53   ACATGAAATTGCCAGAGTATGT   TCGGATAGCCTAGTGCGAGC  
EphA4a   GCTCCGCAGTACATTTTAGGG   GTCTTTCCTCTCACAGTGGGA  





ephrinB3b   GAGAGAGTATCCCGCACACACG   TAGATGGGCTCCATGTTGGT  
Table  1  Primers  used  for  genotyping  
  
The  PCR   reaction   to   identify   tp53  mutants  was  set  up  as  shown   in  Table  2.  The  
reaction  was   incubated   at   95   °C   for   30   seconds,   then   35   cycles   of   95   °C   for   30  
seconds,   53   °C   for   30   seconds   and   68   °C   for   20   seconds,   followed   by   a   final  
incubation  at  68  °C  for  2  minutes.  
  
The  PCR  reaction  to  identify  EphA4a  mutants  was  set  up  as  shown  in  Table  3.  The  
reaction  was  incubated  at  98  °C  for  1  minute,  then  40  cycles  of  98  °C  for  10  seconds,  
67  °C  for  20  seconds  and  72  °C  for  20  seconds,  followed  by  a  final  incubation  at  72  
°C  for  2  minutes.  
  
The  PCR  reaction  to  identify  EphB4a  mutants  was  set  up  as  shown  in  Table  4.  The  
reaction  was  incubated  at  98  °C  for  1  minute,  then  40  cycles  of  98  °C  for  10  seconds,  
67  °C  for  20  seconds  and  72  °C  for  20  seconds,  followed  by  a  final  incubation  at  72  
°C  for  2  minutes.  
  
The  PCR  reaction  to   identify  ephrinB2a  mutants  was  set  up  as  shown  in  Table  5.  
The  reaction  was  incubated  at  94  °C  for  90  seconds,  then  44  cycles  of  94  °C  for  30  
seconds,   64   °C   for   30   seconds   and   68   °C   for   20   seconds,   followed   by   a   final  
incubation  at  72  °C  for  7  minutes.  
     




Reagent   Volume  
cDNA  (diluted  DNA  digest  1:10)   1.0  µl  
10X  Standard  Taq  Reaction  Buffer   2.0  µl  
10mM  dNTPs   0.4  µl  
tp53  Forward  primer  (10  µM)   1.0  µl  
tp53    Reverse  primer  (10  µM)   1.0  µl  
Taq  DNA  polymerase   0.3  µl  
DEPC-­treated  water   14.3  µl  
Total  volume   20.0  µl  
Table  2  PCR  reaction  for  tp53  genotyping  
  
Reagent   Volume  
cDNA  (diluted  DNA  digest  1:50)   4.0  µl  
5X  Q5  Reaction  Buffer   5.0  µl  
10mM  dNTPs   0.5  µl  
EphA4a  Forward  primer  (10  µM)   1.0  µl  
EphA4a  Reverse  primer  (10  µM)   1.0  µl  
Q5  High-­Fidelity  DNA  polymerase   0.1  µl  
DEPC-­treated  water   13.4  µl  
Total  volume   25.0  µl  
Table  3  PCR  reaction  for  EphA4a  genotyping  
  
Reagent   Volume  
cDNA  (diluted  DNA  digest  1:50)   4.0  µl  
5X  Q5  Reaction  Buffer   5.0  µl  
10mM  dNTPs   0.5  µl  
EphB4a  Forward  primer  (10  µM)   1.0  µl  
EphB4a  Reverse  primer  (10  µM)   1.0  µl  
Q5  High-­Fidelity  DNA  polymerase   0.1  µl  
DEPC-­treated  water   13.4  µl  
Total  volume   25.0  µl  
Table  4  PCR  reaction  for  EphB4a  genotyping  
     




Reagent   Volume  
cDNA  (diluted  DNA  digest  1:50)   2.0  µl  
5X  Q5  Reaction  Buffer   5.0  µl  
10mM  dNTPs   0.5  µl  
ephrinB2a  Forward  primer  (10  µM)   1.0  µl  
ephrinB2a  Reverse  primer  (10  µM)   1.0  µl  
Q5  High-­Fidelity  DNA  polymerase   0.1  µl  
DEPC-­treated  water   13.4  µl  
Total  volume   25.0  µl  
Table  5  PCR  reaction  for  ephrinB2a  genotyping  
  
PCR   products   were   visualised   by   agarose   gel   electrophoresis   before   restriction  
digestion,  set  up  as  shown   in  Table  6.  The  reaction  was   incubated  at  37  °C  for  3  
hours   before   being   visualised   by   agarose   gel   electrophoresis   to   determine   the  
genotype.   The   enzymes   used   and   the   interpretation   of   the   restriction   digest   are  
shown  in  Table  7.    
  
Reagent   Volume  
PCR  product   5.0  µl  
CutSmart  Buffer   1.5  µl  
Restriction  enzyme   1.0  µl  
DEPC-­treated  water   7.5  µl  
Total  volume   15.0  µl  
Table  6  Restriction  digest  for  genotyping  
  
Gene   Restriction  enzyme   Mutated  gene  cut  or  uncut?  
tp53   MboII   cut  
EphA4a   AleI   uncut  
EphB4a   AlwNI   cut  
ephrinB2a   PshAI   cut  
Table  7  Restriction  enzyme  used  and  interpretation  of  genotyping  result  
  
High  Resolution  Melt  Curve  (HRM)  analysis    
HRM  was  used  to  identify  ephrinB3b  mutants  and  has  been  previously  described  in  
(Dahlem  et  al.  2012).  RT-­PCR  was  carried  out  using  the  ephrinB3b  primers  shown  
in  Table  1,  and  in  the  presence  of  MeltDoctorTM  HRM  Dye  (applied  Biosystems)  using  
an  ABI  7900  qPCR  machine  according  to  the  manufacturer’   instructions.  This  was  




followed   by   a   melt   curve   analysis   using   HRM   Software   V2.0.2   from   Life  
Technologies.  
  
2.1.5   Microinjection  with  morpholino  oligonucleotides  
MOs   (GeneTools,   USA)   were   re-­suspended   to   a   final   concentration   of   1   mM   in  
ddH2O  as   described   (Gerety   and  Wilkinson,   2011),   and   stored   at  RT.  MOs  were  
injected   up   until   the   2-­cell   stage   and   into   p53   homozygous  mutants   to   avoid   the  
effects  of  toxicity  that  can  result  from  MO  use.  MOs  used  are  listed  in  Table  8.  
  




Sequence  5'-­3'   References  
EphA4a   TB   AACACAAGCGCAGCCATTGGTGTC   (Cooke  et  al.,  
2005)  
EphB4a   TB   TAAAATGAGTGAGTTACCTTCCTCC     
ephrinB2a   TB   CGGTCAAATTCCGTTTCGCGGGA   (Cooke  et  al.,  
2005)  
ephrinB3b   SB   TTGCGGCTCTTACCTTTTGTTCAAG   (Terriente  et  
al.,  2012)  
Table  8  MOs  used  for  knockdown  experiments  
  
2.1.6   Heat  shock  
Embryos  were  collected  at   the  desired  stage  and  subjected  to  heat  shock   in  0.6X  
Danieau’s  solution  at  38  °C  for  1  hour  before  returning  to  28.5  °C.    
  
2.2   Analysis  of  gene  expression  
2.2.1   Whole  embryo  and  hindbrain  tissue  dissections  
Embryos  were  collected  at  19  hpf  or  20  ss,  dechorionated,  de-­yolked,  and  hindbrains  
dissected  using  forceps  in  autoclaved  PBS.  Dissected  hindbrains  were  transferred  
to  Non-­Stick  RNase-­Free  1.5  ml  Microfuge  Tubes  (Ambion,  UK)  and  centrifuged  at  




0.3  xg  for  30  seconds.  The  supernatant  was  discarded  and  350  µl  lysis  buffer  (The  
Epigenetics  Company,  USA)  added.  
  
Whole  embryos  were  collected  at  19  hpf  or  20  ss,  dechorionated  then  transferred  to  
Non-­Stick  RNase-­Free  1.5  ml  Microfuge  Tubes  (Ambion,  UK)  and  centrifuged  at  0.3  
xg  for  30  seconds.    The  supernatant  was  discarded  and  350  µl   lysis  buffer  added  
prior  to  RNA  extraction.  
  
2.2.2   RNA  extraction  
RNA  was  extracted  following  the  protocol  described  by  Lan  et  al.  (2009)  using  the  
RNeasy®  Micro  Kit  (Qiagen,  Netherlands)  or  Quick-­RNA  Microprep  (The  Epigenetics  
Company,  USA)  and  the  manufacturer’s  recommended  protocol.    
  
2.2.3   cDNA  synthesis  
cDNA  was   synthesised   using   SuperScript®   III   First-­Strand   Synthesis   System   for  
RT-­PCR  (Invitrogen,  USA)  following  the  manufacturer’s  protocol.  The  reaction  was  
set  up  with  100  ng  RNA,  1  µl  oligo(dT)20  and  1  µl  dNTP  mix  made  up  to  10  µl  with  
DEPC-­treated  water  and  incubated  at  65  °C  for  5  minutes  followed  by  incubation  on  
ice  for  1  minute.  The  cDNA  synthesis  mix  was  then  added  in  the  following  order:  2  µl  
RT   buffer,   4   µl  MgCl2,   2   µl  DTT,   1   µl  RNaseOUTTM,   1   µl   SuperScript   III  RT   and  
incubated  at  50  °C  for  50  minutes  then  85  °C  for  5  minutes  followed  by  an  incubation  
on   ice   for  1  minute.  1  µl  of  RNaseH  was  added  before   incubating  at  37  °C  for  20  
minutes.  cDNA  was  used  for  RT-­qPCR  or  stored  at  -­20  °C.  
  
2.2.4   Reverse   transcriptase   –   quantitative   polymerase   chain   reaction   (RT-­
qPCR)  
A   dilution   series   of   the   cDNA   synthesised   was   used   to   confirm   the   amplification  
efficiency  of  each  primer  pair  using  the  following  dilutions:  1:3,  1:6,  1:12,  1:24  and  
1:48.   A   no   template   control   was   also   used   to   determine   any   contamination   and  
primer   dimer   formation.   qPCR  analysis  was   carried   out   using  Platinum®  SYBR®  




Green   qPCR   Supermix-­UDG   and   reagents   unless   otherwise   stated   (Invitrogen,  
USA).  A  typical  RT-­qPCR  reaction  is  shown  in  Table  9.  The  reaction  was  incubated  
at  50  °C  for  2  minutes,  95  °C  for  2  minutes,  then  40  cycles  of  95  °C  for  15  second  
and  60  °C  for  30  seconds,  followed  by  a  melting  curve  analysis.  
  
Reagent   Volume  
cDNA  (diluted)   1.0  µl  
SYBR  mix   10.0  µl  
ROX   0.4  µl  
Forward  primer  (10  µM)   0.5  µl  
Reverse  primer  (10  µM)   0.5  µl  
DEPC-­treated  water   7.6  µl  
Total  volume   20.0  µl  
Table  9  RT-­qPCR  reaction  
  
2.2.5   RT-­qPCR  primer  sequences  
The  primers  used  for  RT-­qPCR  are  shown  in  Table  10.  These  were  all  designed  for  
this  project  except  for  b-­actin  which  was  the  same  as  for  previously  published  work  
(Lan  et  al.,  2009).    




Gene   Forward  primer  5'-­3'   Reverse  primer  5'-­3'  
b-­actin   CGAGCTGTCTTCCCATCCA   TCACCAACGTAGCTGTCTTT  
six3a   AAGCCACTGGACTCACTCCT   CTGCCCTATTGCTTGATGCT  




otx2   CAAGCAACCACCTTACACGG   TCGTCTCTGCTTTCGAGGAG  
cd9a   AAGTGGCTGCTGGAATTTGG   TGCTTTGTTGGTAGGTGTCG  
ppfia4   GTCCGGGGTCTCTAGTGAAG   AGTCACCCTTTCAAGAGCCA  
tmppe   GGGACAAATGAAGCCTCGAC   TGCCCATTGAGTGTAAGAGC  
dnm2a   GGTACAGATGCCCGGGATAT   CAGCACGAATGTCCTTACGG  
ube2_z   TACCATAACGAGCCGGGTTT   ACCCTCCAGCATATCACACA  
ttc32   ACACACAGTTCATCGAGTCCT   CCACCCGGAGATACTTCACC  




hmgb2a   AGGGACCTCGGTGAACTTTT   GCGAACCTTATCAGTCTTAGCC  




tubb2b   TCTTCAAGCTGGACAATGCG   TTGAAGGTCGCTGTCTCCAT  
mdka   AGGCTCTCTTCAACGTCGAA   TAGTTCCCTTTCCCCTTGCC  
marcksb   CGGAGCAAAAGACGAGACTG   TCCCGTTGGTTTTAGCATGG  
ybx1   ATATCTCCGTAGCGTTGGGG   GGGCCGGTAACATTTGCTG  
rpl15   ACCAGATCAAGTTTGCACGC   CAGTAGGAGTTCAGGACCCG  
fubp1   ACTACTCTAACGTGGCTCCG   GTACCCCATCACCTCCTATTTT  
col15a1b   GAGGCTCCAAGGGTCACC   CCCAAAAGAGTAGGCAGGGT  
fam117aa   GCCTGTTACCTGTGTCAACG   TCTCGTAGGTGTTCGGCG  
abi1b   CCTCAGCCCCACCTAAACG   CAGTGAGGGGAATCTGGGG  
wsb1   AGGACATCGGATTGTGAGACT   ACTGTTCTGCCGAGAGAGTC  
Table  10  RT-­qPCR  primers  
  
2.2.6   Statistical  significance  
Statistical  significance  was  determined  by  one-­way  ANOVA  test  or  Pearson’s  Chi-­
square  test  using  Microsoft  Excel.  




2.3   In  situ  hybridisation  
2.3.1   Cloning  new  in  situ  hybridisation  probes  
PCR  of  probe  sequence  
In  situ  hybridisation  probe  sequences  were  amplified  by  PCR  from  a  cDNA  library  
generated  from  whole  wild  type  zebrafish  embryos  at  20  ss.  The  primer  sequences  
in  Table  11  and  the  reaction  was  set  up  as  described  in  Table  12.  Reagents  were  
purchased   from  New  England  Biolabs,  UK,  unless  otherwise  stated.  The   reaction  
was  initiated  with  an  incubation  at  98  °C  for  30  seconds,  followed  by  35  cycles  of:  
98  °C  for  10  seconds,  57  °C  for  20  seconds  and  72  °C  for  20  seconds,  then  a  final  










hmgb2a   TAATCAAGTTTGTGCGCGCA   GCTTCTGCCTTCTTTCCTGC  
mdka   TAGTTCAGCCACTCCTCTGC   GACTTGTCTACCACTGCCCT  
tubb2b   GTGTCTACTCCCAGCCAGTT   TTCATGATGCGGTCGGGATA  
nap1l1   TCCCTCGAAGCATGACACTT   CTCAGGGCAAAACTCGCAAT  
Table  11  Primers  for  in  situ  hybridisation  probes  
  
Reagent   Volume  
cDNA  library  (diluted  1:3)   1.0  µl  
10X  Standard  buffer   2.5  µl  
dNTPs  (2  mM)   0.5  µl  
forward  primer  (10  µM)   0.1  µl  
reverse  primer  (10  µM)   0.1  µl  
DEPC-­treated  water  (Sigma  Aldrich,  UK)   20.6  µl  
Taq  polymerase   0.2  µl  
Total  volume   25.0  µl  
Table  12  In  situ  hybridisation  probe  PCR  
  
Purification  of  PCR  product  
The  PCR  reaction  products  were  then  run  on  an  agarose  gel  and  purified  using  the  
MiniElute  ®  Gel  Extraction  Kit  (Qiagen,  Netherlands)  and  the  recommended  protocol.  
DNA  eluted  in  a  final  volume  of  15  μl  DEPC-­treated  water  (Sigma  Aldrich,  UK).  





Ligation  of  probe  sequence  into  vector  
The  vector  and  insert  were  ligated  at  a  ratio  of  1:3  with  a  7.5  μl  reaction  set  up  as  
follows:  0.5  μl   insert,  5.8  μl  vector,  0.7  μl  10X  buffer  and  0.5  μl  T4  DNA  ligase.  A  
control  reaction  was  set  up  in  which  the  insert  was  replaced  with  DEPC-­treated  water  
(Sigma  Aldrich,  UK).  The  reactions  were  incubated  at  room  temperature  (RT)  for  16  
hours.  
  
Transformation  to  competent  cells  
2  µl  of  the  ligation  product  was  transformed  to  Library  Efficient®  DH5αTM  Competent  
Cells  (Invitrogen,  USA)  and  incubated  on  ice  for  30  seconds  before  being  subject  to  
heat  shock  at  42  °C  for  1  minute.  The  cells  were  then  incubated  on  ice  for  1  minute  
and  1  ml  LB  added  before  incubation  at  37  °C  for  1  hour.  The  cells  were  centrifuged  
at   0.4   xg   for   1   minute   and   all   except   150   μl   LB   was   removed.   The   cells   were  
re-­suspended   in   the   liquid   and   all   150   μl   plated   onto   pre-­warmed   LB   agar  
supplemented  with  100  μg/ml  ampicillin  at  37  °C  for  16  hours.  
  
Colony  selection  
Single  colonies  were  selected  using  a  sterilised  pick  and  inoculated  in  LB  with  the  
addition  of  100  μg/ml  ampicillin,  cultures  were  incubated  at  37  °C  with  gentle  shaking  
for  16  hours.  
  
Preparation  and  isolation  of  plasmid  DNA  
Plasmid  DNA  was  extracted  from  E.  coli  cells  using  the  QIAprep®  Spin  Miniprep  Kit  
(Qiagen,   Netherlands)   following   the   recommended   protocol   and   eluted   in   50   μl  
DEPC-­treated  water  (Sigma  Aldrich,  UK).  
  
Confirmation  of  insert  sequence  
Constructs   that   had   the   expected   molecular   weight   visualised   by   agarose   gel  
electrophoresis,  after  restriction  digestion  with  NotI  (New  England  Biolabs,  UK)  were  
selected   for   sequencing   by  Source  Biosicence   sequencing   services   (Nottingham,  
UK)  for  confirmation  of  sequence.  
  
RNA  probes  were  then  synthesised  from  the  plasmid  DNA  as  described  below.  




2.3.2   Synthesising  in  situ  hybridisation  probes  
Some  probes  have  been  previously  published  (Table  13).  
  
Gene   Publication  
rfng   (Terriente  et  al.,  2012)  
deltaD   (Amoyel  et  al.,  2005)  
neurogenin1   (Gonzalez-­Quevedo  et  al.,  2010)  
neuroD4   (Terriente  et  al.,  2012)  
huC/D	   Wilkinson  Lab,  Francis  Crick  Institute  
Table  13  Probes  used  for  in  situ  hybridisation  
  
2-­5   µg   of   plasmid  DNA   containing   the   probe  was   linearised  with   the   appropriate  
restriction  enzyme.  The  reaction  is  shown  in  Table  14.  
  
Reagent   Volume  
DNA  plasmid   3  µl  
10X  Buffer  H  (New  England  Biolabs,  UK)   4  µl  
BSA  (Promega,  USA)   0.4  µl  
EcoRI    (New  England  Biolabs,  UK)   2  µl  
DEPC-­treated  water  (Sigma  Aldrich,  UK)   48.4  µl  
Total  volume   40  µl  
Table  14  Linearisation  of  plamid  DNA  
  
The  reaction  was  incubated  at  37  °C  for  16  hours  before  purifying  the  linearised  DNA  
using  the  Illustra  GFX  PCR  DNA  and  Gel  Band  Purification  Kit  (GE  Healthcare)  and  
their   suggested  protocol.  DNA  was  eluted   in  DEPC-­treated  water   (Sigma  Aldrich,  
UK)  into  a  final  volume  of  30  µl.  The  RNA  synthesis  reaction  was  set  up  as  shown  in  
Table   15,   using   reagents   purchased   from   New   England   Biolabs,   UK,   unless  
otherwise  stated.  The  reaction  was  incubated  at  37  °C  for  3  hours  before  purifying  
the  RNA  probe.  The   following  were  added   to   the   finished   reaction   in  order:  60  µl  
DEPC-­treated   water   (Sigma   Aldrich,   UK),   10   µl   10   M   ammonium   acetate,   2   µl  
glycogen  and  130  µl  isopropanol.  The  reaction  was  mixed  by  pipetting  and  incubated  
at   -­20   °C   for   30  minutes   then   centrifuged   at   16   xg   at   4   °C   for   30  minutes.   The  
supernatant  was  removed  and  500  µl  70%  ethanol   in  DEPC-­treated  water  (Sigma  
Aldrich,   UK)   added   to   the   pellet.   The   liquid   was   pipetted   up   and   down   without  




disrupting  the  pellet  and  removed  before  centrifugation  at  4  xg  at  4  °C  for  30  seconds.  
The  pellet  was  dried  then  re-­suspended  in  40  µl  DEPC-­treated  water  (Sigma  Aldrich,  
UK)  and  160  µl  hybridisation  solution  added  for  long-­term  storage.  
  
Reagent   Volume  
Linearised  DNA  (1  µg)   x  µl  
10X  buffer   4  µl  
DTT   4  µl  
  DIG/F  labelled  NTPs   2  µl  
RNase   1  µl  
T7  Polymerase   4  µl  
DEPC-­treated  water  (Sigma  Aldrich,  UK)   x  µl  
Total  volume   40  µl  
Table  15  RNA  synthesis  reaction  
  
2.3.3   In  situ  hybridisation  solutions  
Hybridisation  solution  
50%  formamide  (Ambion,  UK),  5XSSC,  50  µg/ml  heparin  (Sigma  Aldrich,  UK),  500  
µg/ml  tRNA  (Roche,  Switzerland),  0.1%  Tween-­20  (Sigma  Aldrich,  UK),  5%  dextran  
sulphate  (Sigma  Aldrich,  UK),  92  mM  citric  acid,  pH  adjusted  to  6.0.    
  
Solution  I  











2  mg/ml  BSA  (Sigma  Aldrich,  UK),  2%  sheep  serum  (Life  Technologies,  USA).  





100  mM  Tris-­HCl  (pH  9.5),  50  mM  MgCl2,  100  mM  NaCl,  0.1%  Tween-­20  (Sigma  
Aldrich,  UK).  
Colouration  solution  
45   µl   NBT   (Roche,   Switzerland),   35   µl   BCIP   (Roche,   Switzerland)   in   10   ml  
colouration  buffer.  
  
2.3.4   In  situ  hybridisation  protocol  
All  washes  and  incubations  were  carried  out  with  gentle  shaking  unless  otherwise  
stated.  Embryos  were  collected  in  a  2  ml  microcentrifuge  tube  at  the  stage  of  interest  
and   fixed   in   4%   PFA   for   3   hours.   Embryos   were   washed   3   times   in   PBST   and  
dechorionated  before  dehydration   in  each  of   the   following   for  10  minutes:  2   times  
1  ml  75%  MeOH,  2  times  1  ml  100%  MeOH.  Embryos  can  be  stored   long  term  in  
100%  MeOH  at  -­20  °C  prior  to  in  situ  hybridisation.    
  
Embryos  were  rehydrated  in  a  2  ml  microcentrifuge  tube  and  washed  in  each  of  the  
following   for   10   minutes:   1   ml   75%,   50%,   25%   MeOH   in   PBST.   Embryos   were  
washed   5   times   in   PBST   for   5   minutes   and   dechorionated.   Embryos   were   then  
pre-­hybridized  in  1  ml  Hybridization  Solution  at  65  °C  for  a  minimum  of  1  hour.  Probes  
were  diluted  at  1-­4/200  µl  in  Hybridization  Solution  and  pre-­warmed  to  65  °C  before  
being  used  for  embryo  incubation  at  65  °C  for  16  hours.    
  
Solutions  I-­IV  were  pre-­warmed  to  65  °C.  Washes  were  carried  out  at  65  °C  with  1  ml  
of  solution  as  follows:  3  washes  in  Solution  I  for  10  minutes,  2  washes  in  Solution  II  
for  10  minutes,  2  washes  in  Solution  III  for  20  minutes  and  one  wash  in  Solution  IV  
for  20  minutes.  Embryos  were  washed  3   times   in  1  ml  PBST  at  RT  for  5  minutes  
before  incubation  in  blocking  solution  at  RT  for  a  minimum  of  1  hour.  Samples  were  
then  incubated  in  200  µl  37.5  U/ml  anti-­digoxigenin  AP  (Roche,  Switzerland)  at  4  °C  
for  16  hours.    
  
Embryos  were  then  washed  10  times  in  1  ml  PBST  at  RT  for  15  minutes  before  4  
washes  in  Colouration  Buffer  for  5  minutes.  Embryos  were  transferred  to  a  12  well  




plate  and   the  Colouration  Buffer  was  replaced  with  1  ml  Colouration  Solution  and  
kept  in  the  dark  to  develop  for  around  1-­4  hours.  
  
After  development,  embryos  were  washed  4  times  in  1  ml  PBST  at  RT  for  5  minutes  
before  fixation  in  1  ml  4%  PFA  at  RT  for  30  minutes.  Embryos  were  washed  4  times  
in  1  ml  PBST  at  RT  before  long-­term  storage  in  75%  glycerol  in  PBST.  Embryos  were  
prepared  for   image  analysis  by  de-­yolking  and  flat  or  side  mounting  onto  slides  in  
75%   glycerol   in   PBST.   Imaging   was   carried   out   using   Zeiss   AxioCam   High  
Resolution  microscope  and  Zen  pro  2012  software.  
  
2.4   Whole  mount  immunofluorescence  
2.4.1   Whole  mount  immunofluorescence  protocol  
All  washes  and  incubations  were  carried  out  with  gentle  shaking  unless  otherwise  
stated.  Embryos  were  collected  in  a  2  ml  microcentrifuge  tube  at  the  stage  of  interest  
and   fixed   in   4%   PFA   for   3   hours.   Embryos   were   washed   3   times   in   PBST   and  
dechorionated  prior  to  whole  mount  immunofluorescence.    
  
Embryos  were  blocked  in  10%  goat  serum  in  PBST  for  a  minimum  of  1  hour  before  
replacing  with  primary  antibodies  in  5%  goat  serum  and  1%  DMSO  (Table  16)  and  
incubating  at  4  °C  for  16  hours.  Embryos  were  then  washed  10  times  in  1  ml  PBST  
at  RT  for  15  minutes  before  replacing  with  secondary  antibodies  (Invitrogen,  USA)  in  
5%  goat  serum  and  1%  DMSO  (Sigma  Aldrich,  UK)  (Table  17)  and  incubating  at  4  °C  
for  16  hours.    
  
Embryos  were  washed  3   times   in  1  ml  PBST  at  RT   for  15  minutes   then,   if  used,  
incubated   with   4’,6-­diaminodino-­2-­phenylindole   (DAPI)   at   RT   for   45   minutes.  
Embryos  were  washed  3  times  in  1  ml  PBST  at  RT  for  15  minutes  before  long-­term  
storage  in  75%  glycerol  in  PBST.  
     




Antigen  (clone)   Species   Dilution     Source  (Cat.  No.)  
ephrinB1a   Rabbit     1:1000   Wilkinson  Lab  
EphB4a   Guinea  pig   1:500   Wilkinson  Lab  
EphA4a   Rabbit     1:500   Wilkinson  Lab  
HuC/D  (16A11)   Mouse  IgG2b   1:200   Molecular  Probes  (A-­21272)  
Table  16  Primary  antibodies  used  for  immunofluorescence  
  
Embryos  were   prepared   for   image   analysis   by   de-­yolking   and   flat  mounting   onto  
slides   in  75%  glycerol   in  PBST.   Imaging  was  carried  out  using  a  Leica  TCS  SP2  
confocal  microscope.  
  
Antibody   Dilution     Source  (Cat.  No.)  
Goat  Anti-­Rabbit  Alexa  Fluor®  488  (IgG  H  +  L)   1:500   Molecular  Probes  
Goat  Anti-­Mouse  Alexa  Fluor®  488  (IgG  H  +  L)   1:500   Molecular  Probes  
Goat  Anti-­Guinea  Pig  Alexa  Fluor®  594  (IgG  H  +  L)   1:500   Molecular  Probes  
Goat  Anti-­Rabbit  594  Alexa  Fluor®  594  (IgG  H  +  L)   1:200   Molecular  Probes  
Table  17  Secondary  antibodies  used  for  immunofluorescence  
  
2.5   RNA-­sequencing  
2.5.1   Library  preparation  
RNA  samples  underwent  quality  control  and  the  concentration  determined  by  using  
the  2100  Bioanalyser  and  recommended  protocol  (Agilent  Genomics).  RNA  samples  
of   high   enough   quality   were   used   to   generate   cDNA   libraries   using   the  
Ovation®  RNA-­Seq   System   V2   and   recommended   protocol   (NuGEN,   The  
Netherlands).    
  
2.5.2   RNA-­sequencing  
cDNA  libraries  were  sequenced  using  a  HiSeq  2000  (Illumina)  performed  by  the  High  
Throughput   Sequencing   facility   at   The   Francis  Crick   Institute.   This   protocol   gave  
paired  end  50  bp  reads.  




2.5.3   Bioinformatic  analysis  of  RNA-­sequencing  data  
RNA-­sequencing  data  analysis  was  performed  by  Probir  Chakravarty  (Francis  Crick  
Institute  Bioinformatic  Platform).  The  quality  of   the  RNA-­sequencing  data  for  each  
sample  was  determined  using  FASTQC  before  aligning  the  reads  to  the  zebrafish  
genome  version  10  using  STAR.  The  number  of  reads  per  gene  were  counted  using  
RSEM   and   quantified   with   genes   less   than   1   transcript   per   million   (TPM)   being  
removed.  The  samples  were  then  normalised  using  DESeq2  and  clustered  based  on  
the   normalised   genes.   Pairwise   comparisons   were   made   between   samples   of  
different   conditions   using   DESeq2   by   carrying   out   a  Wald   Test.   Heat   maps   and  
MAplots  of  differentially  expressed  genes  were  constructed  using  DESeq2.  




Chapter  3.   Blocking  Eph-­ephrin  signalling  in  the  
zebrafish  hindbrain  
3.1   Introduction  
The  aim  of  this  project  is  to  discover  which  genes  are  downstream  of  Eph  receptor  
and  ephrin  signalling  in  the  zebrafish  hindbrain.  One  way  of  identifying  transcriptional  
targets  is  to  block  a  signalling  event  from  occurring  and  compare  the  difference  in  
transcripts  between  this  situation  to  the  wild  type  signalling  state.  In  order  to  identify  
downstream   target   genes,   the   first   aim   of   this   project   was   to   block   Eph-­ephrin  
signalling  in  the  zebrafish  hindbrain.  
  
Previous   studies   have   shown   that   using  MOs  against   various  Eph   receptors   and  
ephrins   known   to   be   expressed   in   the   hindbrain   results   in   the   selective   loss   of  
hindbrain  boundaries  (Cooke  et  al.,  2005;;  Terriente  et  al.,  2012).  This  demonstrates  
that  Eph-­ephrin  signalling  is  upstream  of  boundary  cell  formation  and  the  absence  of  
hindbrain  boundaries  can  be  used  as  a  readout  of  whether  Eph-­ephrin  signalling  has  
been  blocked.    
  
This  chapter  will   focus  on  the  different   techniques  explored   in  an  attempt  to  block  
Eph-­ephrin   signalling   in   the  zebrafish  hindbrain.  MOs,  mutant   zebrafish   lines  and  
soluble  ephrin  ligands  will  be  used  as  methods  to  block  Eph-­ephrin  signalling.  These  
techniques  will  be  used  in  combination  with  in  situ  hybridisation  to  identify  changes  
to   rfng   expression,   a   marker   of   hindbrain   boundaries   which   is   downstream   of  
Eph-­ephrin  signalling  and  will  determine  if  signalling  has  successfully  been  blocked.  
Each  technique  has  advantages  and  disadvantages,  making  it  necessary  to  evaluate  
whether   one,   or   a   combination   of   these,   would   be   needed   to   give   the   desired  
phenotype  of  complete  hindbrain  boundary  cell  loss.  It  will  be  shown  that  expressing  
soluble   ephrinB1a   ligand   at   specific   times   during   development   is   the   optimal  
technique  to  remove  all  rfng  expression,  and  therefore  block  Eph-­ephrin  signalling  in  
the  hindbrain.  




3.2   Morpholino  oligonucleotides  
Morpholino  oligonucleotides  (MOs)  are  short  nucleotide  sequences  around  25  base  
pairs  in  length  that  bind  complementary  RNA  sequences,  thus  blocking  translation  
or  splicing  of  transcripts  and  prevents  protein  expression.  The  MO  structure  differs  
from   that   of  RNA  as   the   ribose  backbone   is   substituted   for  morpholine   rings  and  
hydroxyl   containing   phosphodiester   bonds   are   replaced   by   neutral  
phosphodiamidate   linkers.   This   ensure   that   they   are   stable   and   unable   to   be  
degraded  by  nucleases  (www.gene-­tools.com).  
  
Using  MOs  to  knockdown  gene  function  in  zebrafish  is  a  well-­established  technique  
which  has  several  advantages  for  blocking  Eph-­ephrin  signalling.  Firstly,  this  method  
is  rapid  because  rather  than  generating  stable  lines,  which  can  take  several  months,  
Eph  receptors  and  ephrins  can  be  knocked  down  in  transient  in  the  embryo  from  MO  
injection  at  the  1-­cell  stage.  Another  advantage  is  that  several  different  MOs  can  be  
injected  in  one  cocktail  to  block  multiple  Eph  receptors  and  ephrins  in  the  hindbrain.  
Finally,  some  of  the  MOs  that  target  the  Eph  receptors  and  ephrins  of  interest  have  
already  been  verified  and  the  phenotypes  are  documented.    
  
The  main  disadvantage  of  using  MOs  is  that  they  can  cause  off-­target  effects  due  to  
toxicity.  There  is  a  major  known  effect  mediated  by  Tp53  activation,  which  leads  to  
the  activation  of  the  cell  death  pathway  and  the  expression  of  many  genes.  This  can  
be  suppressed  by  knockdown  or   in  a   tp53  mutant  background  (Robu  et  al.,  2007;;  
Gerety   and  Wilkinson,   2011).   In   addition,   there   is   also   the   uncertainty   of   how   to  
interpret  MO  data  after  several  reported  phenotypes  from  blocking  gene  function  with  
MOs  differing  from  the  phenotypes  found  in  mutants.  This  could  be  the  result  of  off-­
target  effects  of  MOs  or  genetic  compensation  occurring  in  the  mutants  (Rossi  et  al.,  
2015).    
  
3.2.1   Individual  morpholino  oligonucleotide  knockdown  
In   order   to   block   Eph-­ephrin   signalling   in   the   hindbrain,   MOs   against   EphA4a,  
EphB4a,  ephrinB2a   and  ephrinB3b  were  used.  These  Eph   receptors  and  ephrins  
were   targeted   because   of   their   complementary   segmented   expression   in   the  




hindbrain  (Figure  5),  as  well  as  their  known  role  in  boundary  cell  formation  (Xu  et  al.,  
1995;;   Xu   et   al.,   1999;;   Cooke   et   al.,   2001).   MOs   were   injected   individually   into  
zebrafish   embryos   at   the   1-­cell   stage.   The   concentrations   were   optimised   in   an  
attempt  to  give  the  predicted  phenotype  based  on  where  the  Eph-­ephrin  binding  pairs  
are  expressed  and  on  previous  observations   (Cooke  et  al.,  2005;;  Terriente  et  al.,  
2012).  Knocking  down  individual  Eph  receptors  or  ephrins  had  different  efficiencies  
in   giving   hindbrain   boundary   loss   phenotypes,   depending   on   which   Eph-­ephrin  
binding  pair   is   targeted.  The  embryos  developed  normally  after   treatment  and  no  
gross  morphological  phenotypes  were  observed  (data  not  shown).  
  
Targeting  either  EphA4a  or  ephrinB3b  with  MOs   individually   resulted   in   the  same  
phenotype.   In   these   embryos,   rfng   expression   is   lost   at   the   boundaries   of  
rhombomeres  2  and  3  (r2/r3),  r3/r4  and  r5/r6  (Figure  6:  C  and  D);;  the  boundaries  at  
which   EphA4a   and   ephrinB3b   are   exclusively   expressed   and   signal   without  
redundancy  by  EphB4a  and  ephrinB2a.  This  was   seen   in   82%  of   embryos  when  
using  EphA4a  MO  and  36%  of  embryos  when  using  ephrinB3b  MO.  The  difference  
in  penetrance  could  be  due  to  the  efficiency  of  the  MOs.  
  
However,   targeting   either  EphB4a   or   ephinB2a   with   MOs   individually   resulted   in  
embryos  that  displayed  weak  rfng  expression  in  affected  hindbrain  boundaries  whilst  
the  remaining  embryos  maintained  wild  type  rfng  expression.  Embryos  that  displayed  
the  phenotype  had  weaker  expression  of   rfng  at  one  or  both  of   the  boundaries  of  
r1/r2  and  r6/r7  (Figure  6:  E  and  F);;  the  boundaries  at  which  EphB4a  and  ephrinB2a  
are  exclusively  expressed  and  signal  without  redundancy  by  EphA4a  and  ephrinB3b.  
This  was  seen   in  36%  of  embryos  when  using  EphB4a  MO  and  69%  of  embryos  
when  using  ephrinB2a  MO.    
  
It   is   evident   from   individual   knockdown   experiments   that   there   is   redundancy   of  
signalling  by  Eph-­ephrin  binding  pairs  in  the  hindbrain  because  the  r4/r5  boundary  
remains   when   either   EphA4a-­ephrinB3b   or   EphB4a-­ephrinB2a   binding   pairs   are  
targeted   individually.   In   addition,   the   r1/r2   and   r6/r7   boundaries   have   weak   rfng  
expression  when  either  EphB4a  or  ephrinB2a   is  targeted  yet  this  pair  are  the  only  
identified   Eph-­ephrins   at   these   boundaries,   highlighting   that   there   may   be  
undiscovered   Eph-­ephrin   binding   pairs.   Despite   this,   in   an   attempt   to   remove   all  




hindbrain   boundary   cells,   both   known   Eph-­ephrin   binding   pairs   were   targeted   by  
MOs.  As  previously  mentioned  with  individual  MO  knockdowns,  morphant  embryos  
developed  normally  after   treatment  and  no  gross  morphological  phenotypes  were  
observed  (Figure  7:  C,  E,  G).  
  
  
Figure  6  rfng  expression  after  MO  mediated  knockdown  
(A-­H)  Embryos  with  homozygous  background  for   tp53-­/-­  at  19  hpf  after   in  situ  hybridisation  for  
rfng  to  mark  the  hindbrain  boundary  cells.  Arrowheads  point  to  boundaries  that  are  not  affected  
by  MO   knockdown.   Numbers   indicate   the   number   of   embryos   that   show   this   phenotype;;   the  
remainder  have  wild  type  rfng  expression.  The  scale  bar  represents  50  µm.  
  
3.2.2   Combined  morpholino  oligonucleotide  knockdown  
Individual   MOs   against   Eph   receptors   or   ephrins   were   able   to   prevent   specific  
hindbrain   boundaries   from   forming.   In   order   to   remove   all   the   boundaries   and  
completely   block   Eph-­ephrin   signalling   in   the   hindbrain,   MOs   were   used   in  
combination  to  target  either  EphA4a  and  EphB4a  or  ephrinB2a  and  ephrinB3b.  Using  
a  combination  of  MOs  to  knockdown  both  EphA4a  and  EphB4a  or  ephrinB3b  and  




ephrinB2a  successfully  prevented  rfng  expression  in  the  hindbrain  (Figure  6:  G,  H).  
However,  this  was  observed  in  a  low  percentage  of  embryos:  18%  when  targeting  
Eph   receptors   and   38%   of   embryos   for   ephrins.   The   remaining   embryos   have   a  
mixture   of   phenotypes   with   wild   type   or   partial   boundary   loss   phenotypes.   This  
suggests  that  although  it  is  possible  to  completely  block  Eph-­ephrin  signalling  in  the  
hindbrain  by  using  a  combined  MO  approach,  it  is  not  consistent.  In  light  of  this  and  
despite   the   low   penetrance,   this   approach   has   had   some   success   in   blocking  
Eph-­ephrin  signalling  in  the  hindbrain  and  if  the  relevant  embryos  could  be  identified  
they  may  be  suitable  for  RNA-­sequencing.  
  
3.2.3   Hindbrain  morphology  phenotypes  
In   order   to   identify   the   embryos   with   absent   hindbrain   boundaries,   a   specific  
hindbrain  morphology  was  used.  Eph-­ephrin  signalling  causes  constrictions  to  arise  
in  the  hindbrain,  which  is  likely  to  be  the  result  of   increased  cortical  tension  at  the  
interface  of   rhombomeres   (Sela-­Donenfeld  et   al.,   2009;;  Calzolari   et   al.,   2014).   In  
embryos  where  Eph-­ephrin  signalling  is  absent,  the  constrictions  will  not  arise.  It  has  
previously   been   observed   that   the   constrictions   are   visible   from   14ss   (16   hpf)  
(Kimmel   et   al.,   1995)   and   therefore,   the   experiment   was   repeated   with   embryos  
selected  based  on  hindbrain  morphology    at  14  ss  (Figure  7),  before  carrying  out  in  
situ  hybridisation  for  rfng.





Figure  7  Morphological  differences  between  control  and  knockdown  embryos  
(A-­H)  Embryos  at  17  hpf  taken  in  brightfield,  arrowheads  point  to  the  visible  constrictions  of  the  
hindbrain  where  the  boundaries  arise.  (A-­B)  Embryos  when  a  control  MO  has  been  injected  and  
has  wild-­type  morphology  and  five  constrictions  can  be  seen.  (C-­H)  Embryos  after  MO  knockdown  
for  both  EphA4  and  EphB4.  (C-­D)  shows  three  constrictions,  (E-­F)  shows  two  constrictions  with  
a   less   defined   constriction   between,   and   G-­H   shows   smooth   hindbrain   morphology   with   no  
constrictions.  
  
When   embryos   are   selected   with   the   smooth   hindbrain   phenotype,   there   is   an  
increase  in  the  percentage  of  embryos  with  the  loss  of  rfng  from  18%  (Figure  6:  G,  
H)   to  67%  (Table  18).  However,  18%  of  embryos  that  were  selected   in   this  group  
have  partial  boundary  loss  and  15%  have  all  the  boundaries  present  (Table  18). Due  
to   the   similarity   between  morphological   phenotypes   and   the   lack   of   a   robust   and  
reproducible  process  to  characterise  them,  this   is  an  error-­prone  method  to  select  
embryos  where  Eph-­ephrin  signalling  is  blocked.  Consequently,  alongside  the  known  
problem  of  off-­target  effects  of  MOs,  other  techniques  were  explored  in  order  to  find  
a  more  reliable  method  for  blocking  Eph-­ephrin  signalling.    












Smooth  hindbrain   22/33   6/33   5/33  
Intermediate  
morphology  
1/22   21/22   0/22  
Defined  
rhombomeres  
0/117   99/117   18/117  
Table  18  Correlation  between  hindbrain  morphology  and  boundary  loss  
Embryos  with  homozygous  background  for  tp53-­/-­  were  injected  with  6  ng  EphA4a  MO  and  10  ng  
EphB4a  MO  before  sorting  into  groups  at  17  hpf  based  on  hindbrain  morphology.  The  ‘smooth  
hindbrain’   embryos   showed   no   constrictions   where   rhombomere   boundaries   form,   the  
‘intermediate  morphology’  group  showed  two  constrictions  and  the  ‘defined  rhombomeres’  group  
showed  multiple   constrictions.  After   in   situ  hybridisation   for   rfng   embryos   in  each  group  were  
counted  to  determine  the  boundary  phenotypes.  Pearson’s  Chi-­square  test  showed  that  sorting  
hindbrains  based  on  morphology  and  the  boundary  loss  phenotype  are  dependent  on  one  another  
(P  value  of  less  than  0.05).  
  
3.3   Mutant  zebrafish  lines  
The  second  approach  tested  to  block  Eph-­ephrin  signalling  in  the  zebrafish  hindbrain  
was  to  use  mutant  zebrafish  lines.  For  this,  four  individual  mutant  lines  were  used:  
EphA4a-­/-­  (Jordi  Cayuso,  Wilkinson  Lab),  EphB4a-­/-­  (Sanger  Institute),  ephrinB3b-­/-­  
(Megan   Addison,   Wilkinson   Lab),   ephrinB2a-­/-­   (Sanger   Institute).   The   EphA4a  
mutant  was  generated  by  CRISPR  and  has  a  nonsense  mutation  caused  by  a  4  bp  
deletion  an  early  stop  codon  and  truncates  the  protein  in  the  ligand  binding  domain  
and   is   a   null   mutant   (Jordi   Cayuso,   unpublished).   The  EphB4a   mutant   line   was  
generated  as  part  of  the  Zebrafish  Mutation  Project  and  has  a  nonsense  mutation  by  
substitution  of  base  A  to  T  at  residue  R238,  which  lies  just  after  the  ephrin  binding  
domain  and  lacks  EphB4a  expression  (Kettleborough  et  al.,  2013).  The  ephrinB3b  
mutant  was  generated  using  transcription  activator-­like  effector  nucleases  (TALENs)  
which  introduced  a  2  bp  deletion  and  2  bp  substitution  at  residue  R5  and  residue  R6,  
respectively  resulting  in  a  null  mutant  (Megan  Addison,  unpublished).  The  ephrinB2a  
mutant  was  generated  as  part  of  the  Zebrafish  Mutation  Project  and  has  a  nonsense  
mutation  by  substitution  of  base  T  to  A  at  residue  R86,  which  lies  in  the  extracellular  
domain  and  results  in  a  null  mutant  (Kettleborough  et  al.,  2013).    
  




The  main   advantage   of   using  mutant   zebrafish   lines   is   that   there   is   no   issue   of  
off-­target   effects,   unlike   when   using   MOs.   When   using   homozygous   adults   all  
embryos  in  a  clutch  will  carry  the  same  mutations  giving  reliable  biological  replicates  
for   the   experiment.  On   the   other   hand,   the  main   disadvantage   is   that   generating  
mutants  can  be  time  consuming  and  several  generations  of  breeding  are  needed  to  
obtain   homozygous   mutants,   which   were   not   available   when   this   project   began.  
Another  disadvantage  of  this  approach  is  that  it  relies  on  all  the  Eph  receptors  and  
ephrins   that   signal   in   the  hindbrain  being  known  so   that   they  can  be   targeted   for  
mutation.   There   is   the   possibility   that   other   Eph-­ephrin   binding   pairs   could  
compensate   for   signalling   lost   by   those   targeted.  This   compensation   could  be  by  
other  Eph   receptors  and  ephrins   that  do  not  usually  have  a   role   in  boundary   cell  
formation  and  have  not  been  identified  as  present  in  the  hindbrain.  Furthermore,  if  
all  the  Eph  receptors  and  ephrins  that  signal  in  the  hindbrain  were  targeted  by  this  
approach  it  could  be  lethal  due  to  the  multiple  roles  of  Eph-­ephrin  signalling  during  
development.    
  
These  data  shown  here  focus  on  individual  or  double  homozygous  mutants  as  the  
heterozygous  mutants  showed  varied  phenotypes  of  hindbrain  boundary  loss.  The  
homozygous   mutants   for   EphA4a   and   ephrinB2a   as   well   as   the   mutant   line   for  
ephrinB3b  were  not  available  at  the  beginning  of  this  project  and  were  generated  in  
parallel  to  other  experiments.  
  
3.3.1   Individual  Eph  receptor  and  ephrin  mutants  
First,  this  project  set  out  to  determine  which  Eph  receptor  and  ephrin  mutants  disrupt  
the  formation  and  maintenance  of  the  different  hindbrain  boundaries.  It  then  went  on  
to   generate   double   mutants   aiming   to   remove   all   hindbrain   boundaries   and  
completely  block  Eph  ephrin  signalling  in  the  hindbrain.  
  
Individual  homozygous  Eph  receptor  and  ephrin  mutant   lines  were  in-­crossed  and  
the   embryos   collected   at   20   ss   (19   hpf)   to   assess   the   hindbrain   boundary  
phenotypes.  For  EphA4a  and  ephrinB3b,  the  phenotypes  were  similar  showing  the  
selective   loss   of   boundaries   r2/r3,   r3/r4   and   r5/r6   (Figure   8:   D,   E).   This   is   in  




agreement  with  the  hindbrain  boundary  phenotypes  after  knockdown  of  either  Eph  
or  ephrin  of  this  binding  pair  individually  using  MOs  (Figure  6:  C,  D).    
  
In  contrast,  for  individual  EphB4a  and  ephrinB2a  homozygous  mutants  there  was  no  
complete  loss  of  the  predicted  hindbrain  boundaries  at  r1/r2  and  r6/r7  (Figure  8:  B,  
C).   EphB4a   homozygous   mutants   showed   weaker   rfng   expression   at   the   r6/r7  
boundary,  but  ephrinB2a  showed  wild  type  rfng  expression.  This  is  different  from  the  
MO  knockdown  experiments  where  the  r1/r2  and  r6/r7  boundaries  were  sometimes  
seen  to  be  weaker  in  EphB4a  and  ephrinB2a  morphants  (Figure  6:  E,  F).  
  
  
Figure  8  Hindbrain  boundary  phenotypes  of   individual  Eph  receptor  and  ephrin  
mutants  
(A-­H)  Embryos  at  19  hpf  after  in  situ  hybridisation  for  rfng  to  mark  the  hindbrain  boundary  cells.  
Arrowheads  point  to  boundaries  that  are  not  affected  in  the  mutant  embryos  (B-­E).  The  scale  bar  
represents  50  µm.    
  
3.3.2   Double  Eph  receptor  and  ephrin  mutants  
In   attempts   to   block   Eph-­ephrin   signalling   in   the   hindbrain   and   lose   all   hindbrain  
boundaries,   double   mutants   were   generated   for   EphA4a   plus   EphB4a   and   for  
ephrinB2a  plus  ephrinB3b.  By  targeting  either  both  receptors  or  both  ligands  it  should  
prevent  any  compensation  by  the  Eph  receptor  or  ephrin  from  the  other  of  the  two  
Eph-­ephrin   binding   pairs.   Double   homozygous   Eph   or   ephrin   mutants   were  
generated  by  out-­crossing  homozygous  fish  of  each  mutation  together  (Figure  9:  A)  
raising   the   double   heterozygous   embryos   then   in-­crossing   these   (Figure   9:   B)   to  
generate   a   mixture   of   phenotypes   and   identify   the   double   homozygous   mutants  
(Figure  9:  C).  The  double  homozygotes  were  then  in-­crossed  (Figure  9:  D)  and  the  
embryos  collected  to  determine  the  hindbrain  boundary  phenotypes  (Figure  9:  E).  





Figure  9  Generation  of  double  homozygous  mutant  embryos  
This  schematic  demonstrates  how  homozygous  double  mutant  embryos  were  generated.  This  
example  shows  EphA4a  and  EphB4a  double  mutants.  The  protocol  was  the  same  for  ephrinB2a  
and  ephrinB3b  double  mutants.   (A)  Single  heterozygous  mutant   lines  are  crossed  and  (B)   the  
double  heterozygous  embryos  are   raised   to  adults  and   in-­crossed.   (C)  The  embryos  are   then  
raised  to  adults  and  genotyped  to  identify  double  homozygous  mutants  (highlighted  by  box).  (D)  
The  double  homozygous  mutants  are  then  in-­crossed  and  (E)  the  embryos  collected  at  20  ss  for  
downstream  analysis.  




The   double   homozygous   mutants   of   EphA4a   and   EphB4a   or   ephrinB2a   and  
ephrinB3b   showed   the   same   hindbrain   boundary   phenotype   as   the   individual  
homozygous  mutants  EphA4a  and  ephrinB3b.  The  remaining  boundaries  are  r1/r2,  
r4/r5  and  r6/r7  (Figure  10).  This  is  surprising  because  in  the  equivalent  double  Eph  
receptor   and   ephrin   morphants   there   is   a   subset   that   completely   lacks   rfng  
expression  in  the  hindbrain.    
  
  
Figure   10   Hindbrain   boundary   phenotypes   of   double   Eph   receptor   and   ephrin  
mutants  
(A-­H)  Embryos  at  19  hpf  after  in  situ  hybridisation  for  rfng  to  mark  the  hindbrain  boundary  cells.  
Arrowheads  point  to  boundaries  that  are  not  affected  in  the  mutant  embryos  (B-­E).  The  scale  bar  
represents  50  µm.    
  
This  suggests  there  is  redundancy  and  that  another  Eph-­ephrin  pair  is  able  to  induce  
hindbrain   boundary   formation   in   addition   to   EphA4a-­ephrinB3b   and  
EphB4a-­ephrinB2a.  One  potential  mechanism  is  the  ephrinB1a-­EphB3a  binding  pair,  
which  also  has  a  segmental  and  complementary  expression  pattern  in  the  hindbrain  
and  was  identified  after  the  multiple  mutant  lines  had  started  to  be  generated.  It  has  
been  shown  that  genetic  compensation  occurs  in  some  mutants  but  not  in  morphants  
(Rossi   et   al.,   2015).   It   is   therefore   possible   that   genetic   compensation   occurs   in  
Eph-­ephrin  mutants  and  not  in  the  morphants.    
  
These   experiments   have   shown   that   it   would   be   necessary   to   generate   further  
mutants  in  order  to  completely  block  Eph-­ephrin  signalling  in  the  hindbrain.  Individual  
mutants  of  EphA4a,  EphB4a,  ephrinB2a  and  ephrinB3b  or  double  mutants  of  the  Eph  
receptors  or  ephrins  are  not  sufficient  to  remove  all  hindbrain  boundaries.  Generating  
a  mutant  that  completely  lacks  all  hindbrain  boundaries  has  not  yet  been  achieved  




at   the   time   of   writing.   However,   the   double   Eph   receptor   or   ephrin   mutants   will  
provide   a   useful   tool   for   confirming   transcriptional   targets   identified   by   RNA-­
sequencing.   There   are   likely   to   be   other   Eph   receptors   and   ephrins   signalling  
redundantly  in  the  hindbrain,   in  which  case  a  broadly  blocking  method  would  be  a  
more  useful  approach  than  targeting  a  specific  Eph-­ephrin  binding  pair  by  MOs  or  
mutation.  
  
3.4   Soluble  ephrin  ligands  
Soluble   ephrins   are   C-­terminally   truncated   so   that   they   lack   the   intracellular   and  
transmembrane  domains  and  as  a  result  are  not  membrane  bound.  Upon  binding  to  
an  Eph   receptor,   soluble  ephrins   cannot   initiate   the   clustering  needed   to  activate  
downstream  signalling,  resulting  in  signalling  inhibition  (Davis  et  al.,  1994).  Due  to  
the   promiscuous   binding   of   Eph   receptors   and   ephrins,   this   technique   has   the  
advantage   that   one   ephrin   can   be   over-­expressed   to   bind   and   block   signalling  
through  multiple  Eph  receptors.  
  
The  UAS   promoter   can   be   cloned   upstream   of   the   soluble   ephrin   enabling   over-­
expression   to   be   controlled   both   spatially   and   temporally.   This   becomes  
advantageous  in  the  event  that  blocking  Eph-­ephrin  signalling  globally  has  a  lethal  
effect  on  embryonic  development,  because  blocking  signalling  can  be  postponed  to  
a   later   stage   of   development.   In   addition,   with   the   use   of   a   hindbrain   specific  
promoter,  blocking  of  Eph-­ephrin  signalling  can  be   targeted   to   the  hindbrain.  This  
avoids   disruption   to   other   areas   of   the   embryo   during   development   as   well   as  
ensuring   any   effects   to   gene  expression  which   are   specific   to   the   hindbrain.   The  
disadvantage   of   this   technique   is   that   there   is   not   a   hindbrain   only   promoter   line  
available,  so  the  expression  of  the  soluble  ephrin  cannot  be  spatially  controlled.  
  
Previous  experiments  measuring  the  binding  affinity  of  ephrin-­Fc  fusion  proteins  to  
Eph  receptors  suggested  that  ephrinB2a  would  be  the  most  suitable  candidate  for  
blocking   Eph-­ephrin   signalling   (Noberini   et   al.,   2012)   (Table   19).   Several   ephrin  
ligands  were  measured  and  ephrinB2a  had  the  highest  binding  affinity  for  the  three  
Eph   receptors   known   to   be   expressed   in   the   hindbrain   (EphA4a,   EphB4a   and  




EphB3a)  and  high  binding  affinity  for  other  EphB  receptors.  Consequently,  if  there  is  
redundant   signalling   by   other   Eph-­ephrin   binding   partners   that   have   not   been  
identified,  this  gives  the  highest  chance  of  blocking  Eph-­ephrin  signalling.  However,  
there  was  already  a  zebrafish  line  available  that  expressed  soluble  ephrinB1a  under  
the   control   of   a   UAS   promoter   (Jordi   Cayuso,   Wilkinson   Lab).   Preliminary  
experimentation  was   carried   out   using   this   line,  which   showed   it  was   possible   to  
block  Eph-­ephrin  signalling  using  soluble  ephrinB1a  and  further  experiments  were  
carried  out  with  this  transgenic  line.  
  
   m-­ephrinB1   m-­ephrinB2   h-­ephrinB3  
m-­EphA4   13  ±  0.84   4.2  ±  0.44   12  ±  3.1  
r-­EphB1   2  ±  0.23   0.88  ±  0.14   6.3  ±  0.85  
m-­EphB2   3.5  ±  0.23   0.73  ±  0.09   7.1  ±  1.5  
m-­EphB3   2.5  ±  1.1   1.2  ±  0.18   2.9  ±  0.21  
m-­EphB4   18  ±  3.0   2.3  ±  0.58   >50  
m-­EphB6   8.3  ±  4.0   1.6  ±  0.58   11  ±  4.5  
Table  19  Binding  affinities  of  Eph  receptors  and  ephrins  
Published  dissociation  constant  (KD)  for  different  Eph  receptors  and  ephrins  (Noberini  et  al.,  2012)  
measured   using   biotinylated   ephrin-­Fc   fusion   proteins   and   Eph   receptor-­Fc   fusion   proteins.  
Fusion  proteins  are  human  (h),  mouse  (m)  or  rat  (r).  
  
3.4.1   Optimisation  of  heat  shock  protocol  
The  optimised  protocol  for  over-­expressing  soluble  ephrinB1a  in  embryos  is  shown  
in  Figure  11.  Due  to  the  HS-­Gal4  line  having  multiple  integrations  of  the  transgene  
as  a   result  of  prolonged  breeding,   the   inheritance  of  both   transgenes  varies   from  
25-­50%,  and   therefore   the  maximum  number  of  embryos  with  complete  hindbrain  
boundary   cell   loss   is   between   these   values.   Initial   experiments   were   carried   out  
crossing  the  UAS-­soluble  ephrinB1a  line  to  a  heat  shock  inducible  Gal4  driver  and  a  
tamoxifen  inducible  Gal4  driver,  to  see  which  was  most  effective.    
  
For  the  heat  shock  induction  experiments,  the  length  of  heat  shock  was  tested  for  30  
minutes  and  1  hour.  The  time  of  heat  shock  was  also  optimised  by  testing  heat  shock  
at  6  ss,  or  at  bud,  or  at  bud  followed  by  12  ss.  These  experiments  showed  that  in  
order   to   obtain   the   maximum   number   of   embryos   possible   with   no   hindbrain  
boundaries  it  is  more  efficient  to  use  the  heat  shock  inducible  Gal4  line  and  it  was  




necessary  to  perform  two  heat  shocks  that  lasted  for  1  hour  at  38oC,  the  first  at  bud  
stage,  then  the  second  at  12  ss  (Figure  11).  
  
  
Figure  11  Heat  shock  protocol  for  over-­expressing  soluble  ephrinB1a  
Two  crossed  were  set  up:  (A)  UAS-­soluble  ephrinB1a  fish  crossed  to  HS-­Gal4   fish  or  (B)  HS-­
Gal4  fish  in-­crossed  as  a  control.  Embryos  were  collected  and  subject  to  two  heat  shocks:  at  bud,  
then  at  12  ss,  before  collecting  at  20  ss  for  analysis.  
  
When  HS-­Gal4  fish  are  out-­crossed  to  UAS-­soluble  ephrinB1a  fish  and  the  embryos  
are  heat  shocked  twice  (Figure  12:  C-­D),  58%  of  embryos  show  complete  boundary  
cell   loss  and  the  remaining  42%  show  no   loss  of  boundary  cells  (Figure  12:  C-­F).  
100%  of  control  embryos  have  all  hindbrain  boundaries  present  (Figure  12:  A-­B).    






Figure  12  Hindbrain  boundary  phenotypes  after  soluble  ephrinB1a  expression  
(A-­H)  Embryos  at  19  hpf  after  in  situ  hybridisation  for  rfng  to  mark  the  hindbrain  boundary  cells.  
Arrowheads  point   to  boundaries   that   remain  after  heat  shock.  A-­B,  C-­D,  E-­F  are  of   the  same  
embryo  at  different  magnifications.  A-­B  are  control  embryos  where  the  HS-­Gal4   line  has  been  
in-­crossed,  C-­F  are  two  different  phenotypes  from  the  HS-­Gal4  x  UAS-­soluble  ephrinB1a  cross.  
The  scale  bar  represents  50  µm.    
  
3.4.2   Confirmation  of  soluble  ephrinB1a  over-­expression  
As  it  is  not  possible  to  simultaneously  detect  ectopic  ephrinB1a  and  rfng  expression,  
the   percentage   of   embryos   expressing   soluble   ephrinB1a   and   the   percentage   of  
embryos  lacking  rfng  expression  was  determined  to  ensure  that  they  correlated.  The  
antibody   used   to   detect   soluble   ephrinB1a   can   also   recognise   the   endogenous  
ephrinB1a.  The  expression  of  the  soluble  protein  thus  led  to  an  increase  in  staining  
in  comparison  to  wild  type.    
  
First,  it  was  ascertained  that  heat  shock  is  inducing  ephrinB1a  transcript  (Figure  13),  
but  it  is  important  to  know  whether  the  soluble  ephrinB1a  protein  is  expressed  since  
this   is   the   blocking   reagent.   Therefore,   immunostaining   for   ephrinB1a   expression  
was  carried  out  (Figure  14).    





At  20  ss,  endogenous  ephrinB1a  is  expressed  broadly  across  the  hindbrain  in  the  
dorsal  region,  shown  in  control  embryos  (Figure  13:  C).  In  41%  of  embryos  from  the  
HS-­Gal4   cross  with  UAS-­soluble  ephrinB1a   there   is   strong  ephrinB1a   expression  
across  the  whole  embryo  (Figure  13:  F;;  Figure  14:  F).  The  percentage  of  embryos  
over-­expressing  soluble  ephrinB1a  protein  was  found  to  be  43-­64%  (Figure  14:  D-­F)  
and  the  percentage  of  embryos  with  absent  hindbrain  boundaries  was  50-­67%  (over  
three  experimental  replicates)  (Figure  12:  C-­D).  
  
A   time   course   was   conducted   in   order   to   see   if   soluble   ephrinB1a   protein   was  
degraded  during  the  time  of  the  experiment.  Embryos  were  collected  1  hour  after  the  
first  heat  shock  at  bud,  at  5  ss,  and  1  hour  after  the  second  heat  shock  at  15  ss  and  
finally   at   20   ss.   43%,   57%   and   41%   of   embryos   from   the   HS-­Gal4   cross   with  
UAS-­soluble  ephrinB1a  showed  over-­expression  of  ephrinB1a  protein,  at  5  ss,  15  ss  
and  20  ss,  respectively  (Figure  14:  D-­F).  This  demonstrates  that  soluble  ephrinB1a  
does  not  degrade  during  the  time  embryos  will  be  collected  for  RNA-­sequencing.    





Figure  13  Confirming  soluble  ephrinB1a  expression  by  in  situ  hybridisation  
A-­I)  Embryos  at  5  ss  (A,  D,  G),  15  ss  (B,  E,  H),  or  20  ss  (C,  F,  I)  after   in  situ  hybridisation  for  
ephrinB1a.   A-­C   Control   embryos   from   HS-­Gal4   in-­cross   and   D-­I   embryos   from   HS-­Gal4   x  
UAS-­soluble  ephrinB1a  out-­cross.  The  scale  bar  represents  100  µm.





Figure  14  Confirming  soluble  ephrinB1a  expression  by  immunofluorescence  
(A-­I)  ephrinB1a  expression  detected  by  immunofluorescence  in  embryos  at  either  5  ss  (A,  D,  G),  
15  ss  (B,  E,  H),  or  20  ss  (C,  F,  I).  A-­C  are  control  embryos  from  HS-­Gal4  in-­cross  and  D-­I  are  
from  HS-­Gal4  x  UAS-­soluble  ephrinB1a  out-­cross,  all  embryos  have  been  heat  shocked  at  bud  
and  12  ss.  The  scale  bar  represents  50  µm.  
  
It   was   observed   that   when   soluble   ephrinB1a   protein   is   expressed   there   is   a  
down-­regulation   of   EphB4a   protein   (Figure   15).   It   is   well   established   that   when  
signalling   is   activated   it   leads   to   internalisation   of   the   receptor-­ligand   complex  
(Marston  et  al.,  2003;;  Zimmer  et  al.,  2003;;  Mann  et  al.,  2003;;  Lauterbach  and  Klein,  
2006;;   Goh   and   Sorkin,   2013).   This   is   a   surprising   observation   because  
over-­expression  of  soluble  ephrinB1a  is  thought  to  block  signalling  and  the  loss  of  




boundary  cells  would  support  this  (Figure  12).  In  contrast,  EphA4a  protein  was  also  
investigated   and   was   not   found   to   be   down-­regulated   upon   soluble   ephrinB1a  
over-­expression.   This   suggests   that   activation   may   be   selective   for   specific   Eph  
receptors.  Further  evidence  to  support  that  soluble  ephrinB1a  is  acting  as  a  blocking  
or  activating  reagent  has  not  been  found  and  will  be  discussed  in  Chapter  7.3.    
  
  
Figure  15  The  effect  of  ephrinB1a  expression  on  EphB4a  
(A-­E)  Immunofluorescence  at  20  ss  detecting  either  ephrinB1a  (A-­C)  or  EphB4a  (D-­F).  A,  D  are  
control  embryos  from  HS-­Gal4  in-­cross  and  B,  C,  E,  F  are  from  HS-­Gal4  x  UAS-­soluble  ephrinB1a  
out-­cross,  all  embryos  have  been  heat  shocked  at  bud  and  12  ss.  The  scale  bar  represents  100  
µm.  
  
3.5   Discussion  
From   the  experiments  described   in   this  chapter,   it  has  been  shown   that   the  most  
effective  way  to  block  Eph-­ephrin  signalling  in  the  hindbrain  is  to  use  a  soluble  ephrin  
approach  to  globally  block  Eph-­ephrin  signalling  in  the  embryo.  The  readout  used  to  
determine  if  Eph-­ephrin  signalling  had  been  blocked  was  to  look  at  rfng  expression  




by  in  situ  hybridisation,  to  see  if  the  hindbrain  boundary  cells  had  been  lost.  Absence  
of  hindbrain  boundary  cells  shows  that  Eph-­ephrin  signalling  has  successfully  been  
blocked  (Xu  et  al.,  1995;;  Cooke  et  al.,  2005;;  Terriente  et  al.,  2012).  
  
Use  of  a  cocktail  of  MOs  generated  embryos  with  the  desired  phenotype  of  complete  
hindbrain   boundary   cell   loss.   However,   this   was   inconsistent   within   a   clutch   of  
injected   embryos   as   there   was   a   mixture   of   phenotypes   ranging   from   complete  
boundary  loss  to  wild  type  hindbrain  boundary  cell  phenotypes.  By  sorting  embryos  
at   17   hpf   on   the   basis   of   hindbrain   morphology,   the   hindbrain   boundary   loss  
phenotype  could  be  enriched.  Unfortunately,  this  only  increased  the  percentage  of  
embryos  with  complete  hindbrain  boundary   loss  from  18%  to  67%.  The  remaining  
embryos  had  partial  hindbrain  boundary  loss  or  were  the  same  as  wild  types.  This,  
in   combination  with   the   off-­target   effects   of  MOs   resulted   in   this   technique  being  
abandoned   for   RNA-­sequencing.   However,   targeting   individual   Eph   receptors   or  
ephrins  with  MOs  could  be  a  useful  tool  for  the  confirmation  of  target  genes  identified  
by  RNA-­sequencing.  
  
Using  mutant  zebrafish   lines  was  unsuccessful  at  giving  the  desired  phenotype  of  
complete   hindbrain   boundary   cell   loss.   However,   the   double   mutant   lines   did  
highlight  that  there  is  further  redundancy  of  signalling  in  the  hindbrain  that  is  able  to  
induce   boundary   cell   formation.   This   was   shown   by   the   persistence   of   the   r4/r5  
hindbrain   boundary   when   signalling   through   both   EphA4a-­ephrinB3b   or   EphB4a-­
ephrinB2a  binding  pairs  was  interfered  with  by  mutating  both  these  Eph  receptors  of  
ephrins.  One  beneficial  outcome  was  that  this  generated  a  useful  tool  for  validating  
transcriptional   targets   that   are   identified   from   RNA-­sequencing.   In   particular,   the  
double   Eph   receptor   and   ephrin   homozygous   mutants   give   partial   hindbrain  
boundary   loss   phenotypes   which   can   be   used   to   investigate   if   more   broadly  
expressed  transcriptional  targets  have  altered  expression  in  localised  regions  of  the  
hindbrain.  Moreover,   it  may  highlight  target  genes  that  are  downstream  of  forward  
and  reverse  signalling.  
  
The   chosen   method   to   block   Eph-­ephrin   signalling   was   to   use   a   soluble   ephrin  
approach.  For   this  approach,   it   is  not  a  prerequisite   to  know  all  of   the  Eph-­ephrin  
interactions  in  the  hindbrain,  unlike  with  the  targeted  approaches  of  MOs  and  mutant  




lines.   By   using   soluble   ephrins,   it   is   possible   to   target   Eph-­ephrin   signalling   in   a  
non-­biased  way,   by  globally   blocking   signalling   from  multiple  Eph   receptors.  This  
ensures  that  any  compensatory  signalling  by  other  Eph-­ephrin  binding  pairs,  that  are  
not   known,   will   also   be   blocked.   Using   this   approach   with   temporal   control   also  
avoids  lethality  from  early  blocking  of  Eph-­ephrin  signalling.  From  these  experiments,  
it   was   found   that   blocking  Eph-­ephrin   signalling   before   bud   stage   resulted   in   the  
death  of  around  50%  of  embryos  which  correlates  to  the  number  that  would  inherit  
both   the   transgenes  and  be  capable  of  over-­expressing  soluble  ephirnB1.  This   is  
likely  to  be  because  of  roles  of  Eph-­ephrin  signalling  in  early  embryonic  development.    
  
To  block  Eph-­ephrin   signalling  using   the  soluble  ephrin  approach,   two   transgenic  
lines   were   out-­crossed.   This   gave   rise   to   a   clutch   of   embryos   in   which   25-­50%  
contain   both   the   HS-­Gal4   and   UAS-­soluble   ephrinB1a   transgenes,   while   the  
remaining  50-­75%  of  embryos  will  contain  one  or  none  of  the  transgenes.  This  has  
the   advantage   that   if   the   embryos   can   be   sorted   according   to   their   transgenic  
inheritance  then  one  subset  of  the  clutch  can  be  used  for  the  controls  with  normal  
Eph-­ephrin   signalling,   and   the   remainder   for   the   experimental   sample   in   which  
Eph-­ephrin   signalling   has   been   blocked.   This   should   minimise   inter-­clutch  
background  gene  expression  differences.    
  
When  collecting  samples  for  RNA-­sequencing  it  will  be  important  to  ensure  that  there  
are  enough  biological  replicates  so  that  there  are  sufficient  numbers  for  the  control  
and  experiments  groups.  It  will  also  be  important  to  identify  a  way  of  screening  the  
samples  prior  to  RNA-­sequencing  so  that  the  genetic  background  of  the  samples  can  
be  confirmed.  
  
3.6   Conclusion  
In  this  chapter,  three  different  methods  were  tested  to  block  Eph-­ephrin  signalling  in  
the  hindbrain.  It  was  discovered  that  the  best  approach  is  to  use  soluble  ephrins  to  
globally  block  Eph-­ephrin  signalling   in   the  embryo,  eliminating  any   redundancy   in  
signalling  by  other  Eph  receptors  and  ephrins.  This  technique  has  also  enabled  any  
potential   problems   of   lethality   to   be   avoided   by   inducing   soluble   ephrinB1a  




expression,  to  block  Eph-­ephrin  signalling  at  a  time  where  endogenous  Eph-­ephrin  
signalling   is   initiated   in   the   hindbrain.   Therefore,   earlier   Eph-­ephrin   signalling   for  
other   roles  during  development   is  not  disrupted.  This  minimises  changes   in  gene  
expression  resulting  from  blocking  Eph-­ephrin  signalling  outside  the  hindbrain  that  is  
not  of  interest  in  this  project.  
  
The   next   chapter   will   focus   on   the   second   aim   of   the   project   ‘to   identify   the  
transcriptional  targets  of  Eph  receptor  and  ephrin  signalling’.  In  order  to  do  this,  firstly  
the  best  sample  type  for  RNA-­sequencing  will  be  investigated.  Secondly,  a  quality  
control  protocol  was  developed  in  order  to  ensure  that  differences  between  samples  
are  minimised.  Finally,  a  method  was  set  up  to  identify  the  control  samples  from  the  
samples  over-­expressing  soluble  ephrinB1a.  The  findings  from  the  RNA-­sequencing  
screen  will  also  be  presented.  




Chapter  4.   Preparation  of  zebrafish  hindbrains  for  
RNA-­sequencing  
4.1   Introduction  
RNA-­Sequencing  is  a  highly  sensitive  technique  that  for  the  scope  of  this  study  could  
enable  the  transcriptome  of  samples  to  be  comparatively  quantified,  generating  a  list  
of   potentially   interesting   candidate   genes   for   investigation.   Previous   experiments  
have   identified   transcriptional   targets   of   Eph-­ephrin   signalling,   in   the   gut   and  
keratinocytes,  some  of  which  were  also  carried  out  in  vitro  (Genander  et  al.,  2009;;  
Walsh   and   Blumenberg,   2011;;  Walsh   and   Blumenberg,   2012).   The   focus   of   this  
study  is  to  identify  target  genes  specific  to  Eph-­ephrin  signalling  in  the  hindbrain.  
  
In  this  chapter,  preparative  investigations  are  undertaken  to  determine  the  optimal  
number   of   embryos   per   sample   and   whether   dissection   is   required   for   the  
identification   of   hindbrain   specific   Eph-­ephrin   target   genes.   After   deciding   that  
hindbrain  dissections  are  more  appropriate,  methods  were  developed  for  screening  
samples  to  ensure  the  least  contamination  from  tissues  surrounding  the  hindbrain.  
These  experiments  were  carried  out  using  RT-­qPCR  and  exploited  the  knowledge  of  
genetic  markers  for  specific  regions  in  the  embryo.  
  
As  discussed  in  Chapter  3.4.1,  expression  of  soluble  ephrinB1a  will  be  used  to  block  
Eph-­ephrin   signalling   in   embryo.   This   is   achieved  by   crossing   the   transgenic   line  
HS-­Gal4  with  the  transgenic  line  UAS-­soluble  ephrinB1a,  which  will  give  a  clutch  of  
embryos   that   inherit   one,   both   or   none   of   the   transgenes.   In   this   chapter,   an  
RT-­qPCR   protocol   has   been   designed   in   order   to   differentiate   between   control  
hindbrains   and   hindbrains   that   express   soluble   ephrinB1a.   This   enables   the  
hindbrains   in   which   Eph-­ephrin   signalling   is   blocked   to   be   selected   and   by  
RNA-­sequencing   and   comparing   transcripts   to   the   control   group,   genes   that   are  
differentially  expressed  can  be  identified.  




4.2   Optimisation  of  sample  
The   first   question   addressed   was   whether   it   was   necessary   to   dissect   out   the  
hindbrain   from  zebrafish  embryos  or  whether  using  whole  embryos  would  suffice.  
The  latter  would  ensure  that  the  hindbrains  remain  undamaged  and  the  sample  can  
be  replicated  reliably  because  there  is  no  manipulation  to  the  embryo.  However,  this  
could  result  in  global  gene  expression  diluting  acute  effects  occurring  specifically  in  
the  hindbrain,  as  it  is  a  small  region  of  tissue  in  comparison  to  the  embryo  as  a  whole.    
  
To  investigate  whether  hindbrain  dissection  is  essential,  40  whole  embryos  and  40  
hindbrain  dissections  were  pooled   into   their   respective  groups  and  converted   into  
cDNA  libraries  for  analysis  by  RT-­qPCR.  Three  genes,  krox20,  six3a  and  hoxB6a,  
were   profiled   to   examine   any   differences   in   relative   expression   between   the   two  
batches.  krox20   is  expressed  in  r3  and  r5  and  was  used  to  determine  if  hindbrain  
specific  genes  were  enriched  when  hindbrains  were  dissected.  six3a   is  expressed  
anteriorly  to  the  hindbrain  and  hoxB6a  is  expressed  posteriorly  to  the  hindbrain;;  both  
of   these  were  used   to  determine   if  genes   that  are  not  expressed   in   the  hindbrain  
could  be  eliminated  or  decreased  in  the  hindbrain  dissected  sample.    
  
In  the  sample  comprised  of  dissected  hindbrains,  there  is  a  4.9-­fold  enrichment  of  
krox20   transcripts   in  comparison  to  whole  embryos.  This  reflects  the  proportion  of  
total   embryo   tissue   in   the   hindbrain   sample.   Although   six3a   and  hoxB6a   are   not  
expressed  in  the  hindbrain,  there  is  still  some  expression  detected  in  the  hindbrain  
dissections.   There   is   a   6.7-­fold   and   1.2-­fold   decrease   of   six3a   and   hoxB6a  
transcripts,   respectively,   in   the   hindbrain   dissections   in   comparison   to   the   whole  
embryos  (Figure  16).  This  shows  that  the  hindbrain  dissections  contain  more  tissue  
that  is  posterior  to  the  hindbrain  than  anterior.  This  is  likely  to  be  due  to  the  difficulty  
of   dissections   as   a   result   of   the   morphological   markers   in   the   posterior   of   the  
hindbrain  being  less  defined  than  in  the  anterior.  
  
  





Figure   16   Comparison   of   gene   expression   in   whole   embryos   and   hindbrain  
dissections  
(A)  Fold  change  of  gene  expression  in  hindbrain  samples  in  comparison  to  whole  embryos.  Each  
sample  contains  40  embryos  or  40  dissected  hindbrains  at  19  hpf.  (B)  Schematic  of  a  zebrafish  
embryo  at  19  hpf  showing  the  expression  pattern  of  krox20  (green),  six3a  (yellow)  and  hoxB6a  
(blue).  
  
Any   contamination   in   the   hindbrain   dissections   could   mean   that   there   are   false  
positives  or  negatives  of   transcripts.  For  example,   it   has  been  observed   that   rfng  
expression   in   the   midbrain-­hindbrain   boundary   (MHB)   remains   when   Eph-­ephrin  
signalling  is  blocked  by  soluble  ephrinB1a  (Figure  12).  If  this  tissue  is  not  eliminated  
from  the  samples  it  could  make  the  data  difficult  to  interpret,  since  it  could  mean  that  
target  genes  with  lower  expression  when  Eph-­ephrin  signalling  is  blocked  may  not  
be  identified  as  expression  in  the  MHB  will  mask  this   loss.  In  addition,  Eph-­ephrin  
signalling   is  active   in  many   tissues  with  different   roles,  such  as  angiogenesis  and  
somite   formation   (Gerety   and   Anderson,   2002;;   Davy   and   Soriano,   2007),   thus  
making  it   important  to  collect  only  the  relevant  tissue.  To  maximise  the  quantity  of  
relevant  material  in  samples  collected  for  RNA-­sequencing  it  was  important  to  ensure  
that  high  quality,  uncontaminated  RNA  could  be  extracted  from  zebrafish  hindbrains.  
Therefore,  it  is  also  important  that  the  dissections  are  consistent  across  all  hindbrain  
samples.  
  




An   additional   problem   with   pooling   embryos   is   that   there   will   be   a   mixture   of  
transgenic   backgrounds.   Only   a   subset   of   these   embryos   will   contain   both   the  
transgenes   HS-­Gal4   and   UAS-­soluble   ephrinB1a   and   over-­express   soluble  
ephrinB1a  when  heat  shocked.  If  embryos  are  pooled  then  this  will  weaken  the  signal  
of  differentially  expressed  genes  when  Eph-­ephrin  signalling  is  blocked.  
  
Embryos  were  therefore  collected  individually  after  hindbrain  dissection  in  order  to  
determine   if  all,  or  some,  of   the  dissections  have  contamination   from  surrounding  
tissue.  The  expression  profile  of  five  genes  that  are  expressed  in  the  hindbrain  and  
the   adjacent   tissues   were   quantified   by   RT-­qPCR   to   measure   the   consistency  
between  dissections  (Figure  17).  
  
There  is  variation  between  the  dissected  hindbrains  in  the  number  of  transcripts  from  
genes   that   are   not   expressed   in   the   hindbrain.   The   dissections   are   technically  
challenging  and  performed  manually  with  forceps,  which  is  likely  to  give  rise  to  some  
differences  from  one  dissection  to  the  next.  In  some  cases,  there  are  higher  levels  
of  six3a  detected  than  otx2,  despite  otx2  being  expressed  in  tissue  adjacent  to  the  
hindbrain   and   six3a   further   towards   the   anterior.   This   may   be   a   result   of   tissue  
fragments  contaminating  hindbrain  dissections.  However,  this  variation  can  be  kept  
to  a  minimum  and  similar  level  by  setting  a  defined  threshold  that  contamination  must  
be   less   than   in   order   to   qualify   for   RNA-­sequencing.   The   level   of   contaminating  
genes   was   measured   in   eight   hindbrain   dissections   to   determine   the   variation  
between  samples  (Figure  17).  From  the  maximum  level  of  expression  detected  of  
the  three  contaminating  genes,  a  threshold  was  set  to  25%  of  the  highest  levels  of  
contamination  detected  for  six3a,  otx2  and  hoxB6a  (Figure  17).  
  
In  some  samples,  there  were  undetectable  levels  of  contaminating  transcripts,  which  
is  characterised  as  undetected   in   the   raw  RT  qPCR  data.  To  enable  comparative  
quantification   of   these   samples   against   samples   with   detectable   levels,   the   CT  
values  were  adjusted  to  40  which  corresponds  to  the  maximum  number  of  cycles  in  
the  protocol,   representing   the   lowest  detectable  amount.   In  all  of   the  sets  of  data  
analysis   there  were   transcripts  with   undetected  CT   values   that  were   altered   to   a  
value  of  40,  reflecting  that  dissections  reproducibly  eliminated  unwanted  tissue.  
  





Figure  17  Expression  profiles  of  genes  representing  contamination   in  wild   type  
hindbrains  
(A)  40-­ΔCT  values  to  show  higher  expression  as  a  higher  value,  expression  is  shown  as  Log2.  
(B)   Expression   of   the   genes   on   a   linear   scale,   shown   as   a   percentage   of   the   gene   with  
contaminating   samples   at   the   highest   level,   in   this   case   hoxB6a   in   HB8.   (A-­B)   The   ΔCT   is  
calculated  by  normalising  to  β-­actin  expression  in  each  hindbrain.  Undetected  gene  expression  
was  given  the  maximum  cycle  value  40  and  the  number  of  undetected  triplicates  is  marked  with  
*.  (C)  Schematic  of  a  zebrafish  embryo  at  19  hpf  showing  where  the  four  genes  are  expressed  in  
the  embryo  at  this  stage.  
  
4.3   Sample  selection  for  RNA-­sequencing  
Three   separate   sets   of   dissections   were   carried   out   and   hindbrains   collected   by  
crossing  HS-­Gal4  fish  with  UAS-­soluble  ephrinB1a  fish,  heat-­shocking  at  bud  and  12  
ss  for  1  hour  and  collecting  at  20  ss  (Figure  11).  RNA  was  then  extracted  from  these  
hindbrains,  and  used  to  generate  cDNA  which  was  then  screened  for  contamination  
with   markers   of   tissues   anterior   and   posterior   to   the   hindbrain   and   for   soluble  
ephrinB1a  expression  by  RT-­qPCR.  The  data  presented  in  Figure  18  and  Figure  19  
is  of  hindbrain  dissections  that  were  selected  for  RNA-­sequencing  as  they  have  low  




expression  of  genes   representing  contamination.  This  dataset  excludes  additional  
replicates  that  were  collected.  
  
4.3.1   Identifying  samples  over-­expressing  soluble  ephrinB1  
RT-­qPCR  was  carried  out  for  soluble  ephrinB1a  to  determine  the  relative  levels  of  
expression   (Figure  18).  The  primers  used   to  detect  soluble  ephrinB1a  expression  
were  designed   to  bind  downstream  of   the  soluble  ephrinB1a  construct  and   in   the  
SV40  polyadenylation  site.  This  ensures  that  the  endogenous  ephrinB1a  transcript  
is  not  amplified.  There  is  no  detection  of  soluble  ephrinB1a  in  heat  shocked  controls  
(CH)  and  high  expression  of  soluble  ephrinB1a  in  the  remaining  samples  (E)  (Figure  
18).  The  large  increase  in  expression  of  soluble  ephrinB1a  means  that  one  can  be  
confident  that  these  are  the  samples  where  Eph-­ephrin  signalling  is  blocked.    
  
Figure   18   Expression   of   soluble   ephrinB1a   in   hindbrains   used   for  
RNA-­sequencing  
Relative   expression   of   soluble   ephrinB1a   in   individual   hindbrain   samples   used   for   RNA-­
sequencing.  CH1-­6  are  heat  shocked  controls  that  do  not  express  soluble  ephrinB1a  and  E1-­5  
express  soluble  ephrinB1a.  The  ΔCT  is  calculated  by  normalising  to  β-­actin  expression  in  each  
hindbrain.  
  
4.3.2   Identification  of  uncontaminated  samples  
The  expression  profiles  of  the  dissected  hindbrains  used  for  RNA-­sequencing  are  all  
below   the   threshold   contamination   level   (Figure   19:   A).   This   level   is   25%   of   the  
amount   of   the   highest   level   of   contamination   found   previously   (Figure   17).   The  
samples  sequenced  from  biological  replicates  two  and  three  were  found  to  contain  




only   control   hindbrains   or   hindbrains   over-­expressing   soluble   ephrinB1a,  
respectively  (Table  20).  
  
  
Figure  19  Gene  expression  profiles  of  hindbrains  used  for  RNA-­sequencing  
(A)  Relative  expression  profiles   of   three  genes   representing   contamination   from   the   forebrain  
(six3a),   the  midbrain   (otx2)   and   the   neural   epithelium   and   spinal   cord   (hoxB6a)   in   individual  
hindbrain   samples   used   for   RNA-­sequencing.   CH1-­6   are   heat   shocked   controls   that   do   not  
express   soluble   ephrinB1a   and   E1-­5   are   over-­expressing   soluble   ephrinB1a.   The   ΔCT   is  
calculated  by  normalising  to  β-­actin  expression  in  each  hindbrain.  Undetected  gene  expression  
was  given  the  maximum  cycle  value  40  and  the  number  of  undetected  triplicates  is  marked  with  
*.  (B)  Schematic  of  a  zebrafish  embryo  at  19  hpf  showing  where  the  three  genes  are  expressed  
in  the  embryo  at  this  stage.  
     




Sample  name   Biological  replicate   Expression  of  soluble  
ephrinB1a?  (Y/N)  
CH1   2   N  
CH2   2   N  
CH3   1   N  
CH4   1   N  
CH5   1   N  
CH6   2   N  
E1   1   Y  
E2   1   Y  
E3   1   Y  
E4   3   Y  
E5   3   Y  
Table  20  Biological  replicates  to  collect  RNA-­sequencing  samples  
Each  sample  is  a  dissected  zebrafish  hindbrain  CH1-­6  are  heat  shock  controls  that  do  not  express  
soluble   ephrinB1a   and   E1-­5   over-­express   soluble   ephrinB1.   Three   biological   repeats   of   the  
experiment  were  carried  out  from  separate  zebrafish  breeding  pairs  on  different  days,   labelled  
biological  replicates  1-­3.    
  
4.4   RNA-­sequencing  
4.4.1   Data  quality  and  alignment  
The  11  hindbrains  with  low  contamination  described  in  Figure  19  were  selected  for  
RNA-­sequencing.  The  sequencing  data  were  analysed  and  comparisons  were  made  
between  the  control  hindbrains  and  hindbrains  over-­expressing  soluble  ephrinB1a  in  
order  to  identify  potential  transcriptional  targets  of  Eph-­ephrin  signalling.  Initially,  the  
raw  RNA-­sequencing  data  were  assessed  to  ensure  that  the  quality  was  high  enough  
for  future  analysis.  This  was  done  using  FastQC  (Babraham  Institute),  which  assigns  
a  value  of  confidence  that  the  base  in  the  sequence  is  correct.  For  this  analysis,  all  
samples  had  a  base  quality  value  of  greater  than  20  (out  of  40)  and  were  used  for  
further  analysis.    
  
Following  quality  control,  the  data  were  aligned  to  version  10  of  the  zebrafish  genome  
using  Spliced  Transcripts  Alignment  to  a  Reference  (STAR)  which  enables  spliced  
transcripts  to  be  mapped  to  the  genome  as  it  allows  for  intronic  gaps  (Dobin  et  al.,  




2013).  At  this  stage,  there  was  an  additional  assessment  for  data  quality  to  ensure  
that  a  threshold  level  of  transcripts  had  aligned  to  the  reference  genome.  For  all  of  
the  samples,  between  70-­90%  of  transcripts  aligned  to  the  zebrafish  genome,  which  
was  sufficient  for  further  analysis.  
  
4.4.2   Differentially  expressed  genes  
The  aligned  reads  were  counted  for  each  gene  per  hindbrain  sample  and  the  genes  
with  less  than  1  transcript  per  million  were  subsequently  removed.  Following  this,  the  
differences   in   gene   expression   between   control   hindbrains   and   hindbrains   over-­
expressing  soluble  ephrinB1a  could  be  identified  by  carrying  out  a  Wald  Test,  where  
pairwise   comparisons   are   made   between   the   level   of   transcripts,   in   the   two  
experimental  groups.  This  was  performed  using  DESeq2,  a  programme  that  is  used  
to  estimate  expression  values  of  genes  and  calculate  differential  expression  (Love  
et  al.,  2014).  There  were  1216  genes  that  were  significantly  differentially  expressed  
between  the  control  and  experimental  conditions  (Figure  20),  of  which  585  of  these  
genes  were  more   highly   expressed   and   631   had   lower   expression  when   soluble  
ephrinB1a  is  over-­expressed.  Genes  that  were  found  to  be  significantly  differentially  
expressed  had  a  q-­value  <  0.05.  The  q-­value  is  the  adjusted  p-­value  and  is  used  to  
remove   genes   that   are   false   positives   from   the   differential   expression   data   as   it  
enables  the  false  discovery  rate  to  be  calculated.  





Figure  20  Volcano  plot  of  differentially  expressed  genes  
Volcano   plot   of   differentially   expressed   genes   between   control   hindbrains   and   hindbrain  
over-­expressing   soluble   ephrinB1a.   Every   dot   represents   one   gene   and   genes   in   red   are  
up-­regulated  and  genes  in  blue  are  down-­regulated  in  soluble  ephrinB1a  expressing  hindbrains.  
The  x-­axis  shows  the  log  fold  change  of  each  gene  and  the  and  the  y-­axis  shows  the  log  q-­value.  
  
To  find  out  whether  genes  were  consistently  up-­  or  down-­regulated  in  the  different  
experimental   conditions,   the   distance   from   the   median   expression   value   for  
statistically  significantly  differentially  expressed  genes   is  presented   in  a  heat  map  
(Figure  21).  This  displays  that  for  the  1216  genes  there  is  an  overall  pattern  where  
genes  that  are  more  highly  expressed  in  one  sample  are  lower  in  the  other.  However,  
there   are   some   genes   with   varied   expression   that   does   not   correlate   with   the  
expression  of  soluble  ephrinB1a.  This  occurs  more  frequently  for  hindbrain  samples  
CH6  and  E1  and  could  be  the  result  of  low  level  contamination  by  surrounding  tissues  
that  were  not  detected  in  the  RT-­qPCR  screen.  For  example,  it  could  be  that  the  otic  
vesicle  has  not  been  consistently  removed  in  all  hindbrain  dissections  given  this  was  
not  screened  for  by  RT-­qPCR.  
  




After  identifying  differentially  expressed  genes  between  the  control  group  and  soluble  
ephrinB1a   expressing   group,   the   samples   can   be   clustered   according   to   their  
expression  profile.  Samples  within  each  group  are  more  similar  to  each  other  than  
samples  from  the  other  condition,  and  this  will  identify  any  samples  that  are  different  
from   the   rest   of   the   group.   The   dendrogram   (Figure   21)   shows   that   the   control  
samples  (CH)  cluster  together  and  are  more  similar  to  each  other  than  the  samples  
expressing  soluble  ephrinB1a  (E),  which  form  a  separate  cluster.  Moreover,  it  shows  
that  there  are  not  any  major  batch  effects  from  collecting  the  samples  because  the  
samples  from  each  batch  of  dissections  do  not  cluster  together.  This  suggests  that  
the   significant   differences   between   samples   are   driven   not   by   the   experimental  
repeat  but  arise  from  changes  to  expression  when  soluble  ephrinB1a  is  expressed,  
in  the  experimental  group  in  comparison  to  the  control.  
  





Figure  21  Significantly  differentially  expressed  genes  between  control  hindbrains  
and  hindbrains  expressing  soluble  ephrinB1a  
Heatmap   showing   1216   genes   that   are   differentially   expressed   and   statistically   significant  
between  control  hindbrains  (CH1-­6)  and  hindbrains  expressing  soluble  ephrinB1a  (E1-­5).  Genes  
and  hindbrain  samples  are  the  rows  and  columns,  respectively.  The  colour  shows  the  distance  
from   the  median   for   each   gene,   with   red   indicating   values   higher   than   the  median   and   blue  
indicating   values   lower.   The   left   dendrogram   shows   the   average   distance   per   gene   and   the  
dendrogram  represents  the  distance  between  the  samples.  
  
Initially,  genes  were  selected  for  validation  by  rank  of  the  most  statistically  significant  
that   are   differentially   expressed   between   the   two   sample   groups.   The   50   most  
significant  have  been  represented  in  a  heatmap  to  show  how  similar  these  are  within  
each  experimental  condition   (Figure  22).  The  genes  can  be  split   into   two  groups:  
those  that  are  detected  at  similar   levels  within  a  sample  group  (unlabelled,  Figure  
22),  and  those  that  have  variation  in  relative  levels  within  each  group  (labelled  with  *,  




Figure   22).   The   latter   group   could   account   for   the   extent   to   which   Eph-­ephrin  
signalling  has  been  blocked,  but,  this  would  only  explain  the  variation  within  group  E.  
It   could   also   reflect   different   amounts   of   contamination   from   other   tissues,   for  
example,  samples  CH6  and  E1  have  different  levels  of  expression  for  several  genes  
than   the  other  samples.  As   there   is   little  or  no  expression  data  on  many  of   these  
genes  it   is  difficult  to  draw  conclusions  from  the  variation.  Some  of  the  genes  that  
vary  have  widespread  expression,  such  as  tuba1a  and  tuba1b  and  could  reflect  other  
biological  variation.  The  variation  in  some  genes  can  also  be  seen  in  the  heatmap  
showing  all  the  statistically  differentially  expressed  genes  (Figure  21).    
     





Figure  22  Heatmap  of  the  50  most  statistically  significant  differentially  expressed  
genes  
Heatmap  showing  50  genes  that  are  differentially  expressed  between  control  hindbrains  (CH1-­6)  
and  hindbrains  expressing  soluble  ephrinB1a  (E1-­5)  that  are  most  statistically  significant.  Genes  
and  hindbrain  samples  are  the  rows  and  columns,  respectively.  The  colour  shows  the  distance  
from  the  median  for  each  gene  (Z-­score),  with  red  indicating  values  higher  than  the  median  and  
blue  indicating  values  lower  than  the  median.  Genes  marker  with  *  have  more  variation.  
  




The  second  way  in  which  the  data  can  be  organised  is  to  show  genes  with  the  highest  
fold  change  out  of  all   the  statistically  significant  genes   identified  between  controls  
and   soluble   ephrinB1a   expressing   hindbrains.   This   is   a   useful   representation   as  
these  genes  are  likely  to  have  the  most  dramatic  change  in  gene  expression  by   in  
situ  hybridisation  between  the  two  experimental  conditions.  The  20  genes  with  the  
highest   fold  change  are  all  statistically  significant  with  an  adjusted  P  value  of   less  
than  0.05  (Table  21).  From  the  list  of  genes  with  the  highest  fold  change  there  are  
13  genes  that  are  also  present  in  the  50  most  statistically  significant  genes.  These  
genes  are  as  follows:  cd9a,  ppfia4,  BX255935.1,  prkcq,  tmppe,  rcan3,  tmppe,  rcan3,  
fgf18a,  zgc:173587,  zgc:163040,  FP236812.5  and  HIST1H2BA  (1  to  many).  
     




Gene   log2FoldChange   q-­value  
efnb1   7.42   0  
cd9a   3.51   1.29E-­15  
ppfia4   3.36   4.36E-­16  
BX255935.1   3.30   7.13E-­10  
CR391997.2   3.25   3.45E-­09  
si:ch211-­203d7.1   3.21   3.23E-­08  
prkcq   2.90   1.14E-­06  
tmppe   2.87   2.09E-­20  
rcan3   2.68   2.62E-­15  
si:dkey-­248e17.5   2.62   2.10E-­05  
pik3cd   2.50   1.03E-­04  
CR388052.1   2.48   6.28E-­05  
si:dkey-­146c18.6   2.40   2.12E-­04  
znf1129   2.35   3.25E-­05  
fgf18a   2.35   2.28E-­08  
zgc:173587   2.31   6.84E-­06  
CABZ01077605.1   2.29   5.83E-­04  
zgc:163040   2.28   1.13E-­09  
FP236812.5   2.25   1.79E-­06  
HIST1H2BA  (1  to  many)   2.25   5.63E-­08  
Table   21   Genes   with   highest   fold   change   from   RNA-­sequencing   that   are  
statistically  significant  
Genes  with  the  highest  average  fold  change  (log2FoldChange)  in  soluble  ephrinB1a  expressing  
hindbrains  in  comparison  to  control  hindbrains  out  of  the  statistically  significant  genes.  Adjusted  
P  values  show  the  level  of  significance  of  differential  expression  between  control  hindbrains  and  
soluble  ephrinB1a  expressing  hindbrains.  
  
When  selecting  candidate  genes  for  validation,  another  way  to  categorise  the  data  
is  to  select  genes  with  the  highest  number  of  reads,  since  these  are  less  likely  to  be  
falsely  identified  as  differentially  expressed.  The  20  genes  with  the  highest  average  
expression   across   the   samples   were   selected   from   the   significantly   differentially  
expressed  genes  (Table  22).  When  comparing  this  list  to  the  top  20  genes  with  the  
highest  fold  change  there  are  no  genes  that  are  present  in  both.  
  




Gene   BaseMean   q-­value  
si:dkey-­153m14.1   613034   5.29E-­05  
zgc:158463   208087   6.90E-­05  
efnb1   41650   0  
hmgb2a   29943   1.11E-­03  
hnrnpaba   23597   1.15E-­03  
tubb2b   20682   2.09E-­02  
mdka   17240   4.36E-­02  
zgc:56493   16863   1.40E-­02  
marcksb   14941   3.95E-­03  
ybx1   12761   1.08E-­03  
rpl15   12172   1.18E-­03  
fubp1   11987   4.64E-­04  
rps9   10830   4.07E-­03  
smarce1   10631   1.28E-­02  
smarca4a   10198   2.98E-­02  
ahnak   9864   5.00E-­02  
zbtb16b   9283   1.91E-­02  
si:ch211-­113a14.12   9222   3.74E-­04  
hmgb3a   9157   3.23E-­02  
smarcc1a   9006   3.33E-­03  
Table   22   Genes   with   highest   read   counts   from   RNA-­sequencing   that   are  
statistically  significant  
Genes   with   the   highest   average   of   normalised   reads   across   all   samples   (BaseMean)   out   of  
statistically   significant   genes.   Adjusted   P   values   show   the   level   of   significance   of   differential  
expression  between  control  hindbrains  and  soluble  ephrinB1a  expressing  hindbrains.  
  
A  final  way  to  select  potential   target  genes  from  the   list   is   to   identify  which  genes  
correlate  to  the  level  of  ephrinB1a,  as  soluble  ephrinB1a  is  over-­expressed  to  block  
Eph-­ephrin  signalling  and  only  present   in   these  samples   (E),  and   is  absent   in   the  
controls  (CH)  (Figure  23).  This  can  be  used  to  identify  which  other  genes  behave  in  
a   similar   manner,   or   the   opposite,   from   control   to   soluble   ephrinB1a   expressing  
samples.   In   this   analysis,   it   is   not   possible   to   differentiate   between   endogenous  
ephrinB1a  and  the  expressed  form,  so  as  a  result  both  transcripts  will  be  included.    
  




When  comparing   the  15  genes  with   the  greatest  positive  correlation   to  ephrinB1a  
with  the  50  most  statistically  significant  genes,  the  11  genes  present  in  both  analyses  
are:   CR391997.2,   tmppe,   prkcq,   ppfia4,   BX255935.1,   MTCL1,   cd9a,   fgf18a,  
si:ch211-­203d7.1,  tuba1b  and  dnm2a.  When  comparing  the  top  15  genes  with  the  
greatest   negative   correlation   to   ephrinB1a   to   the   50   most   statistically   significant  
genes,  the  four  genes  present  in  both  analyses  include:  si:ch211-­238e22.2,  znf995,  
ttc32  and  wsb1.  There  are  also  six  genes  that  appear  on  the  list  of  genes  with  highest  
fold   change   that   are   also   present   on   the   list   of   genes   with   the   greatest   positive  
correlation  to  ephrinB1a.  This  includes:  CR391997.2,  tmppe,  prkcq,  ppfia4,  cd9a  and  
fgf18a.  In  contrast,  there  are  no  genes  that  overlap  between  the  highest  fold  change  
and  the  genes  with  the  greatest  negative  correlation  to  ephrinB1a.       





Figure  23  Correlation  of  gene  expression  with  ephrinB1a  across  RNA-­sequencing  
samples  
Graphs  showing  differentially  expressed  genes  which  have   the  highest  positive  correlation  (A)  
and   the   highest   negative   correlation   (B)   to   ephrinB1a   in   the   RNA-­sequencing   samples.  
RNA-­sequencing  samples  are  shown  on  the  x-­axis  and  the  normalised  Log2  expression  is  shown  
in  the  y-­axis.  
  
4.5   Discussion  
In  this  chapter,  the  optimal  sample  type  for  RNA-­sequencing  has  been  determined  
and  a  quality  control  method  has  been  developed  to  ensure  that  samples  used  are  




as  similar  as  possible.  The  ideal  sample  type  is  dissected  hindbrains,  which  enables  
enrichment  of  hindbrain  specific  transcripts.  Contamination  from  tissues  surrounding  
the   hindbrain   can   be   kept   to   minimal   levels   by   keeping   hindbrain   dissections  
separate  and  selecting  those  with  the  lowest  expression  of  genes  which  are  present  
in  neighbouring  tissues.    
  
Within  a  clutch  of  embryos  there  is  a  mixture  of  transgene  inheritance,  with  fish  that  
carry  one  of  either  the  HS-­Gal4  or  UAS-­soluble  ephrinB1a  transgenes,  fish  that  carry  
none   of   the   transgenes   and   fish   that   carry   both.  Only   the   embryos   carrying   both  
transgenes   will   express   soluble   ephrinB1a   upon   heat   shock,   which   can   be  
retrospectively  detected  by  performing  RT-­qPCR  on  RNA  that  was  used  for  RNA-­
sequencing.  This  ensured  that  control  and  soluble  ephrinB1a  expressing  embryos  
come  from  the  same  zebrafish  cross  and  have  identical  treatment  by  heat  shock.  As  
a  result,  any  experimental  variation  was  kept  to  a  minimum  and  any  changes  in  gene  
expression  arising  from  heat  shock  should  not  be  present  in  the  data.  
  
The   data   generated   by   RNA-­sequencing   were   of   high   quality   with   70-­90%   of  
transcripts  aligning   to   the  zebrafish  genome.  Reassuringly,   the  samples  clustered  
into   two   groups   based   on   whether   Eph-­ephrin   signalling   had   been   blocked;;   the  
control  hindbrains  (CH)  and  hindbrains  that  expressed  soluble  ephrinB1a  (E).  This  
gave  confidence  that  the  experimental  replicates  did  not  have  significant  differences  
in   gene   expression   and   that   the   experimental   procedure   had   not   affected  overall  
gene  expression.  There  were  1216  transcripts  found  to  be  significantly  differentially  
expressed  between  control  embryos  and  embryos  that  express  soluble  ephrinB1a,  
which  is  too  large  to  investigate  all  of  them.  Therefore,  several  ways  to  categorise  
the   data   were   explored.   These   were   to   select   the  most   significantly   differentially  
expressed  genes,  the  genes  with  the  greatest  fold  change,  the  genes  that  behave  
most   similarly   across   the   samples   as   soluble   ephrinB1a   and   the   genes   with   the  
highest   read   count.   The   different   analyses  make  different   assumptions   about   the  
expression  of  the  relevant  genes  and  are  likely  to  find  different  candidates,  so  genes  
will  be  selected  from  multiple  lists  for  validation.  
  
The  first  way  to  categorise  the  significantly  differentially  expressed  genes  was  to  rank  
them  in  order  of  the  most  statistically  significant.  These  are  the  genes  that  change  




the  most  reliably  between  the  two  experimental  conditions  and  provides  a  starting  
point  for  validating  targets  as  they  are  the  most  likely  to  be  representative  targets.  
The  significance  of  the  change  in  expression  is  a  reflection  of  the  variation  across  
the  samples  within  each  condition.  Lower  statistical  significance   for  a  gene   is   the  
result  of   increased  variation  and  could  be  due   to  contamination   from  surrounding  
tissues,  differences   in  blocking  of  Eph-­ephrin  signalling  and  unidentified  biological  
variation.  Therefore,  it  is  essential  that  only  genes  that  are  significantly  different  are  
considered,  but  the  most  significant  will  not  necessarily  be  the  most  relevant  genes.  
One  example  is  if  genes  involved  in  differentiation  were  to  be  affected,  then  a  small  
delay  in  timing  across  the  samples  would  affect  the  level  of  gene  expression.  This  
would  mean  that  the  significance  of  such  genes  would  be  lower  due  to  the  variability,  
despite  being   relevant.   In  addition,   there  may  be   intrinsically   variable  effects.  For  
example,   it   is   known   that   the   boundary   cells   are   absent   when   ephrinB1a   is  
over-­expressed  (Figure  12),  which  in  turn  is  known  to  result  in  the  misplacement  of  
FGF20a-­expressing   neurons   and   changes   in   neurogenesis   in   a   variable  manner  
(Terriente  et  al.,  2012).  
  
Secondly,  the  statistically  significant  genes  were  ranked  in  order  from  the  greatest  
fold  change.  The  changes  in  gene  expression  should  be  easier  to  detect  by   in  situ  
hybridisation  as  the  differences  will  be  greater.  One  issue  with  this  method   is   that  
genes   with   lower   fold   changes   may   be   those   that   are   biologically   relevant.   For  
example,  if  a  gene  is  expressed  in  multiple  regions  of  the  hindbrain  it  may  only  alter  
at  one  site,  this  would  result  in  a  lower  fold  change.  In  addition,  genes  that  change  
as  a  consequence  of  the  rate  of  differentiation  being  altered  may  also  be  subtle.  rfng  
is   no   longer   expressed  when  Eph-­ephrin   signalling   is   blocked,   but,   this   does   not  
appear  on  the  list  of  significantly  differentially  expressed  genes.    
  
Another  way   that  genes  were  categorised   in  order   to   rule  out   false  positives   is   to  
select  genes  that  have  a  high  number  of  read  counts.  Genes  with  a  low  number  of  
read  counts  are  likely  to  fluctuate  as  a  result  of  noise.  For  example,  a  change  in  read  
count   from   control   to   experimental   condition   of   10   to   12   is   a   difference   of   20%.  
However,  this  is  a  change  in  2  transcripts  and  could  just  be  a  natural  fluctuation  in  
gene  expression,  whereas  a  20%  increase  from  1000  to  1200  is  a  numerically  robust  
difference  and  more  likely  to  be  statistically  significant.  Despite  this,  some  genes  with  




a  low  level  of  expression  may  still  be  relevant.  However,  selecting  genes  with  only  
high   read   counts   will   favour   genes   that   are   widely   expressed   and   not   those  
expressed  in  specific  cell  types.    
  
Finally,  genes  were  identified  that  had  the  most  correlated  expression  to  ephrinB1a  
or  had   the  opposite  expression   levels  across  all   the  hindbrain  samples.  From   the  
RNA-­sequencing   data,   ephrinB1   transcripts   detected   are   both   the   endogenous  
ephrinB1a   and   soluble   ephrinB1a.   From   the   RT-­qPCR   carried   out   to   identify  
hindbrains  where  Eph-­ephrin  signalling  had  been  blocked  it  is  clear  that  the  levels  of  
soluble   ephrinB1a   expression   varies.   If   there   is   a   dose   response   effect   then   by  
looking  at  genes  that  correlate  to  ephrinB1a  expression  we  are  likely  to  identify  genes  
that   alter   expression   downstream   of   Eph-­ephrin   signalling.   However,   soluble  
ephrinB1a  expression  may  be  well  above  the  threshold  level  required  to  block  Eph-­
ephrin  signalling.  This  would  mean  that  this  analysis  would  identify  genes  that  have  
the   most   consistent   level   of   expression   across   the   sample   where   Eph-­ephrin  
signalling  is  blocked.  Thus,  this  would  be  a  similar  method  of  categorising  the  data  
as   ranking  by  statistical   significance.  By   looking  at   the  normalised   read  counts   in  
each  sample  for  the  genes  that  correlate  most  with  ephrinB1a  expression,  it  is  clear  
that  the  differences  in  gene  expression  are  smaller  than  for  ephrinB1a  (Figure  23).  
This  is  unsurprising  given  that  the  level  of  over-­expression  of  ephrinB1a  will  dwarf  
changes  to  endogenous  gene  expression.  
  
There   is  overlap   in   the  genes  present   in   the  different  categories  of  organising   the  
RNA-­sequencing  data.  There  are  also  several  genes  that  only  appear  in  one  of  these  
categories,  and  it  will  be  useful  to  be  inclusive  and  take  a  subset  of  genes  from  each  
list  for  validation.  This  will  reveal  if  there  is  a  particular  way  of  categorising  the  data  
that  identifies  validated  target  genes.  The  validation  will  be  imperative  because  even  
when  looking  at  the  most  statistically  significant  genes  in  the  form  of  a  heatmap  it  is  
clear   that   there   is   some   fluctuation   in   expression   levels   across   the   experimental  
samples  (Figure  22).  In  addition,  in  situ  hybridisation  validation  will  also  be  important  
to  reveal  the  expression  patterns  of  genes  as  this  will  determine  if  they  are  relevant.  
It  is  important  to  note  that  the  genes  identified  as  differentially  expressed  may  not  be  
direct  transcriptional  targets  but  secondary  to  other  effects  of  Eph-­ephrin  signalling.  




One  example  is  that  the  change  in  expression  may  be  a  consequence  of  the  loss  of  
the  hindbrain  boundary  cells  or  because  of  effects  of  altered  morphogenesis.  
  
4.6   Conclusion  
In  this  chapter,  candidate  target  genes  of  Eph  receptor  and  ephrin  signalling  in  the  
hindbrain  have  been  identified  by  RNA-­sequencing.  When  Eph-­ephrin  signalling  is  
blocked,   there   are   1216   genes   that   have   statistically   significant   differential  
expression   in  comparison   to  control.  A  comprehensive  analysis  of  a  group  of   this  
size   is   beyond   the   scope   of   this   study.   In   order   to   reduce   the   number   to   a  
manageable   figure,  genes  were  categorised   in  different  ways   to  see   if   there  were  
genes   that   were   flagged   repeatedly   as   potential   targets   for   validation.   The  
significantly  differentially  expressed  genes  were  categorised  in  the  following  way:  the  
most   significantly   differentially   expressed,   the   highest   fold   change,   the   highest  
average  number  of  reads  and  the  genes  with  the  most  positive  or  negative  correlation  
to  ephrinB1a  expression  across  the  samples.    
  
In  the  next  chapter,  differentially  expressed  genes  identified  here  will  be  validated  by  
RT-­qPCR   to   determine   which   genes   are   regulated   downstream   of   Eph-­ephrin  
signalling.  This  technique  provides  a  way  to  screen  through  multiple  genes  from  the  
different   categories.   Then   validated   targets   will   then   be   screened   by   in   situ  
hybridisation  to  identify  the  expression  patterns  in  the  hindbrain  before  determining  
how  the  expression  changes  when  Eph-­ephrin  signalling  is  blocked.




Chapter  5.   Validation  of  genes  regulated  
downstream  of  Eph-­ephrin  signalling  
5.1   Introduction  
In   the   previous   chapter,   genes   potentially   regulated   downstream   of   Eph-­ephrin  
signalling   were   identified   by   blocking   signalling   and   comparing   the   transcripts  
present   to   those  without  blocking.  This   identified  1216  candidate  genes   that  have  
significantly   different   expression   between   the   two   experimental   groups.   Some   of  
these  genes  could  be  the  result  of  slight  differences  in  the  amount  of  contaminating  
tissues  present  in  the  hindbrain  dissections  of  the  two  conditions.  Despite  measures  
being  taken  to  keep  this  contamination  to  a  minimum,  it  was  notable  that  for  some  
genes  the  levels  of  expression  varied  within  the  experimental  condition.  As  a  result,  
before   carrying   out   further   investigation,   it   will   be   important   to   validate   candidate  
genes  which  were  selected  using  four  criteria  that  were  discussed  in  Chapter  4.  
  
RT-­qPCR   and   in   situ   hybridisation   were   used   to   validate   potential   target   genes.  
RT-­qPCR  can  be  used  to  quantify  changes  in  gene  expression  and  compared  to  the  
RNA-­sequencing  results,  determining  if  altered  expression  of  the  gene  is  the  same  
for  both   techniques.  Genes   that  are  validated  by  RT-­qPCR  will   then  be  screened  
using  in  situ  hybridisation  to  determine  whether  they  are  expressed  in  the  hindbrain  
at   detectable   levels   and   reveal   their   expression   pattern.   To   examine   how   the  
expression   of   candidate   genes   alter   when   Eph-­ephrin   signalling   is   blocked,  
comparisons   will   be   made   between   wild   type   embryos   and   embryos   where  
Eph-­ephrin  signalling  has  been  disrupted  either  by  expressing  soluble  ephrinB1a  or  
in  double  Eph  receptor  and  ephrin  mutants.  From  this  dataset,  genes  with  modified  
expression   patterns   when   Eph-­ephrin   signalling   is   blocked   will   be   investigated  
further.  
  
5.2   Validating  changes  in  gene  expression  by  RT-­qPCR  
In  order  to  validate  changes  in  gene  expression  by  screening  multiple  genes,  rather  
than  genes  individually,  RT-­qPCR  was  carried  out  on  whole  embryos.  Although  the  




RNA-­sequencing   was   performed   on   hindbrain   dissections,   whole   embryos   have  
been  chosen  for  several  reasons.  Firstly,  when  using  whole  embryos  any  genes  that  
were  identified  from  RNA-­sequencing  as  a  result  of  contamination  from  surrounding  
tissues   should   be   eliminated,   since   false   positive   genes   will   not   be   differentially  
expressed  between  control  whole  embryos  and  whole  embryos  where  Eph-­ephrin  
signalling   is  blocked.   In  addition,  whole  embryos  can  be  collected  more  easily  as  
there   is   no   manipulation   to   the   embryo.   Embryos   can   then   be   selected   which  
over-­express  soluble  ephrinB1a  and  controls  that  do  not.  This  method  eliminates  the  
need   for   embryo   dissections   that   require   a   quality   control   step   to   ensure   low  
contamination  from  surrounding  tissues.  
  
The  disadvantage  of  using  whole  embryos  is  that  that  Eph-­ephrin  signalling  has  a  
variety  of  roles  during  development   in  multiple  tissues.  For  example,   for  boundary  
cell  formation  in  the  hindbrain  and  somites  (Durbin  et  al.,  1998;;  Cooke  et  al.,  2005;;  
Terriente  et  al.,  2012),  as  well  as  for  angiogenesis  (Cheng  et  al.,  2002),  and  in  control  
of  cell  migration,  proliferation  and  apoptosis  (Davy  and  Soriano,  2007;;  Holmberg  et  
al.,   2006;;   Park,   2013).   Therefore,   there   is   a   possibility   that   changes   in   gene  
expression  elsewhere   in   the  embryo  may  mask   the  changes   in  expression   in   the  
hindbrain.  Nevertheless,   because  of   the  high   throughput   nature  and   the  ability   to  
eliminate  targets  found  due  to  contamination,  this  technique  was  used  to  see  if  it  was  
possible  to  validate  Eph-­ephrin  transcriptional  targets.  
  
For  a  gene  to  be  validated  as  affected  by  blocking  of  Eph-­ephrin  signalling  it  should  
firstly  have  similar  levels  of  expression  within  each  of  the  two  experimental  groups.  
Secondly,  the  gene  should  also  have  different  levels  of  expression  between  the  two  
conditions,   showing   that   it   has   changed   when   Eph-­ephrin   signalling   has   been  
blocked.  However,  because  of  the  potential  effects  of  blocking  signalling  elsewhere  
in  the  embryo  masking  changes  in  gene  expression  in  the  whole  embryo,  the  first  
criterion  will  be  more  important  than  the  latter.  This  will  inform  us  that  the  expression  
level   of   the   gene   in   question   is   reproducible   in   each   condition   and   also   that   the  
expression  is  altered  when  Eph-­ephrin  signalling  is  blocked.  
  




5.2.1   Validation  in  embryos  where  Eph-­ephrin  signalling  is  blocked  
Whole  embryos  for  analysis  were  derived  by  crossing  HS-­Gal4  fish  to  UAS-­soluble  
ephrinB1a  fish,  carrying  out  two  1  hour  heat  shocks  at  bud  and  12  ss,  and  collecting  
at  19  hpf  (Chapter  3.4.1,  Figure  11).  The  level  of  soluble  ephrinB1a  expression  was  
quantified  to   identify  which  of   the  embryos  were  heat  shocked  controls  and  which  
over-­expressed   soluble   ephrinB1a   (Figure   24).   As   observed   previously   with  
hindbrain   dissections   used   for   RNA-­sequencing   (Chapter   4.3.1,   Figure   18),   the  
relative  levels  of  soluble  ephrinB1a  expression  vary  between  the  embryos  collected.  
The  embryos  which  express  soluble  ephrinB1a  are  embryos  7,  16  and  19  (Figure  
24),  which  will  now  be  referred  to  as  wE1,  wE2  and  wE3,  respectively  (Figure  26).  
For  the  control  samples,  the  three  embryos  with  no  expression  of  soluble  ephrinB1a  
were  chosen:  embryos  6,  14  and  20  (Figure  24),  which  will  now  be  referred  to  as  
wCH1,  wCH2  and  wCH3,  respectively  (Figure  26).  By  choosing  samples  with  similar  
levels  of  soluble  ephrinB1a  for  E1-­3,  the  validation  experiments  should  be  easier  to  
interpret  as  it  would  be  expected  that  gene  expression  changes  would  be  similar.  If  
there  is  a  threshold  level  of  soluble  ephrinB1a  expression  which  is  sufficient  to  block  
Eph-­ephrin  signalling,   this  should  be  reached   in  all   three  samples  as   they  are   the  
highest  across  the  20  embryos  and  are  similar  to  one  another.    
  
  
Figure  24  Expression  of  soluble  ephrinB1a  in  individual  whole  embryos  
Relative   expression   of   soluble   ephrinB1a   in   individual   whole   embryos   to   select   samples   for  
validation  experiments.  ΔCT  is  calculated  by  normalising  to  β-­actin  expression  in  each  hindbrain.  
  
Genes  were  selected  for  validation  from  the  four  different  criteria  used  to  organise  
the  RNA-­sequencing  data,  discussed  in  Chapter  4.4.2.  The  22  genes  are   listed   in  
Table  23  along  with  which  category  they  appear.       



















hmgb2a         ✓        
nap1l1      ✓           
tubb2b         ✓        
ybx1         ✓        
mdka         ✓        
marcksb         ✓        
rpl15         ✓        
cd9a   ✓   ✓      ✓     
akr7a3               ✓  
stx4   ✓              
ube2z   ✓              
ttc32   ✓            ✓  
hnrnpaba         ✓        
fubp1         ✓        
abi1b   ✓              
col15a1b   ✓              
fam117aa   ✓              
ppfia4   ✓   ✓      ✓     
tmppe   ✓   ✓      ✓     
dnm2a   ✓         ✓     
wsb1   ✓            ✓  
Table  23  Criteria  of  candidate  gene  selection  
Candidate  genes  were  selected  for  RT-­qPCR  based  on  the  above  criteria.  
  
The   first   step   of   validation  was   to   determine   if   expression   of   the   selected   genes  
changes  when  Eph-­ephrin  signalling  is  blocked,  using  RT-­qPCR  in  whole  embryos  
(Figure  25).  Any  genes  with   less  than  1.2-­fold   increase  or  decrease  in  expression  
when  Eph-­ephrin  signalling  was  blocked  were  considered  not  to  alter.  
  
Seven  genes  did  not  change  in  expression  (hmgb2a,  nap1l1,  ybx1,  stx4,  wsb1,  rpl15  
and  hnrnpaba).  Eight  genes  had  increased  expression  when  Eph-­ephrin  signalling  
was  blocked  (tubb2b,  marcksb,  cd9a,  ube2z,  abi1b,  fam117aa,  ppfia4  and  tmppe).  
Six  genes  had  decreased  expression  when  Eph-­ephrin  signalling  was  blocked  (mdka,  
dnm2a,  ttc32,  akr7a3,  col15a1b  and  fubp1)  with  ttc32  being  significantly  decreased.  
Three  genes  had  opposing  changes  in  expression  when  Eph-­ephrin  signalling  was  




blocked   and   quantified   in   whole   embryos   in   comparison   to   hindbrain   dissections  
(mdka,  dnm2a  and  col15a1b).  In  addition,  stx4  and  wsb1  expression  does  not  alter  
in   whole   embryos   but   have   lower   expression   in   the   hindbrain   when   Eph-­ephrin  
signalling  is  blocked.  These  opposing  changes  are  likely  to  be  the  consequence  of  
differences  in  sample  type  and  reflect  changes  in  gene  expression  that  are  occurring  
elsewhere   in   the   embryo.   The   lack   of   significance   in   the   observations   made   by  
RT-­qPCR  in  whole  embryos  could  be  a  result  of  variation  across   the  replicates  of  
each  condition,  which  may  be  solved  by  additional  replicates,  or  could  be  the  result  
of  biological  variation.       






































































































































































































































































































































































































































































The   normalised   read   counts   of   a   gene   for   individual   hindbrains,   determined   by  
RNA-­sequencing,  and  the  relative  expression  of  a  gene  for  individual  whole  embryos,  
determined  by  RT-­qPCR,  were  plotted  to  compare  the  similarity  between  replicates  
for   each   gene   (Figure   26).   This   is   informative   because   many   of   the   changes   in  
expression   when   Eph-­ephrin   signalling   is   blocked   are   not   statistically   significant  
when  analysed  by  one-­way  ANOVA  (Figure  25).    
  
When  evaluating   the  RT-­qPCR  analysis   of   individual  whole  embryos   (Figure  27),  
genes  could  be  split  into  3  categories:  (1)  genes  that  have  similar  expression  levels  
in  all  control  and  soluble  ephrinB1a  expressing  embryos,  (2)  genes  that  have  similar  
replicates  within  each  experimental  condition  that  is  different  from  the  other  condition,  
and  (3)  genes  that  do  not  have  similar  replicates  within  the  same  condition.    
  
stx4,  ybx1,  rpl15  and  hnrnpaba  have  similar  expression  across  the  3  control  embryos  
and  3  embryos  expressing  soluble  ephrinB1a  (Figure  26).  Since  no  change  occurs  
in   whole   embryos,   the   difference   found   in   dissected   hindbrains   could   be   due   to  
contamination  with  other  tissues.  Alternatively,  this  could  indicate  that  changes  to  the  
expression  of  these  genes  in  the  hindbrain  are  being  equalised  by  opposing  changes  
elsewhere.    
  
The   genes   found   by   RT-­qPCR   to   have   fairly   similar   replicates   within   each  
experimental   condition   and   change   expression   from   control   to   experimental  
condition   (Figure   26),   include:   ttc32,   tmppe,   hmgb2a,   tubb2b   and   fubp1.   The  
RT-­qPCR   validation   shows   that   ttc32   and   fubp1   decrease   in   expression   when  
Eph-­ephrin   signalling   is   blocked.   In   contrast,   tmppe   and   tubb2b   have   increased  
expression,  and  hmgb2a  did  not  alter.  These  genes  will  be  investigated  further.    
  
Finally,   there   was   a   subset   of   genes   with   variation   between   replicates   within   an  
experimental   condition   (Figure   26),   including:   cd9a,   ube2z,   abi1b,   col15a1b,  
fam117aa,  ppfia4,  dnm2a,  wsb1,  nap1l1,  mdka,  marcksb  and  akr7a3.  For  some  of  
these  genes  there  is  just  one  outlier  within  a  sample,  such  as  ube2z,  abi1b,  mdka,  
dnm2a  and  marcksb.  However,   for  others   there   is  no  pattern  across   the  samples  
within  a  group,  such  as  the  control  samples  for  col15a1b,  fam117aa,  ppfia4,  wsb1,  




nap1l1  or  akr7a3.  The  fluctuations  between  samples  suggests  that  these  genes  may  
not   be   biologically   relevant   as   they   are   not   similarly   modulated   within   each  
experimental  group.  However,  it  will  be  informative  to  investigate  a  subset  of  these  
genes  to  determine  if  the  expression  does  vary  from  one  embryo  to  another.  
  
Consideration  should  also  be  taken  as  to  what  is  known  about  the  candidate  genes.  
This  may  indicate  whether  it  is  likely  to  have  a  specific  function  in  the  hindbrain  or  a  
broader  role  in  the  embryo.  Previous  studies  have  shown  that  hmgb2a  and  tubb2b  
are  implicated  in  brain  development  (Table  24).  In  addition,  the  RT-­qPCR  validation  
showed  that  the  replicates  were  similar  within  the  two  experimental  conditions.  ttc32  
and  tmppe  also  had  similar  expression  in  replicates  of  each  experimental  condition  
but  were  not  chosen  to  pursue  at  this  time  due  to  a  lack  of  information  about  what  
role  they  may  play  (Table  24).    
  
nap1l1  and  mdka  did  not  have  similar  replicates  for  the  experimental  conditions  in  
the   RT-­qPCR   validation,   although   there   was   an   overall   trend   of   mdka   gene  
expression  being  down-­regulated  when  Eph-­ephrin  signalling  was  blocked  (Figure  
26).  This  is  interesting  because  this  trend  is  in  contrast  to  the  RNA-­sequencing  data  
where  mdka   expression   is   up-­regulated.   It  will   be  useful   to  explore   this   further   in  
order   to   resolve   why   there   may   be   differences   between   what   is   observed   by  
RNA-­sequencing  and  RT-­qPCR.  In  addition,  mdka  is  known  to  be  a  marker  of  neural  
differentiation,  making  it  an  interesting  candidate  to  investigate  further  (Schafer  et  al.,  
2005)  (Table  24).  nap1l1  was  also  selected  because  of  previous  work  showing  that  
it   is  expressed  in  progenitor  cells  (Yan  et  al.,  2016)  (Table  24).  cd9a  and  stx4  are  
also  involved  in  neuronal  development  based  on  previous  studies.  However,  efforts  

























Figure   26  Comparison   of   individual   samples   from  RT-­qPCR   validation   to  RNA-­
sequencing  data  
(Ai-­Ui)  Graphs  showing  relative  levels  of  gene  expression  calculated  by  RT-­qPCR  in  individual  
whole  embryos  (Ai-­Ui).  The  ΔCT  is  calculated  by  normalising  to  β-­actin  expression   in  embryo.  
C1-­3   are   control   embryos   and   E1-­3   are   over-­expressing   soluble   ephrinB1a   and   Eph-­ephrin  
signalling   has   been   blocked.   All   embryos   have   been   heat   shocked.   (Aii-­Uii)   Graphs   showing  
normalised  react  counts  from  RNA-­sequencing  for  each  gene.    Samples  are  individual  hindbrains  
and   CH1-­6   are   controls   and   E1-­5   are   over-­expressing   soluble   ephrinB1a   and   Eph-­ephrin  
signalling  has  been  blocked.  All  hindbrains  have  been  heat  shocked.  The  whole  embryos  (i)  and  
hindbrains  (ii)  are  from  different  experiments  and  are  different  embryos.    




Gene   Known  roles   References  
hmgb2a   Regulation  of  neuronal  cell  differentiation   (Abraham  et  al.,  2013;;  
Bronstein  et  al.,  2017)  
nap1l1   Regulates  proliferation  in  iPSCs   (Yan  et  al.,  2016)  
tubb2b   Neuronal  migration  and  differentiation   (Jaglin  and  Chelly,  2009;;  
Breuss  et  al.,  2015)  
ybx1   Regulation  of  Nodal  signalling   (Kumari  et  al.,  2013;;  Zaucker  et  
al.,  2017)  
mdka   Neural  Tube  formation   (Schafer  et  al.,  2005)  
marcksb   Gastrulation/cell  membrane  protrusion   (Wang  et  al.,  2013)  
rpl15   Ribosome  assembly   (Provost  et  al.,  2013)  
cd9a   Regulation  of  neuronal  cell  differentiation   (Howe  et  al.,  2013)  
akr7a3   Tumour  suppressor,  blocks  ERK/c-­jun  NFkB   (Chow  et  al.,  2017)  
stx4   Membrane  trafficking  in  dendritic  spines   (Kennedy  et  al.,  2010)  
ube2z   Ubiquitin  conjugating  enzyme  protein   (Gu  et  al.,  2007)  
ttc32   No  information     N/A  
hnrnpaba   Activates  EMT  and  metastasis  in  hepatocyte  
cancer  
(Zhou  et  al.,  2014)  
fubp1   Pro-­proliferative  and  anti  apoptotic  oncogene   (Wesely  et  al.,  2017)  
abi1b   No  information     N/A  
col15a1b   Type  of  collagen  expressed  in  slow  myosin  
heavy  chain-­positive  cells    
(Bretaud  et  al.,  2011)  
fam117aa   No  information     N/A  
ppfia4   No  information     N/A  
tmppe   No  information     N/A  
dnm2a   Cardiac  function,  neuromuscular  
development  
(Li   et   al.,   2013;;   Gibbs   et   al.,  
2013)  
wsb1   Midblastula  Transition   (Gibbs  et  al.,  2013)  
Table  24  Previously  published  roles  of  candidate  genes  
Review  of  the  literature  on  known  roles  of  candidate  genes.  
  
5.2.2   Validation  in  Eph  receptor  and  ephrin  mutants  
The  four  candidate  genes  selected  were  also  analysed  by  RT-­qPCR  in  double  Eph  
receptor   and   ephrin   mutants   to   quantitate   changes   in   gene   expression   prior   to  
qualitative  analysis  by   in   situ  hybridisation.  The  mutants  used  were:  EphA4a  




EphB4a   double   mutants,   and   ephrinB2a   and   ephrinB3b   double   mutants.   In   the  
double   Eph   receptor   mutants   signalling   will   not   occur   via   EphA4a   and   EphB4a  
receptors  with  their  respective  binding  partners.  However,  other  Eph  receptors  still  
present  in  the  hindbrain  can  signal  redundantly  with  the  ephrin  binding  partners  of  
these  Eph  receptors.  In  the  double  ephrin  mutants  signalling  will  not  occur  through  
ephrinB2a  and  ephrinB3b  with  their  respective  binding  partners.  Again,  other  ephrins  
are  able  to  signal  redundantly  with  the  Eph  receptors  that  usually  bind  these  ephrins.  
As  there  are  only  three  ephrinBs  present  in  the  hindbrain,  and  in  this  mutant  two  are  
absent,  it  would  be  expected  that  there  would  be  less  redundancy  of  signalling  than  
for  the  double  Eph  receptor  mutant.  Both  double  mutants  have  partial  boundary  loss,  
with  the  boundaries  of  r1/r2,  r4/r5  and  r6/r7  remaining  (Chapter  3.3.2,  Figure  10).  
  
There  were  alterations   in  gene  expression   in   the  Eph   receptor  and  ephrin  double  
mutants  in  comparison  to  wild  type  embryos  (Figure  27).  Any  genes  with  a  less  than  
1.2-­fold  increase  or  decrease  in  expression  were  considered  not  to  alter.  nap1l1  and  
tubb2b   did  not   alter   in   the  Eph   receptor  double  mutants   in   comparison   to   control  
embryos,  whereas  mdka  and  hmgb2a  decreased  significantly  by  1.4-­fold  and  1.5-­fold,  
respectively.  In  the  double  ephrin  mutants,  hmgb2a  and  tubb2b  expression  did  not  
change,  mdka  expression  increased  by  1.5-­fold  and  nap1l1  expression  decreased  
by  1.4-­fold.  The  change  in  expression  of  mdka  in  double  Eph  receptor  mutants  was  
roughly  equal  and  opposite  to  the  change  in  double  ephrin  mutants.    
  





Figure  27  Fold  change  of  genes  in  double  Eph  receptor  and  ephrin  mutants  
Fold  change  of  gene  expression  in  Eph  receptor  and  ephrin  double  mutants  in  comparison  to  wild  
type  embryos.  Analysis  was  carried  out  on  embryos  at  19  hpf,  n=3  of  pools  of  40  whole  embryos  
for  each  condition.  Error  bars  show  standard  deviation,  **  represents  p-­value  ≤  0.05,  *  represents  
trending   towards  significance  p-­value  ≤  0.07   for  RT-­qPCR  data  Expression  was  normalised  to  
b-­actin  for  each  sample.  
  
5.3   Validating  selected  genes  by  in  situ  hybridisation  
To  further   investigate   tubb2b,  hmgb2a,  nap1l1  and  mdka,   their  expression  pattern  
was  determined  in  wild  type  embryos.  All  four  of  these  genes  are  highly  expressed  
in   the   hindbrain   according   to   the   normalised   read   counts   (baseMean   values)  
determined   by  RNA-­sequencing,   which   range   from   17,000-­30,000   transcripts   per  
million.  RNA  probes  were  designed  for  in  situ  hybridisation  and  expression  analysed  
at  20  ss,  the  stage  that  RNA-­sequencing  was  carried  out.  In  situ  hybridisation  can  be  
utilised   to   detect   changes   in   the   pattern   of   gene   expression,   but   is   not   sensitive  
enough  to  quantitate  differences  in  expression  unless  this  is  large.    
  
5.3.1   Expression  of  candidate  genes  in  wild  type  embryos  
tubb2b  expression  is  mainly  uniform  along  the  A-­P  axis,  but  with  localised  expression  
in  lateral  regions,  which  appears  to  be  in  neural  epithelial  cells  (Figure  28:  A,  B).  The  
expression  pattern  of  hmgb2a  is  uniform  and  the  same  as  previously  reported  (Moleri  




et  al.,  2011).  nap1l1  expression  is  higher  in  some  segments  than  others  (Figure  28:  
E,  F),  which  is  in  agreement  with  previous  data  (Thisse  and  Thisse,  2014).  mdka  has  
higher  localised  expression  in  the  segments  and  lower  expression  in  what  appears  
to  be  the  hindbrain  boundaries  (Figure  28:  G,  H),  which  is  in  agreement  with  previous  
data  (Winkler  et  al.,  2003).    
  
  
Figure  28  Expression  of  validated  target  genes  in  wild  type  embryos  
(A-­H)  Embryos  at  20  ss  /  19  hpf  after  in  situ  hybridisation  for  tubb2b  (A-­B),  hmgb2a  (C-­D),  nap1l1  
(E-­F)  and  mdka  (G-­H).  (A,  C,  E,  G)  Are  flat  mounted  embryos  and  (B,  D,  F,  H)  are  side  mouted  
embryos.  Scale  bar  represents  100  µm.  
  
5.3.2   Expression  of  candidate  genes  in  embryos  where  Eph-­ephrin  signalling  
is  disrupted  
In   order   to   determine   if   the   expression   of   the   candidate   genes   is   affected   by  
Eph-­ephrin   signalling,   their   expression  patterns  were   identified   in   embryos  where  
signalling   had   been   blocked.   Embryos   were   collected   in   the   same   way   that   the  
RNA-­sequencing   samples   were   obtained   by   out-­crossing   the   HS-­Gal4   and  
UAS-­soluble  ephrinB1a  transgenic  fish.  This  induces  soluble  ephrinB1a  expression  
in   around   50%   of   embryos   from   a   clutch   to   globally   block   Eph-­ephrin   signalling  




(Chapter   4.3.1,   Figure   11).   These   embryos   have   complete   loss   of   hindbrain  
boundaries.   The   numbers   and   images   depicted   in   the   proceeding   figures   for   this  
cross  are  the  embryos  that  have  expression  patterns  that  are  different  from  wild  type  
embryos   and   are   predicted   to   have   inherited   both   transgenes   and   over-­express  
soluble  ephrinB1a.  Double  Eph  receptor  or  double  ephrin  mutant  embryos  were  also  
used,  which  have  partial  boundary  loss,  with  the  boundaries  of  r1/r2,  r4/r5  and  r6/r7  
remaining  (Chapter  3.3.2,  Figure  10).  As  with  previous  validation  experiments,  the  
embryos  were   collected   at   20   ss,   the   same   stage   that   the  RNA-­sequencing  was  
carried  out.  From  this  analysis,  changes  in  expression  patterns  were  clearer  to  see  
when   the   embryos   were   side   mounted,   rather   than   flat   mounted.   Therefore,   the  
numbers  quoted  for  a  given  phenotype  will  refer  to  side  mounted  embryos.    
  
tubb2b   expression   does   not   alter   when   Eph-­ephrin   signalling   is   blocked   with  
expression  of  soluble  ephrinB1a  (Figure  29:  B,  F,  J,  N).  Likewise,  tubb2b  expression  
does  not  alter  in  double  Eph  receptor  mutants  (Figure  29:  C,  G,  K,  M),  nor  in  double  
ephrin  mutants  (Figure  29:  D,  H,  L,  N).  
  





Figure  29  tubb2b  expression  at  20  ss  when  Eph-­ephrin  signalling  is  blocked  
Embryos  at  20  ss  /  19  hpf  after  in  situ  hybridisation  for  tubb2b.  (A-­H)  Flat  mount  view  and  (I-­P)  
and  a  side  mount  view  with  A-­D  and  I-­L  at  a  higher  magnification  than  E-­H  and  M-­P.  A-­D  and  E-­H  
show  the  same  embryo  in  each  column  at  a  different  magnification,  as  well  as  I-­L  and  M-­P.  Scale  
bar  represents  100  µm.    
  




hmgb2a   expression   does   not   alter   when   Eph-­ephrin   signalling   is   blocked   with  
expression  of  soluble  ephrinB1a  (Figure  30:  B,  F,  J,  N),  nor  in  double  Eph  receptor  
mutants  (Figure  30:  C,  G,  K,  M),  nor  in  double  ephrin  mutants  (Figure  30:  D,  H,  L,  
N).  





Figure  30  hmgb2a  expression  at  20  ss  when  Eph-­ephrin  signalling  is  blocked  
Embryos  at  20  ss  /  19  hpf  after  in  situ  hybridisation  for  hmgb2a.  (A-­H)  Flat  mount  view  and  (I-­P)  
and  a  side  mount  view  with  A-­D  and  I-­L  at  a  higher  magnification  than  E-­H  and  M-­P.  A-­D  and  E-­H  
show  the  same  embryo  in  each  column  at  a  different  magnification,  as  well  as  I-­L  and  M-­P.  Scale  
bar  represents  100  µm.    
  
  




In  wild  type  embryos  nap1l1  expression  is  higher  in  specific  regions  of  the  hindbrain  
(black  arrowheads,  Figure  31:  A,  E,  I,  M),  and  has  a  region  of  lower  expression  (white  
arrowheads,  Figure  31:  A,  E,  I,  M).  The  expression  pattern  of  nap1l1  changes  when  
Eph-­ephrin   signalling   is   disrupted.   When   Eph-­ephrin   signalling   is   blocked   with  
soluble  ephrinB1a  the  expression  of  nap1l1  is  uniform  (Figure  31:  B,  F,  J,  N).  This  is  
observed   in  62%  of  embryos,   those   likely   to  be   the  ones  over-­expressing  soluble  
ephrinB1a.   There   is   also   uniform   nap1l1   expression   in   the   Eph   receptor   double  
homozygous  mutants  (Figure  31:  C,  G,  K,  O),  as  well  as  in  the  ephrin  double  mutants  
(Figure  31:  D,  H,  L,  P).  





Figure  31  nap1l1  expression  at  20  ss  when  Eph-­ephrin  signalling  is  blocked  
Embryos  at  20  ss  /  19  hpf  after   in  situ  hybridisation  for  nap1l1.  (A-­H)  Flat  mount  view  and  (I-­P)  
and  a  side  mount  view  with  A-­D  and  I-­L  at  a  higher  magnification  than  E-­H  and  M-­P.  A-­D  and  E-­H  
show   the   same   embryo   in   each   column   at   a   different  magnification,   as  well   as   I-­L   and  M-­P.  
Arrowheads  indicate  regions  of  higher  nap1l1  expression.  Scale  bar  represents  100  µm.    
  




In  wild   type  embryos,  mdka   expression   is   localised  and  segmented   (arrowheads,  
Figure  32:  A,  E,  I,  M).  In  the  Eph  receptor  double  mutants,  mdka  expression  is  more  
uniform  than  in  wild  type  embryos  but  there  is  higher  expression  in  certain  segments  
(arrowheads,  Figure  32:  K,  O).  When  Eph-­ephrin  signalling  is  blocked  globally  with  
soluble  ephrinB1a,  43%  of  embryos  have  uniform  mdka  expression  throughout  the  
hindbrain  (Figure  32:  B,  F,  J,  N).  The  expression  of  mdka  in  ephrin  double  mutants  
is  similar  to  the  double  Eph  receptor  mutants,  with  more  uniform  expression  than  in  
wild   type  embryos  but  higher  expression   in  certain  segments  (arrowheads,  Figure  
32:  L,  P).  
  





Figure  32  mdka  expression  at  20  ss  when  Eph-­ephrin  signalling  is  blocked  
Embryos  at  20  ss  /  19  hpf  after  in  situ  hybridisation  for  mdka.  (A-­H)  Flat  mount  view  and  (I-­P)  and  
a  side  mount  view  with  A-­D  and  I-­L  at  a  higher  magnification  than  E-­H  and  M-­P.  A-­D  and  E-­H  
show   the   same   embryo   in   each   column   at   a   different  magnification,   as  well   as   I-­L   and  M-­P.  
Arrowheads  indicate  regions  of  higher  mdka  expression.  Scale  bar  represents  100  µm.    




5.4   Expression  of  target  genes  in  the  tail  
In  situ  hybridisation  analysis  revealed  that  when  Eph-­ephrin  signalling  was  disrupted,  
nap1l1  and  mdka  had  altered  expression  patterns,  whereas  changes  in  expression  
could  not  be  detected  by  this  technique  for  tubb2b  and  hmgb2a,  which  had  uniform  
expression   in   the   hindbrain.   The   four   genes   selected   have   been   previously  
implicated   in  neuronal  differentiation  and  cell  proliferation  and   thus   these  markers  
may  reflect  the  pattern  of  progenitors  and  neurogenesis.  It  is  known  that  hindbrain  
boundary  cells  have  lower  neurogenesis  than  non-­boundary  regions  (Cheng  et  al.,  
2004).  There  were  differences  observed  for  some  of  these  genes  by  whole  embryo  
RT-­qPCR  and  hindbrain  RNA-­sequencing,  which  could  be  the  result  of  Eph-­ephrin  
signalling   regulating   the  progression  of  neurogenesis.  The  stage  of   neurogenesis  
differs  along  the  A-­P  axis,  with  the  anterior  being  earlier  than  the  posterior.  Therefore,  
when  observing  changes  in  gene  expression  in  the  whole  embryo  the  effects  may  be  
different  to  the  hindbrain  because  it   includes  tissues  that  are  at  different  stages  of  
neurogenesis.   In   addition,   this   may   also   be   a   result   of   Eph-­ephrin   signalling  
regulating  the  progression  of  neurogenesis  throughout  the  embryo.  In  order  to  test  
this  hypothesis,  the  expression  of  the  four  candidate  genes  was  investigated  in  the  
tail  as   this   is  at  an  earlier   stage   than   the  hindbrain.  At   the  caudal  end  of   the   tail,  
neural  epithelial  cells  are  being  generated,  as  these  progress  to  a  more  mature  stage  
and   undergo   neurogenesis.   The   stage   used   was   19   hpf,   the   stage   at   which  
RNA-­sequencing  and  RT-­qPCR  validation  was  carried  out.  
  
The   expression   of   tubb2b,   hmgb2a,   nap1l1   and  mdka   were   analysed   in   tails   of  
embryos   where   Eph-­ephrin   signalling   had   been   disrupted   (Figure   33).   For   these  
genes,  the  wild  type  expression  patterns  were  not  consistent  with  them  marking  the  
transition  in  cell  differentiation  in  the  tail  as  they  do  not  have  a  gradient  of  expression  
along  the  A-­P  axis  or  a  domain  of  expression  where  neural  progenitors  are  situated  
in   the   tail   (Figure   33:   A,   F,   K,   P).   These   data   argue   against   the   hypothesis   of  
Eph-­ephrin   signalling   regulating   the   progression   of   neurogenesis   throughout   the  
embryo.   In   addition,   no   major   changes   in   expression   were   observed   when  
Eph-­ephrin  signalling  was  disrupted  (Figure  33:  B-­E,  G-­J,  L-­O,  Q-­T).  





Figure  33  Expression  of  candidate  genes  in  the  tail  
(A-­T)  Embryos  at  19  hpf  after  in  situ  hybridisation  for  tubb2b  (A-­E),  hmgb2a  (F-­J),  nap1l1  (K-­O)  
and  mdka  (P-­T).  Values  indicate  the  number  of  embryos  with  the  phenotype.  Scale  bar  represents  
100  µm.    
  
5.5   Discussion  
In   this   chapter,   candidate   transcriptional   targets   of  Eph-­ephrin   signalling   that   had  
been   identified   by  RNA-­sequencing  were   validated   using   a   two-­step   approach   of  
RT-­qPCR  and   in  situ  hybridisation.  The  genes  chosen  for  validation  were  selected  
by   ranking   the  RNA-­sequencing  data   in   four  different  ways:   the  most  significantly  
differentially  expressed  genes,  genes  with  the  highest  fold  change,  genes  with  the  




most   correlated   expression   to   ephrinB1a   and   genes   with   the   highest   number   of  
reads.   Individual   whole   embryos   were   used   in   order   to   screen   through   multiple  
potential   candidate   genes   rather   than   single   genes   and   to   eliminate   any   bias  
resulting  from  hindbrain  dissection.  The  outcomes  of  this  validation  were  interpreted  
with   caution   as   this   was   carried   out   in   whole   embryos   and   blocking   Eph-­ephrin  
signalling  in  other  regions  of  the  embryo  may  mask  the  effects  in  the  hindbrain.  For  
this   reason,  when   genes  were   selected,   the   known   functions  were   considered   in  
order  to  identify  the  genes  that  are  regulated  downstream  of  Eph-­ephrin  signalling  
and  potentially  involved  in  hindbrain  development.  
  
The  four  genes  selected  for  further  investigation  were  tubb2b,  hmgb2a,  nap1l1  and  
mdka.   These   genes   have   been   implicated   in   neural   progenitor  maintenance   and  
neural  differentiation  and  are  likely  markers  of  the  state  of  neurogenesis.  Firstly,  the  
changes  in  expression  were  quantified  by  RT-­qPCR  in  double  Eph  receptor  mutant  
and  double  ephrin  mutants,  which  showed  that  there  were  opposing  changes  in  gene  
expression   for   some   of   the   genes   in   the   two  mutants   in   comparison   to  wild   type  
embryos.   This   will   reflect   where   the   Eph   receptor   or   ephrins   are   expressed   and  
signal.  Some  of  the  Eph  receptors  and  ephrins  are  likely  to  have  roles  elsewhere  in  
the   embryo   and   bind   other   partners.   The   alteration   in   expression   of   these   genes  
elsewhere  in  the  embryo  will  depend  on  these  factors.    
  
There  were  also  differences  observed  between  the  changes  in  gene  expression  in  
whole  embryos  detected  by  RT-­qPCR  and  hindbrains  detected  by  RNA-­sequencing.    
The  expression  of  hmgb2a  and  nap1l1  did  not  alter  in  whole  embryos,  but  expression  
increased  in  the  hindbrain  when  Eph-­ephrin  signalling  was  blocked.  mdka  expression  
decreased  in  whole  embryos  but  increased  in  the  hindbrain,  and  tubb2b  expression  
increased  in  both  samples  but  was  greater  in  the  hindbrain.    
  
It   was   hypothesised   that   the   findings   may   be   the   result   of   Eph-­ephrin   signalling  
regulating   the  progression  of   neurogenesis,   based  on   the   candidate  genes  being  
markers  of  neurogenesis.  Identifying  the  expression  patterns  of  these  genes  in  the  
tail   argued   against   this   hypothesis   as   the   expression   patterns   did   not   suggest   a  
correlation  with  neural  differentiation.  However,  this  does  not  rule  out  the  possibility  
that  these  genes  may  be  expressed  in  other  tissues  and  their  expression  is  affected  




there  when  Eph-­ephrin  signalling   is  blocked.  As   the  main  aim  of   this  project   is   to  
identify  transcriptional  targets  in  the  hindbrain,  it  was  beyond  the  scope  of  this  study  
to  investigate  this  further.    
  
In  situ  hybridisation   revealed   that   the  expression  patterns  of   tubb2b   and  hmgb2a  
were  uniform  along  the  A-­P  axis  of  the  hindbrain,  whereas  nap1l1  and  hmgb2a  had  
localised  expression.  Unfortunately,  this  technique  is  not  sensitive  enough  to  detect  
subtle   alterations   in   broad   expression,   and   as   a   result   changes   to   tubb2b   and  
hmgb2a  expression  were  not  observed.  However,  the  localised  expression  of  nap1l1  
and  mdka   altered  when  Eph-­ephrin   signalling  was   disrupted,   and   the   expression  
patterns  of   these   two  genes  became  uniform  along   the  A-­P  axis  of   the  hindbrain.  
This  is  similar  to  what  has  been  observed  previously,  when  boundary  cell  formation  
is   inhibited   leading   to   a   disruption   in   neuronal   patterning   in   the   hindbrain.   The  
consequence  is  an  increase  in  the  number  of  differentiating  neurons  (Terriente  et  al.,  
2012).  It  is  known  that  the  boundary  cells  are  absent  when  Eph-­ephrin  signalling  is  
blocked   by   soluble   ephirnB1a   and   that   nap1l1   and   mdka   are   markers   of  
neurogenesis.   Therefore,   these   data   suggest   that   Eph-­ehprin   signalling   may   be  
altering   gene   expression   indirectly   via   the   loss   of   the   boundary   cells.   This   is  
supported  by  the  phenotypes  observed   in  double  Eph  receptor  or  ephrin  mutants,  
where   there   is   a   specific   loss   of   boundaries.   The   regions   of   the   hindbrain  where  
expression  becomes  more  uniform  corresponds  to  where  Eph-­ephrin  signalling  had  
been   disrupted   and   the   hindbrain   boundaries   are   lost.   These   data   argue   that  
Eph-­ephrin  signalling  may  be  disrupting  the  expression  of  neurogenic  markers  via  
the  loss  of  hindbrain  boundary  cells.    
  
5.6   Conclusion  
In  summary,  candidate  genes  of  Eph-­ephrin  signalling  identified  by  RNA-­sequencing  
were  validated  by  RT-­qPCR  and  subsequent   in  situ  hybridisation.  This  shortlisted  
four   genes   to   identify   their   expression   patterns   when   Eph-­ephrin   signalling   was  
blocked  via  different  methods.  The  genes  selected  were:  tubb2b  and  mdka,  markers  
of  neural  differentiation,  and  hmgb2a  and  nap1l1,  markers  of  progenitor  cells.  nap1l1  
and  mdka   have   localised   expression   patterns   in   the   hindbrain   which   alter   when  




Eph-­ephrin   signalling   is   disrupted.   These   data   suggest   that   Eph-­ephrin   signalling  
may  play  a  role  in  the  balance  between  progenitor  cell  maintenance  and  neural  cell  
differentiation   in   the   hindbrain.   However,   because   little   is   known   about   these  
candidate  genes  in  the  context  of  hindbrain  development  it  is  difficult  to  decipher  the  
sequence   of   events,   as   well   as   how   these   proteins   are   interacting   to   control  
neurogenesis.   Therefore,   in   order   to   investigate   the   regulation   of   Eph-­ephrin  
signalling  on  neuronal  progenitor  maintenance  and  neuronal  cell  differentiation  in  the  
hindbrain,   known   molecular   markers   of   neurogenesis   will   be   used.   This   will   be  
investigated  by  in  situ  hybridisation  and  changes  in  gene  expression  will  be  identified  
in  embryos  where  Eph-­ephrin  signalling  has  been  disrupted  by  soluble  ephrinB1a  or  
in  Eph  receptor  and  ephrin  mutants  in  comparison  to  wild  type  embryos.




Chapter  6.   Investigating  the  role  of  Eph-­ephrin  
signalling  during  neurogenesis  in  the  hindbrain  
6.1   Introduction  
In  the  previous  chapter,  four  genes  tubb2b,  hmgb2a,  nap1l1  and  mdka,  were  found  
to  be  regulated  downstream  of  Eph-­ephrin  signalling  in  the  hindbrain.  These  genes  
have  roles  in  cell  differentiation  and  proliferation,  in  particular  in  neuronal  cell  types.  
In  order  to  explore  the  hypothesis  that  Eph-­ephrin  signalling  may  be  controlling  the  
balance  between  neuronal  progenitors  and  neurogenesis,  expression  of  neurogenic  
markers   was   investigated.   Eph   receptor   and   ephrin   double   mutants,   and  
over-­expression  of  soluble  ephrinB1a  were  used  to  disrupt  Eph-­ephrin  signalling  in  
attempt  to  elucidate  if  and  how  signalling  regulates  neurogenesis.    
  
6.2   Wild  type  expression  of  neural  markers  
The   following   genes   were   chosen   to   explore   the   potential   effects   of   Eph-­ephrin  
signalling   on   neurogenesis:   nestin,   deltaD,   neurogenin1   (neurog1),   neuroD4   and  
huC/D   (Figure   34).   nestin   is   expressed   in   neural   progenitor   cells   and   is   broadly  
expressed  in  the  zebrafish  central  nervous  system  at  24  hpf  and  is  down-­regulated  
as  the  neural  precursors  undergo  differentiation  (Dahlstrand  et  al.,  1995;;  Yamaguchi  
et  al.,  2000;;  Wiese  et  al.,  2004;;  Mahler  and  Driever,  2007).  deltaD   is  a  marker  of  
neurogenesis  and  is  expressed  in  neurogenic  clusters  that  are  undergoing  neuronal  
differentiation.  deltaD   is   important   for   lateral   inhibition   to   prevent   neurogenesis   in  
neighbouring  cells  and  when   its   function   is  blocked  neurons  arise   in  excess.  This  
gene   is   expressed   in   the   hindbrain,   other   regions   of   the   brain,   the   presomitic  
mesoderm  and  in  the  posterior  region  of  newly  formed  somites  (Haddon  et  al.,  1998).  
Another   early  marker   of   neurogenesis   is   neurog1,   which   is   a   bHLH   transcription  
factor  and  is  expressed  in  cells  undergoing  neuronal  differentiation.  It  is  expressed  
in   Type   B   proneural   clusters,   from   which   the   primary   neuronal   network   will   be  
established   (Gradwohl   et   al.,   1996;;   Ma   et   al.,   1996).   Proneural   genes,   such   as  
neurog1,   up-­regulate   the   expression   of  Notch   ligands,  which   then   activate  Notch  
receptor   in   adjacent   cells   leading   to   the   inhibition   of   proneural   gene   expression  




(Blader   et   al.,   1997).  An  additional  marker   of   neuronal   differentiation   is  neuroD4,  
which   is   expressed   downstream   of   proneural   genes   in   post-­mitotic   neurons   that  
migrate  from  the  neurogenic  zones  to  the  mantle  layer  (Lee  et  al.,  1995;;  Gonzalez-­
Quevedo  et  al.,  2010;;  Wang  et  al.,  2003).  huC/D  is  a  marker  of  late  neurogenesis  as  
it  is  expressed  in  post-­mitotic  neurons  in  the  mantle  zone  of  the  neural  epithelium,  
which   have   already   undergone   neuronal   differentiation   (Marusich   et   al.,   1994).   It  
promotes  neuronal  differentiation  by  stabilising  neuronal  transcripts  (Kim  et  al.,  1996;;  
Antic  et  al.,  1999).  huC/D  is  expressed  in  neurons  in  the  mantle  zone  that  occupy  the  
spaces  between  radial  glial  fibres  (Trevarrow  et  al.,  1990;;  Terriente  et  al.,  2012).  
  





Figure  34  Markers  of  neurogenesis  
Schematic   showing   the   stages   of   neural   differentiation   from   neural   progenitor   cell   through   to  
differentiated   neuron   and   the   gene   expression   associated   with   the   respective   stage   in  
development.  
  
The  expression  patterns  of  the  five  markers  of  neurogenesis  were  first  determined  in  
wild  type  embryos.  The  stages  chosen  were  24  hpf  and  30  hpf.  It  has  been  previously  
shown  that  at  20  hpf,  neurogenesis  is  widespread  and  there  are  small  differences  in  
expression  across  the  hindbrain.  This  then  becomes  restricted  to  neurogenic  zones  
that  are  adjacent  to  the  hindbrain  boundaries  by  36  hpf  (Cheng  et  al.,  2004;;  Amoyel  
et  al.,  2005;;  Gonzalez-­Quevedo  et  al.,  2010).  The  neurogenic  zones  are  flanked  by  




non-­neurogenic  zones  in  which  these  markers  are  absent  (Cheng  et  al.,  2004).  This  
is  regulated  by  FGF20a-­expressing  neurons  which  are  found  in  the  segment  centres  
in   the  mantle   zone  and   inhibit   neurogenesis   in   the  centre  of   rhombomeres   in   the  
adjacent  neural  epithelium  (Gonzalez-­Quevedo  et  al.,  2010;;  Terriente  et  al.,  2012).  
Notch  activation  inhibits  neurogenesis  at  hindbrain  boundaries  (Cheng  et  al.,  2004).  
Therefore,   these   time   points   enable   neurogenesis   to   be   observed   as   it   becomes  
increasingly  restricted.  
  
nestin   is   expressed   laterally   in   segment   centres   in   the   hindbrain   at   24   hpf   and  
excluded  from  the  boundary  cells  (Figure  35:  A,  F),  and  at  30  hpf  expression  occurs  
throughout  the  hindbrain  and  up-­regulated  in  the  neurogenic  zones  (Figure  35:  K,  P).  
deltaD  and  neurog1  expression  is  widespread  at  24  hpf  (Figure  35:  B,  G,  C,  H)  and  
their   expression   becomes   restricted   to   the   neurogenic   zones   adjacent   to   the  
boundaries   at   30   hpf   (Figure   35:   B,   G,   C,   H),   as   shown   previously   (Gonzalez-­
Quevedo  et  al.,  2010).  neuroD4  is  expressed  in  lateral  regions  of  the  hindbrain  and  
is   widespread   along   the   A-­P   axis   at   24   hpf   (Figure   35:   D,   I),   and   expression   is  
restricted   to   the   regions   adjacent   to   the   boundaries   at   30   hpf   (Figure   35:   N,   S).  
Finally,  huC/D  expression  is  lateral  and  segmented  at  24  hpf  (Figure  35:  E,  J),  and  
becomes  more  widespread  at  30  hpf  but  is  excluded  from  the  regions  underlying  the  
hindbrain  boundaries  (Figure  35:  O,  T),  as  observed  previously  (Gonzalez-­Quevedo  
et  al.,  2010;;  Terriente  et  al.,  2012).  
  





Figure  35  Expression  of  neuronal  markers  in  wild  type  embryos  
(A-­T)  Embryos  after  in  situ  hybridisation  for  markers  of  neurogenesis.  A-­J  are  at  24  hpf  and  K-­T  
are  at  30  hpf,  in  flat  mount  (A-­E,  P-­T)  and  side  mount  (F-­J,  P-­T).  Scale  bar  represents  100  µm.  
  
6.3   Expression  of  neuronal  markers  when  Eph-­ephrin  signalling  
is  blocked  
Once  the  expression  patterns  of  the  neurogenic  markers  had  been  identified  in  wild  
type   embryos   (Figure   35),   they   were   observed   in   embryos   where   Eph-­ephrin  
signalling  had  been  blocked.  In  previous  experiments,  soluble  ephrinB1a  had  been  
over-­expressed   by   heat   shock   at   bud   and   15   hpf   /   12   ss,   to   block   Eph-­ephrin  




signalling   from   the   onset   in   the   hindbrain.   In   the   experiments   to   follow,   soluble  
ephrinB1a   expression   was   induced   at   18   hpf   /   18   ss   in   attempt   to   separate  
Eph-­ephrin  signalling  from  the  role  in  boundary  cell  formation  to  observe  more  direct  
effects  of  blocking  signalling.  Previous  experiments  in  optimising  the  conditions  for  
blocking  Eph-­ephrin  signalling  to  completely  remove  all  hindbrain  boundaries  found  
that  inducing  soluble  ephrinB1a  expression  at  15  hpf  /  12  ss  did  not  prevent  boundary  
cell  formation  (Chapter  3.4.1).  For  these  experiments,  expression  will  be  induced  at  
19  hpf  /  20  ss  with  the  intention  that  the  boundaries  may  not  be  disrupted.  In  these  
experiments,  around  50%  of  embryos  will  express  soluble  ephirnB1a  because  of  the  
inheritance   of   the   HS-­Gal4   and   UAS-­soluble   ephrinB1a   transgenes.   From   this  
analysis,   the   numbers   quoted   for   a   given   phenotype   will   refer   to   changes   in  
expression  patterns  observed  in  side  mounted  embryos.  
  
6.3.1   The   effect   on   hindbrain   boundary   cells   when   disrupting   Eph-­ephrin  
signalling  at  18  hpf  
Firstly,  the  experiment  described  above  was  carried  out  and  embryos  were  collected  
at  24  hpf  before  rfng  expression  was  analysed  by  in  situ  hybridisation  to  determine  
the  effect  on  hindbrain  boundary  cells.  This  showed  that  from  the  experimental  cross  
when  Eph-­ephrin  signalling  is  blocked  at  19  hpf  there  is  a  decrease  in  rfng  expression  
at  the  boundaries  in  59%  of  embryos  (Figure  36:  E).  The  remaining  41%  of  embryos  
from  the  experimental  cross  have  the  same  expression  as  control  embryos  (Figure  
36:  D).  This  shows  that  blocking  Eph-­ephrin  signalling  at  this  stage  leads  to  partial  
disruption  of  boundary  cell  formation.    
     





Figure  36  rfng  expression  after  blocking  Eph-­ephrin  signalling  at  18  hpf  
(A-­E)  Embryos  at  24  hpf  after  in  situ  hybridisation  for  rfng  to  mark  the  hindbrain  boundary  cells.  
A-­C  are  control  embryos,  D  and  E  are  two  different  phenotypes  from  the  HS-­Gal4  x  UAS-­soluble  
ephrinB1a  cross.  The  scale  bar  represents  50  µm.    
  
6.3.2   nestin  expression  when  Eph-­ephrin  signalling  is  blocked    
At   24   hpf,   there   is   a   striking   difference   in  nestin   expression   between   the   control  
embryos  (Figure  37:  A,  B)  and  56%  of  embryos  of  the  experimental  condition  (Figure  
37:  D,  F),  which  are  likely  to  be  the  embryos  where  Eph-­ephrin  signalling  is  blocked.  
When  Eph-­ephrin  signalling   is  blocked   there   is  more  uniform  expression  of  nestin  
along   the   A-­P   axis   of   the   hindbrain,   showing   that   there   is   a   more   widespread  
distribution   of   neural   progenitor   cells   (Figure   37:   D,   F),   in   comparison   to   control  
embryos  (Figure  37:  A,  B).  
  
There  are  also  changes  in  the  expression  pattern  of  nestin  in  some  embryos  of  the  
experimental   condition   at   30   hpf.   Control   embryos   have   widespread   nestin  
expression  in  the  hindbrain  with  higher  expression  in  clusters  of  cells  more  medial  
than  at  24  hpf  (Figure  37:  G,  H).  In  the  experimental  condition,  25%  of  embryos  have  
more  uniform  and  much  weaker  nestin  expression  (Figure  37:  J,  L)  than  in  the  control  
embryos.   In   the   remaining   75%   of   embryos   in   the   experimental   condition,   the  
expression  of  nestin  is  slightly  weaker  than  in  controls,  but  the  expression  patterns  
are   the   same   as   control   embryos   (Figure   37:   I,   K).   These   data   show   that   the  
distribution   of   neural   progenitors   is   altered   at   24   hpf   with   progenitor   cells   being  
present  in  regions  where  the  boundaries  would  normally  reside.  At  30  hpf  there  are  
fewer  neural  progenitors.    






Figure  37  nestin  expression  when  Eph-­ephrin  signalling  is  blocked  
(A-­L)  Embryos  after  in  situ  hybridisation  to  show  nestin  expression.  A-­J  are  at  24  hpf  and  K-­T  are  
at  30  hpf,  in  flat  mount  (A,  C,  D,  G,  I,  J)  and  side  mount  (F-­J,  P-­T).  Control  embryos  (A-­B,  G-­H)  
are  derived  from  an  in-­cross  of  the  transgenic  line  HS-­Gal4  and  the  experimental  samples  (C-­F,  
I-­L)  are  derived   from  a  cross  of   two   transgenic   lines:  HS-­Gal4   x  UAS-­soluble  ephrinB1a,  with  
around  50%  of  embryos  inheriting  both  transgenes.  All  embryos  have  been  heat  shocked  at  18  
hpf  for  1  hour  at  38  °C.  Scale  bar  represents  100  µm.  
  
6.3.3   deltaD  expression  when  Eph-­ephrin  signalling  is  blocked  
The  early  marker  of  neurogenesis,  deltaD,  showed  a  subtle  change   in  expression  
when   Eph-­ephrin   signalling   is   blocked.   At   24   hpf,   control   embryos   have   broad  
expression  in  the  hindbrain  with  regions  of  higher  expression  (Figure  38:  A,  B).   In  
embryos  from  the  experimental  condition,  56%  had  the  same  expression  pattern  as  
the  control  embryos   (Figure  38:  C,  E)  and  44%  show  a  more  uniform  expression  
pattern  (Figure  38:  D,  F).    
  
At   30   hpf,   the   difference   between   embryos   is   clearer,   as   there   is   organisation   of  
neurogenic  and  non-­neurogenic  zones  in  control  embryos  at  this  stage  (Figure  38:  
G,   H).   In   contrast,   40%   of   embryos   from   the   experimental   condition   have   more  
uniform  deltaD  expression  that  is  weaker  than  in  the  controls  and  the  non-­neurogenic  
zones  can  no  longer  been  seen  (Figure  38:  K,  L).  
  





Figure  38  deltaD  expression  when  Eph-­ephrin  signalling  is  blocked  
(A-­L)  Embryos  after  in  situ  hybridisation  to  show  deltaD  expression.  A-­J  are  at  24  hpf  and  K-­T  are  
at  30  hpf,  in  flat  mount  (A,  C,  D,  G,  I,  J)  and  side  mount  (F-­J,  P-­T).  Control  embryos  (A-­B,  G-­H)  
are  derived  from  an  in-­cross  of  the  transgenic  line  HS-­Gal4  and  the  experimental  samples  (C-­F,  
I-­L)  are  derived   from  a  cross  of   two   transgenic   lines:  HS-­Gal4   x  UAS-­soluble  ephrinB1a,  with  
around  50%  of  embryos  inheriting  both  transgenes.  All  embryos  have  been  heat  shocked  at  18  
hpf  for  1  hour  at  38  °C.  Scale  bar  represents  100  µm.  
  
6.3.4   neurog1  expression  when  Eph-­ephrin  signalling  is  blocked  
The  second  gene  investigated  to  determine  the  effects  Eph-­ephrin  signalling  has  on  
differentiating  neurons  is  neurog1.  The  changes  in  expression  are  easier  to  see  at  
30   hpf,   although   there   is   a   mild   phenotype   at   24   hpf.   Control   embryos   express  
neurog1   throughout   the   hindbrain   at   24   hpf,   with   higher   expression   in   stripes  
adjacent  to  the  boundaries  (Figure  39:  A,  B).  In  the  experimental  condition  56%  of  
embryos  have  more  continuous  neurog1  expression  along  the  A-­P  axis  compared  to  
control  embryos  (Figure  39:  D,  F).  The  remaining  44%  have  similar  expression   to  
control  embryos  (Figure  39:  C,  E).  
  
Analysis  at  30  hpf  shows  clearer  changes  to  neurog1  expression  that  are  similar  to  
those  seen  at  24  hpf.  In  the  experimental  condition,  43%  of  embryos  have  continuous  
neurog1  expression  along  the  A-­P  axis  with  no  separation  between  neurogenic  and  
non-­neurogenic  zones  (Figure  39:  J,  L).  The  remaining  57%  of  embryos  show  striped  
neurog1  expression  in  neurogenic  zones,  the  same  as  controls  (Figure  39:  G,  H).    
  





Figure  39  neurog1  expression  when  Eph-­ephrin  signalling  is  blocked  
(A-­L)  Embryos  after  in  situ  hybridisation  to  show  neurog1  expression.  A-­J  are  at  24  hpf  and  K-­T  
are  at  30  hpf,  in  flat  mount  (A,  C,  D,  G,  I,  J)  and  side  mount  (F-­J,  P-­T).  Control  embryos  (A-­B,  
G-­H)  are  derived  from  an  in-­cross  of  the  transgenic  line  HS-­Gal4  and  the  experimental  samples  
(C-­F,  I-­L)  are  derived  from  a  cross  of  two  transgenic  lines:  HS-­Gal4  x  UAS-­soluble  ephrinB1a,  
with  around  50%  of  embryos  inheriting  both  transgenes.  All  embryos  have  been  heat  shocked  at  
18  hpf  for  1  hour  at  38  °C.  Scale  bar  represents  100  µm.  
  
6.3.5   neuroD4  expression  when  Eph-­ephrin  signalling  is  blocked  
neuroD4  is  a  late  marker  of  differentiating  neurons  and  its  expression  too  was  found  
to  alter  when  Eph-­ephrin  signalling  was  blocked.  At  24  hpf,  control  embryos  express  
neuroD4   in   lateral   clusters   in   the   hindbrain,   although   at   this   stage   the   regions   of  
expression  are  not  clearly  defined  (Figure  40:  A,  B).  neuroD4  expression  has  subtle  
differences   in   60%   of   embryos   in   the   experimental   condition,   which   have   more  
continuous  expression  (Figure  40:  D,  F).  The  remaining  40%  of  embryos  from  the  
experimental  condition  have  similar  expression  to  control  embryos  (Figure  40:  C,  E).  
  
At  30  hpf,  defined  regions  of  neuroD4  expression  are  seen  in  control  embryos  (Figure  
40:  G,  H),  which  are  absent  in  43%  of  embryos  from  the  experimental  condition  that  
have  more  continuous  and  weaker  expression  (Figure  40:  J,  L).  The  remaining  57%  
of  embryos  have  the  same  expression  as  control  embryos  (Figure  40:  I,  K).  These  
data   show   that   the   localisation   of   differentiating   neurons   is   disrupted   when  
Eph-­ephrin  signalling  is  blocked,  and  that  there  is  ectopic  expression  in  the  hindbrain.    
  





Figure  40  neuroD4  expression  when  Eph-­ephrin  signalling  is  blocked  
(A-­L)  Embryos  after  in  situ  hybridisation  to  show  neuroD4  expression.  A-­J  are  at  24  hpf  and  K-­T  
are  at  30  hpf,  in  flat  mount  (A,  C,  D,  G,  I,  J)  and  side  mount  (F-­J,  P-­T).  Control  embryos  (A-­B,  G-­
H)  are  derived  from  an  in-­cross  of  the  transgenic  line  HS-­Gal4  and  the  experimental  samples  (C-­
F,  I-­L)  are  derived  from  a  cross  of  two  transgenic  lines:  HS-­Gal4  x  UAS-­soluble  ephrinB1a,  with  
around  50%  of  embryos  inheriting  both  transgenes.  All  embryos  have  been  heat  shocked  at  18  
hpf  for  1  hour  at  38  °C.  Scale  bar  represents  100  µm.  
  
6.3.6   huC/D  expression  when  Eph-­ephrin  signalling  is  blocked  
The  final  marker  of  neurogenesis   investigated  is  huC/D,  a  marker  of  differentiated  
neurons.  Similar   to   the  previous  neuronal  markers   investigated,   the  phenotype   is  
subtle   at   24   hpf   with  more   obvious   differences   at   30   hpf.   Control   embryos   have  
segmented  expression  of  huC/D,  marking  the  differentiated  neurons   in   the  mantle  
zone   (Figure  41:  A,  B).  huC/D  expression   is  more  continuous   in  56%  of  embryos  
from  the  experimental  condition  (Figure  41:  D,  F).  The  remaining  44%  of  embryos  
have  similar  expression  to  the  control  embryos  (Figure  41:  C,  E).    
  
huC/D  expression  is  more  widespread  at  30  hpf  in  control  embryos  (Figure  41:  G,  H),  
as   more   neurons   have   differentiated.   In   56%   of   embryos   from   the   experimental  
condition  huC/D  expression  is  weaker  and  more  continuous  (Figure  41:  J,  L).  The  
remaining   embryos   have   similar   expression   to   control   embryos   (Figure   41:   I,   K).  
These  data  show   that   there   is  ectopic  neurogenesis  at  24  hpf  and  a  depletion  of  
neurons  at  30  hpf.  





Figure  41  huC/D  expression  when  Eph-­ephrin  signalling  is  blocked  
(A-­L)  Embryos  after  in  situ  hybridisation  to  show  huC/D  expression.  A-­J  are  at  24  hpf  and  K-­T  are  
at  30  hpf,  in  flat  mount  (A,  C,  D,  G,  I,  J)  and  side  mount  (F-­J,  P-­T).  Control  embryos  (A-­B,  G-­H)  
are  derived  from  an  in-­cross  of  the  transgenic  line  HS-­Gal4  and  the  experimental  samples  (C-­F,  
I-­L)  are  derived   from  a  cross  of   two   transgenic   lines:  HS-­Gal4   x  UAS-­soluble  ephrinB1a,  with  
around  50%  of  embryos  inheriting  both  transgenes.  All  embryos  have  been  heat  shocked  at  18  
hpf  for  1  hour  at  38  °C.  Scale  bar  represents  100  µm.  
  
6.4   Expression  of  neuronal  markers  in  Eph  receptor  and  ephrin  
mutants  
Blocking  Eph-­ephrin   signalling  with   soluble  ephrinB1a  showed   that   the   impact  on  
neurogenesis  was  greater  at  30  hpf  than  24  hpf,  likely  due  to  this  being  a  cumulative  
effect.  To  further  understand  the  effects  of  Eph-­ephrin  signalling  on  neurogenesis,  
expression   of   the   neurogenic  markers  was   observed   in   Eph   receptor   and   ephrin  
double  mutants  at  30  hpf.  In  the  double  Eph  receptor  or  ephrin  mutants,  the  hindbrain  
boundaries  are  disrupted  earlier  and  only  at  the  boundaries  of  r2/r3,  r3/r4  and  r6/r7,  
whereas  with  soluble  ephrinB1a  expression  Eph  ephrin  signalling  is  blocked  later,  at  
18   hpf,   which   results   in   disruption   to   the   boundaries   and   weaker   boundary   cell  
marker  expression  at  24  hpf.  
  
Firstly,  nestin   expression   is  uniform  along   the  A-­P  axis   in  wild   type  embryos  with  
regions   of   segmented   higher   expression   (Figure   42:   Ai,   Aii).   nestin   is   more  
continuous  along  the  A-­P  axis  in  double  Eph  receptor  mutants  (Figure  42:  Fi,  Fii)  and  
double  ephrin  mutants  (Figure  42:  Ki,  Kii).    





deltaD  is  expressed  in  stripes  along  the  A-­P  axis  of  the  hindbrain  in  wild  type  embryos,  
marking  the  neurogenic  zones  (arrowheads  indicate  non-­neurogenic  zones,  Figure  
42:  Bi,  Bii).  In  double  Eph  receptor  mutants,  deltaD  expression  is  more  continuous  
along   the   A-­P   axis,   although   there   is   higher   expression   in   the   neurogenic   zones  
(Figure   42:   Gi,   Gii).   In   the   double   ephrin   mutants   deltaD   expression   is   more  
continuous   and   the   neurogenic   and   non-­neurogenic   zones   are   no   longer   visible  
(Figure  42:  Li,  Lii).    
  
The  second  marker  of  differentiating  neurons,  neurog1,  is  expressed  in  stripes  along  
the  anterior  posterior  axis,  marking  the  neurogenic  zones  (arrowheads  indicate  non-­
neurogenic  zones,  Figure  42:  Ci,  Cii).  In  the  double  Eph  receptor  mutants,  neurog1  
expression  is  more  continuous,  showing  that  the  non-­neurogenic  zones  are  absent  
(Figure  42:  Hi,  Hii),  which  is  also  observed  for  the  double  ephrin  mutants  (Figure  42:  
Mi,  Mii).  Interestingly,  in  double  ephrin  mutants  there  is  a  gap  in  the  A-­P  expression  
of  neurog1  (arrowheads,  Figure  42:  Gi).  This  could  coincide  with  the  r4/r5  boundary  
at  which  Eph-­ephrin  signalling  persists  (Chapter  3:  Figure  10),  and  may  explain  why  
this  non-­neurogenic  zone   is  still   present.  However,   it  would  be  expected   that   this  
phenotype  would  be  the  same  in  the  double  Eph  receptor  mutants  because  they  both  
have  the  same  boundary  loss  phenotype.    
  
The  marker   of   late   neural   differentiation,  neuroD4,   is   expressed   in   stripes   and   is  
absent   in   regions   that   correspond   to   the   hindbrain   boundaries   and   the   segment  
centres  (black  arrowheads  and  white  arrowheads,  respectively,  Figure  42:  Di,  Dii).  
In   the  double  Eph   receptor  mutants,  neuroD4  expression   is  more  continuous  and  
weaker  in  the  hindbrain  (Figure  42:  Ii,  Iii),  which  is  also  observed  in  the  double  ephrin  
mutants  (Figure  42:  Ni,  Nii).  
  
In  wild  type  embryos,  huC/D  expression  is  widespread  with  up-­regulated  expression  
in   stripes  along   the  A-­P  axis   (Figure  42:  Ei,  Eii).   In  double  Eph   receptor  mutants  
huC/D,  expression  is  more  continuous  and  weaker  than  in  wild  type  embryos  (Figure  
42:  Ji,  Jii),  and  this  is  also  observed  in  double  ephrin  mutant  embryos  (Figure  42:  Oi,  
Oii).  This  is  a  surprising  observation  as  there  is  no  evidence  to  suggest  that  huC/D  
expression   is   down-­regulated   in   post-­mitotic   neurons   and   should   mark   the  




accumulation   of   neurons.   Previous   work   has   shown   that   transcripts   can   still   be  
detected  by  in  situ  hybridisation  at  5  days  post  fertilisation  (Cox  et  al.,  2016).  In  order  
to  investigate  this  further,  HuC/D  protein  was  detected  by  immunofluorescence.





Figure  42  Expression  of  neuronal  markers  in  wild  type,  double  Eph  receptor  and  
double  ephrin  mutants  
(A-­O)   Embryos   at   30   hpf   after   in   situ   hybridisation   for   markers   of   neurogenesis   in   wild   type  
embryos  (A-­E),  EphA4a  and  EphB4a  double  mutants  (F-­J)  and  ephrinB2a  and  ephrinB3b  double  
mutants   (K-­O).   Black   arrowheads   mark   non-­neurogenic   zones   in   rhombomeres   and   white  
arrowheads  mark  non-­neurogenic  zones  at  hindbrain  boundaries.  Scale  bar  represents  100  µm.    




6.4.1   HuC/D  expression  in  Eph  receptor  and  ephrin  mutants  
After   fewer   huC/D   transcripts   were   detected   when   Eph-­ephrin   signalling   was  
disrupted   (Figure  41;;  Figure  42),  protein  was  detected  by   immunofluorescence   in  
order  to  confirm  the  changes  observed  (Figure  43).  This  analysis  was  carried  out  in  
EphA4a  and  EphB4a  double  mutant  embryos  as  well  as  ephrinB2a  and  ephrinB3b  
double  mutant  embryos.  At  18  hpf   there   is   little  difference   in  HuC/D  expression   in  
wild   type  embryos  and  double  Eph   receptor  or  double  ephrin  mutants   (Figure  43:  
A-­C).  At  24  hpf,  30  hpf  and  36  hpf,  ectopic  HuC/D  expression  is  seen  in  double  Eph  
receptor  mutants  (Figure  43:  E,  H,  K),  and  more  strikingly  in  double  ephrin  mutants  
(Figure  43:  F,   I,  L),   in  comparison  to  wild   type  embryos  (Figure  43:  D,  G,  J).  This  
suggest  that  there  is  ectopic  neurogenesis  when  Eph-­ephrin  signalling  is  disrupted  
and  agrees  with  the  finding  of  increased  neural  differentiation  observed  by  ectopic  
expression   of   neural   differentiation   markers.   However,   this   contradicts   the  
observations  by   in  situ  hybridisation  for  huC/D  where  there   is  a  decrease  in  RNA.  
This  could  be  regulated  by  mechanisms  that  we  do  not  understand  well  enough  to  
interpret.   As   there   are   numerous   studies   that   use  HuC/D   protein   as   a  marker   of  
differentiated   neurons   rather   than   RNA   detection   by   in   situ   hybridisation,   the  
observations  made  by  immunostaining  will  be  used  interpret  these  findings.    
  





Figure  43  Immunofluorescence  of  HuC/D  
(A-­L)  Embryos   flat  mounted  after   immunofluorescence   for  HuC/D   from  18-­36  hpf   in  wild   type  
embryos   (A,  E,  G,   J),   double  EphA4a   and  EphB4a   receptor  mutants   (B,  F,  H,  K)  and  double  
ephrinB2a  and  ephrinB3b  mutants  (C,  G,  I,  L).  Scale  bar  represents  100  µm.  
  




6.5   Discussion  
In   this  chapter,  markers  of  different   stages  of  neurogenesis  have  been  utilised   to  
determine   the   role  of  Eph-­ephrin  signalling   in   the  context  of  neural  differentiation.  
The   reason   for  exploring  neurogenesis  was   that   the  genes   found   to  be   regulated  
downstream   of   Eph-­ephrin   signalling   are   markers   of   progenitor   cells   and   neural  
differentiation.   To   explore   this,   embryos   were   collected   at   later   stages   of  
development   which   coincided   with   when   neurogenesis   is   becoming   increasingly  
restricted   to   the   neurogenic   zones   adjacent   to   the   hindbrain   boundaries.   Two  
methods  of  disrupting  Eph-­ephrin  signalling  were  used  to  observe  any  changes.  The  
first  method  was  to  express  soluble  ephrinB1a  at  18  hpf  in  attempt  look  specifically  
at  any  changes  to  neurogenesis  more  directly  as  signalling  has  been  blocked  at  a  
later  stage  of  development.  However,  this  still  resulted  in  disruption  to  the  boundary  
cells,  shown  by  weaker  expression  of  rfng.  Secondly,  Eph  receptor  and  ephrin  double  
mutants   were   used   to   determine   the   effects   on   neurogenesis   when   Eph-­ephrin  
signalling  was  disrupted  earlier  in  development  and  embryos  have  partial  hindbrain  
boundary   loss   (remaining   boundaries   r1/r2,   r4/r5   and   r6/r7).   Despite   attempts   to  
separate  Eph-­ephrin  signalling  from  the  role  in  boundary  cell  formation  to  find  more  
direct  effects  of  blocking  signalling,  from  the  phenotypes  observed  it  appears  that  the  
effects   on   neurogenesis   are   an   indirect   consequence   of   boundary   cell   loss.   This  
suggests   that   the  decreased  expression  of  rfng  at   the  boundaries  at  24  hpf   is  not  
sufficient  to  enable  the  normal  function  of  boundary  cells.  
  
When  Eph-­ephrin  signalling  is  blocked  at  18  hpf  by  expression  of  soluble  ephrinB1a,  
at  24  hpf  there  is  ectopic  neurogenesis  in  the  hindbrain.  This  is  observed  by  neuronal  
progenitor  cells,  differentiating  cells  and  neurons  being  more  widespread  throughout  
the  hindbrain  than  in  control  embryos.  The  phenotypes  observed  are  similar  to  what  
has   been   found   previously   when   boundary   cells   are   lost   or   FGF20   signalling   is  
disrupted  (Gonzalez-­Quevedo  et  al.,  2010;;  Terriente  et  al.,  2012).  This  suggests  that  
the  effects  on  neurogenesis  are  a  result  of  boundary  cell  loss  and  that  the  weaker  
rfng  expression  observed  at  24  hpf  when  Eph-­ephrin  signalling  is  blocked  at  18  hpf,  
is  not   sufficient   for   the   inhibition  of  neurogenesis   in  boundary  cells   (Cheng  et  al.,  
2004).  Instead  the  boundaries  are  now  neurogenic  progenitors  and  are  differentiating  
to  form  neurons  (shown  by  the  expression  of  nestin  and  deltaD).  At  30  hpf,  blocking  




Eph-­ephrin   signalling   then   results   in   fewer   neural   progenitor   cells   and   ectopic  
neurogenesis   in   segment   centres   and   an   increase   in   differentiated   neurons.   This  
suggests  that  blocking  Eph-­ephrin  signalling  results  in  neurogenesis  in  regions  of  the  
hindbrain  where  it  is  normally  absent,  which  leads  to  a  depletion  of  progenitor  cells  
at  the  later  stage  of  30  hpf.    
  
The   double   Eph   receptor   and   double   ephrin  mutants   disrupt   signalling   via   either  
EphA4a  and  EphB4a,  or  ephrinB2a  and  ephrinB3b,  respectively,  and  have  a  loss  of  
boundaries  at   r2/r3,   r3/r4  and  r5/r6.   In  both  mutants,  at  30  hpf,   there  was  ectopic  
neurogenesis  in  the  hindbrain  and  an  increase  in  differentiated  neurons.  However,  
in  contrast,  the  neural  progenitor  cells  did  not  decrease  in  the  double  Eph  receptor  
and   double   ephrin   mutants,   but   instead   were   more   continuous.   The   effect   on  
neurogenesis  would  be  expected   to  greater   in   the  double  ephrin  mutant  embryos  
because  in  the  hindbrain  there  are  three  ephrinBs  present  and  signalling  via  two  has  
been  disrupted,  whereas  in  the  double  Eph  receptor  mutant  embryos  there  are  more  
Eph   receptors   that   are   able   to   signal   redundantly.   There   was   more   ectopic  
neurogenesis   in   the   double   ephrin  mutant   than   the   double   Eph   receptor  mutant,  
shown  by  deltaD  expression,  but,  this  was  not  clearly  observed  for  any  of  the  other  
neurogenic  markers.  The  phenotypes  observed  are  likely  to  be  secondary  to  the  loss  
of  boundaries  as  there  is  ectopic  neurogenesis  which  is  a  known  consequence  of  the  
loss  of  boundaries.  In  addition,  direct  phenotypes  would  show  a  correlation  between  
Eph  receptor  or  ephrin  expression,  in  the  respective  mutants,  which  is  not  observed  
for   nestin,   deltaD   and   neurog1.   neuroD4   and   huC/D   are   altered   in   double   Eph  
receptor  and  double  ephrin  mutants  in  regions  that  are  not  specific  to  the  boundaries  
and  thus  would  argue  that  Eph-­ephrin  signalling  is  regulating  neurogenesis  indirectly.  
  
6.6   Conclusion  
In  this  chapter,  known  markers  of  neuronal  progenitors,  neuronal  differentiation  and  
differentiated  neurons  were  used  to  decipher  the  role  in  which  Eph-­ephrin  signalling  
may  play  in  neurogenesis  during  hindbrain  development.  It  was  found  that  at  24  hpf  
blocking   of   Eph-­ephrin   signalling   leads   to   increased   ectopic   neurogenesis   which  
results   in   the   depletion   of   neural   progenitors   at   30   hpf.   In   double   EphA4a   and  




EphB4a  mutant  embryos,  or  double  ephrinB2a  and  ephrinB3b  mutant  embryos,  there  
is  also  ectopic  neurogenesis  and  an  increase  in  differentiated  neurons  at  30  hpf,  but  
a  decrease  in  neural  progenitors  is  not  observed.  The  effects  observed  are  likely  to  
be  secondary   to   the   loss  of  boundary  cells  as   this  has  been  previously  shown   to  
result  in  ectopic  neurogenesis.




Chapter  7.   Discussion  
7.1   Identification  of  genes  regulated  downstream  of  Eph-­ephrin  
signalling  in  the  hindbrain  
The  aim  of   this  project  was   to   identify   transcriptional   targets  of  Eph   receptor  and  
ephrin  signalling  in  the  zebrafish  hindbrain  in  order  to  further  understand  the  role  of  
this  signalling.  Among  the  genes  identified  are  markers  of  neural  progenitor  cells  and  
neural  differentiation.  hmgb2a  and  nap1l1  are  expressed  in  neural  stem  cells,  whilst  
tubb2b   is  a  marker  of  differentiating  neurons  and  mdka  a  marker  of  differentiation  
and  proliferation.  The  expression  of  these  four  genes  was  quantified  by  RT-­qPCR  in  
whole  embryos  and  the  expression  patterns  determined  by  in  situ  hybridisation.  This  
identified  two  types  of  expression  patterns  in  the  hindbrain:  expression  localised  to  
specific   regions,   and   uniform   expression.   The   localised   expression   of  mdka   and  
nap1l1   in   the   hindbrain   becomes   more   uniform   when   Eph-­ephrin   signalling   was  
blocked  and   the  gaps   in  expression  at   the  boundary  cells  are  no   longer   seen   for  
mdka.  In  addition,  the  change  in  expression  of  mdka  is  the  same  in  both  EphA4a  and  
EphB4a  double  mutants  and  ephrinB2a  and  ephrinB3b  double  mutants,  and  there  is  
the   same   boundary   loss   in   both   mutants.   The   effect   of   Eph-­ephrin   signalling   on  
neurogenesis  was  investigated  further  by  looking  at  known  markers  of  neurogenesis  
and  it  was  found  that  disrupting  Eph-­ephrin  signalling  results  in  ectopic  neurogenesis  
and  at   later   stages   and   this   causes   a   depletion   of   neural   progenitor   cells.  These  
findings   suggested   that   Eph-­ephrin   signalling   is   involved   in   regulating   the  
progression  of  neurogenesis  in  the  hindbrain  and  that  this  is  occurring  indirectly  via  
the  loss  of  boundary  cells.  
  
7.2   Direct  versus  indirect  consequences  of  blocking  Eph-­ephrin  
signalling  
Due  to  the  complementary  segmental  expression  of  Eph  receptors  and  ephrin  that  
have  high  binding  affinity,  activation  occurs  at  segment  borders.  However,  what   is  
observed  is  that  the  effects  on  neurogenesis  are  found  within  the  hindbrain  segments  
in   Eph   receptor   and   ephrin   double   mutants   and   when   signalling   is   blocked   with  




soluble  ephrinB1a.  Previous  work  has  down  that  Eph-­ephrin  signalling  is  required  for  
formation  of  boundary  cells  and  it  was  anticipated  that  boundary  markers  would  be  
found  in  the  RNA-­sequencing  analysis  (which  will  be  discussed  in  Chapter  7.3).  This  
raises  the  question  of  why  blocking  Eph-­ephrin  signalling  alters  progenitor  cells  and  
neural  differentiation,  which  are  not  located  at  the  site  of  Eph-­ephrin  signalling.  
  
The  boundary  cells  are  essential  for  the  positioning  of  FGF20a-­expressing  neurons  
by   acting   as   a   source   of   chemorepellent,   which   localises   these   neurons   to   the  
segment  centres  in  the  mantle  zone  (Terriente  et  al.,  2012).  The  FGF20a-­expressing  
neurons  then  inhibit  neurogenesis  at  the  segment  centres  of  the  neural  epithelium  
(Gonzalez-­Quevedo  et  al.,  2010).  When  boundary  cell   formation   is  prevented,   the  
FGF20a-­expressing   neurons   are   no   longer   positioned   in   the   segment   centres   to  
provide  a  concentrated  source  of  FGF  to  inhibit  neurogenesis  and  establish  the  non-­
neurogenic   zones.   Consequently,   boundary   cell   disruption   results   in   ectopic  
neurogenesis   (Terriente   et   al.,   2012).   In   the   experiments   in   the   current   study,  
blocking   Eph-­ephrin   signalling   results   in   weaker   expression   of   the   boundary   cell  
marker  rfng,  and  ectopic  neurogenesis  at  boundaries  is  observed  (shown  by  nestin  
and  deltaD  expression).  This  suggests  that  weaker  rfng  expression  is  not  sufficient  
for   the   inhibition  of  neurogenesis  at   the  boundaries   (Cheng  et  al.,  2004).  Another  
possibility  is  Eph-­ephrin  signalling  acts  in  parallel  to  rfng  to  inhibit  neurogenesis  at  
boundaries.    
  
In  addition  to  the  effect  on  neurogenesis  as  a  result  of  disrupted  boundaries,  there  is  
a   depletion   of   nestin-­expressing   neural   progenitors,   which   is   a   novel   finding.  
Previous  work  has  shown  that  nestin  is  expressed  in  some  radial  glial  progenitor  cells  
and  that  when  radial  glial  cells  are  ablated  nestin-­expressing  neural  progenitor  cells  
are  lost  in  the  neural  tube  (Johnson  et  al.,  2016).  The  observations  made  during  this  
project  have  shown  that  HuC/D  expressing  cells  are  increased  in  the  hindbrain  from  
24   hpf   to   36   hpf   in   embryos  where   Eph-­ephrin   signalling   is   disrupted   (shown   by  
immunofluorescence).  HuC/D  is  expressed  in  neurons  and  excluded  from  radial  glial  
cells  (Trevarrow  et  al.,  1990;;  Terriente  et  al.,  2012),  and  the  change  in  expression  is  
complementary   to   the   loss   of   nestin-­expressing   neural   progenitor   cells.   The  
decrease   in   nestin-­expressing   neural   progenitors   suggests   that   ectopic  
neurogenesis  leads  to  a  lack  of  radial  glial  cells.    




Based  on  previous  work,  it  is  possible  that  the  non-­neurogenic  zones  are  a  source  
of   neural   progenitors   for   the   neurogenic   zones.   Consequently,   the   ectopic  
neurogenesis  observed  in  the  non-­neurogenic  zones  results  in  a  depletion  of  neural  
progenitor  cells  at  later  stages.  This  is  observed  in  other  parts  of  the  nervous  system  
where   FGF   signalling   maintains   progenitor   cells   by   promoting   proliferation   and  
inhibiting  neural  differentiation  (Fu  et  al.,  2017).  Cells  that  are  further  away  from  the  
source  of  FGF  are  able  to  differentiate,  which  is  similar  to  the  hindbrain  where  the  
neurogenic   regions   are   furthest   from   the   segment   centres   where   the   FGF20a-­
expressing  neurons  are  clustered  (Gonzalez-­Quevedo  et  al.,  2010).  The  hindbrain  
boundary  cells   in  chick  have  been  suggested   to  be  a  source  of  neural  progenitor  
cells   (Peretz  et  al.,  2016),  although  unlike   in  zebrafish   the  boundary  cells  are  not  
separate   from   the   neurogenic   populations.   The   boundary   cells   in   the   zebrafish  
hindbrain  could  also  be  a  source  of  progenitor  cells  and  when  Eph-­ephrin  signalling  
is  blocked  these  are  no  longer  maintained,  due  to  ectopic  neurogenesis.  
  
It   would   be   interesting   to   test   further   whether   blocking   Eph-­ephrin   signalling   is  
regulating  neurogenesis  directly  or  indirectly.  One  way  to  do  this  would  be  to  disrupt  
the  boundary  cells  via  another  mechanism  and  study  how  this  alters  the  expression  
of   neurogenic   markers.   This   could   be   done   by   knocking   down   genes   that   are  
expressed  in  the  boundaries,  such  as  rfng.  By  comparing  the  phenotypes  to  those  
observed  in  my  study,  this  would  determine  if  signalling  is  acting  indirectly  as  a  result  
of  boundary  cell  loss.    
  
7.3   Is  soluble  ephrinB1a  blocking  or  activating  signalling?  
It  was   initially  expected   that  carrying  out  RNA-­sequencing  on  hindbrains  with  and  
without  blocking  of  Eph-­ephrin  signalling  would  identify  genes  that  are  boundary  cell  
markers.  However,  no  boundary  cell  markers  were   identified.  rfng  expression  was  
used   to   confirm  whether  Eph-­ephrin   signalling  had  been  blocked   in   the  hindbrain  
when  soluble  ephrinB1a  was  over-­expressed  and  was  found  by  in  situ  hybridisation  
to  no   longer  be  expressed.  However,  RNA-­sequencing  showed   that   there  was  no  
overall   change   in   the   level   of   rfng   expression   in   the   hindbrain.   One   potential  




explanation  for  this  is  that  soluble  ephrinB1a  is  in  fact  weakly  activating,  rather  than  
blocking  Eph  receptor  activation.    
  
It  was  observed  that  when  soluble  ephrinB1a  is  over-­expressed  there  is  a  decrease  
in  the  level  of  EphB4a  protein  in  the  hindbrain,  but  not  for  EphA4a  protein.  This  result  
implies  that  soluble  ephrinB1a  is  activating  some  Eph-­ephrin  signalling  rather  than  
blocking,   as   internalisation   and   degradation   of   Eph   receptor   is   a   hallmark   of  
activation  (Marston  et  al.,  2003;;  Zimmer  et  al.,  2003;;  Mann  et  al.,  2003;;  Lauterbach  
and  Klein,  2006;;  Goh  and  Sorkin,  2013).  However,  this  contradicts  the  observation  
that  rfng  expression  is  absent  when  soluble  ephrinB1a  is  over-­expressed,  implying  
that  signalling  is  blocked.    
  
In  the  majority  of  cases,  soluble  ephrins  block  signalling  as  they  are  not  membrane  
bound,   and   are   unable   to   form   higher   order   clusters   needed   for   signal   activation  
(Davis  et  al.,  1994).  However,  some  studies  have  reported  that  soluble  ephrin  ligands  
are  able  to  activate  signalling.  Firstly,  the  addition  of  soluble  ephrinA1  in  rat  cortical  
neurons  results  in  EphA2  receptor  internalisation  and  induces  the  cellular  response  
of  growth  cone  collapse.  The  same  response  is  found  when  EphA2  is  activated  with  
dimeric  ephrinA1  (Wykosky  et  al.,  2008).  Another  study  showed  that  adding  soluble  
ephrinA1   to   cells   that   over-­express   EphA2   causes   EphA2   internalisation   and  
changes   in   cell  morphology,   which   are   known   responses   of   EphA2   activation   by  
ephrinA1   (Beauchamp   et   al.,   2012).   Previous   work   has   also   shown   that   forward  
signalling   can   be   activated   by   soluble   ephrins   through   cross-­linking   by  
transglutaminase  action,  which   results   in   increased  Eph   receptor   phosphorylation  
and  a  change  in  cell  behaviour  (Alford  et  al.,  2007).  It  has  also  been  suggested  that  
the   formation   of   tetramers   for   signal   activation,   which   is   comprised   of   two   Eph  
receptors  and  two  ephrins,  is  initially  formed  by  one  ephrin  and  two  Eph  receptors  
and  one  ephrin.   In  addition,  soluble  ephrins  could  activate  Eph  receptors  but  at  a  
lower  affinity  than  dimeric  ephrins  (Pabbisetty  et  al.,  2007).    
  
The  examples  discussed  of  soluble  ephrins  activating  signalling  are   less  common  
than   for   blocking   and   have   not   been   shown   for   ephrinB   ligands.   Based   on   this  
evidence   that   soluble   ephrinB1   may   be   a   weak   activator,   I   propose   that   where  
Eph-­ephrin  signalling  is  normally  strongly  activated  at  the  boundaries,  there  is  weak  




activation   of   rfng   expression.   However,   within   the   segments   where   Eph-­ephrin  
signalling   is   not   normally   active   soluble   ephrinB1a   is   able   to   weakly   activate  
signalling  and  low  level  rfng  expression.  Thus,  boundary  cell  marker  expression  is  
decreased   at   the   region   where   the   boundary   cells   normally   arise   and   increased  
within  the  segments,  resulting  in  no  overall  change  in  RNA  levels  (Figure  44).  
  
  
Figure  44  Hypothesis  of  soluble  ephrinB1a  effect  on  Eph  receptor  activity  in  the  
hindbrain  
Schematic  showing  hypothesis  of  the  effect  of  soluble  ephrinB1a  on  Eph-­ephrin  signalling  in  the  
hindbrain.  (A)  Wild  type  Eph-­ephrin  signalling  results  in  the  formation  six  boundaries,  shown  by  
in  situ  hybridisation  for  rfng  (Ai).  Eph-­ephrin  signalling  is  highest  at  the  boundaries  (Aii).  (B)  Over-­
expression  of  soluble  ephrinB1a  results  in  decreased  Eph-­ephrin  activation  and  rfng  expression  
at  boundaries.  However,  weak  activation  now  occurs  throughout  the  segments  which  may  induce  
weak  rfng  expression.  
  
In  order  to  investigate  whether  soluble  ephrinB1a  is  activating  or  blocking  signalling,  
experiments  were  carried  out   to   try   to   identify   if   the  Eph   receptors  present   in   the  
hindbrain   were   phosphorylated   upon   soluble   ephrinB1a   over-­expression.   The  
approach  taken  was  to  pull  down  phosphorylated  proteins  in  whole  embryo  lysates  
after   soluble   ephrinB1a   over-­expression.   Despite   attempts   to   optimise  




immunoprecipitation  and  carrying  out  western  blots,  the  results  are  currently  unclear  
and  leave  open  the  question  as  to  how  this  reagent  is  acting.    
  
7.4   Future   work   to   identify   direct   targets   of   Eph-­ephrin  
signalling  in  the  hindbrain  
To  further  this  study,  it  would  be  interesting  to  identify  the  direct  targets  of  Eph-­ephrin  
signalling.  In  order  to  identify  direct  targets  one  approach  would  be  to  look  earlier  in  
development   before   the   boundary   cells   have   formed   and   thus   eliminates   any  
changes  that  are  downstream  of  boundary  cell  formation.    
  
A   more   direct   approach   would   be   to   find   a   cleaner   way   to   disrupt   Eph-­ephrin  
signalling.  This  may  be  possible  in  the  future  when  more  Eph-­ephrin  binding  pairs  
are  identified  that  account  for  the  boundaries  that  remain  when  EphA4a-­ephrinB3b  
and  EphB4a-­ephrinB2a  signalling  is  blocked.  During  this  project,  a  quadruple  mutant  
was  generated  for  EphA4a-­EphB4a-­ephrinB2a-­ephrinB3b,  but  due  to  the  complexity  
of  crosses  only  one  quadruple  homozygous  mutant   fish  was   identified.   If  more  of  
these  were   to  be  generated   in   the   future,   these  or  other  Eph   receptor  and  ephrin  
mutants  may  generate  embryos  with  complete  hindbrain  boundary  loss.  
  
A  further  approach  is  to  find  pathways  downstream  of  Eph-­ephrin  signalling  that  are  
required  for  boundary  marker  expression.  There  is  evidence  for  a  role  of  the  Jak-­Stat  
signalling   pathway  which   is   known   to   be   activated   by  Eph   receptors   and   ephrins  
(Angela  Cheung,  Wilkinson  Lab).  Another  approach  being  currently  undertaken  is  to  
use  single  cell  RNA-­sequencing  of  hindbrain  cells  (Monica  Tambalo,  Wilkinson  Lab).  
This  will   reveal   the   transcription  of  boundary  cells,  and  genes   that  are  specifically  
expressed  by  boundary  cells  can  then  be  analysed  to  determine  if  they  are  targets  
of  Eph-­ephrin  signalling.  
  
One  approach  to  further  investigate  the  differentially  expressed  genes  identified  by  
RNA-­sequencing   could   be   to   use  Gene  Ontology   (GO)   terms.  This   could   identify  
known  functions  of  validated  genes  and  to  see  what  other  genes  also  known  to  have  
the  same   function.  These  could  be  of   interest   to   investigate   further.   In  addition,   it  




would  be  interesting  to  see  which  differentially  expressed  genes  are  known  to  have  
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